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Stress
Stress, in the broadest sense, is defined as an environmental stimulus that threatens 
homeostasis in an organism. Stress-inducing stimuli, or stressors, can take on many 
forms but be they physical, social, psychological, the aforementioned description 
applies to all of them. The stress response is defined as the efforts the organism 
undertakes in order to restore homeostasis, including neuroendocrine, neuroplasticity 
and behavioral adjustments. Respectively, these help prepare the individual for action 
and increase vigilance, learn and store relevant information about the stressor to 
optimize future encounters with it, and protect the organism, either actively by 
initiating a fight/flight response in order to remove or escape the stressor, or passively 
to minimize harm resulting from the stressor and conserve energy (Chrousos and Gold 
1992). These mechanisms of the stress response provide vital benefits to the organism, 
allowing it to survive and thrive in threatening environments. However, prolonged or 
repeated exposure to stress, or extreme stress, have been shown to turn the stress 
response maladaptive and contribute to the pathogenesis of psychiatric disorders, 
such as major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). 
A substantial degree of inter-individual variation exists in the susceptibility to these 
detrimental effects of stress. This may be caused by differences in endocrine as well 
as behavioral responses to stress due to disparities in genetic and environmental 
circumstances. In this thesis, we will examine how a genetic factor that regulates the 
reuptake of serotonin in the brain interacts with properties of a stressor to affect stress 
coping behavior and the consequences of stress exposure.
The neuroendocrine stress response
Detection of a stressor initiates a cascade of stress hormone release, orchestrated 
primarily by the hypothalamus, the pituitary and the adrenal glands (i.e., the hypotha-
lamic-pituitary-adrenal (HPA) axis). The neuroendocrine stress response is initiated 
when sensory systems in the central nervous system perceive a stimulus or situation 
as threatening. This triggers the release of corticotropin-releasing hormone (CRH) 
from the neurons originating in the paraventricular nucleus of the hypothalamus. CRH 
subsequently activates the anterior pituitary, causing it to secrete adrenocorticotropic 
hormone (ACTH), which then stimulates cortisol (CORT) release from the adrenal gland 
(De Kloet et al. 1998). CORT provides the energy required to cope with the stressor by 
increasing blood sugar levels through gluconeogenesis and accelerating metabolism 
of nutrients and lipid reserves (Ray et al. 1964, Nieuwenhuizen and Rutters 2008). In 
addition, CORT dampens its own release; it is instrumental in the negative feedback 
loop that controls activity of the HPA axis and inhibits further release of CRH and 
ACTH. While CORT is an essential component of the acute adaptive stress response, it 
is also strongly implicated in the detrimental effects of prolonged and excessive stress 
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exposure; abnormalities in basal CORT and responsivity of the HPA axis are implicated 
in both MDD and PTSD (Plotsky et al. 1998, Meewisse et al. 2007). Parallel to the 
actions of the HPA axis, sensory detection of a stressor initiates sympathetic activation 
and induces the synthesis and peripheral release of noradrenalin from the adrenal 
glands, mediating the effects of stress on heart rate and blood pressure (Iversen 
2000), as well as central release from the locus coeruleus, eliciting a state of arousal 
(Aston-Jones and Cohen 2005, Sara and Bouret 2012).
The neuroendocrine stress response affects mnemonic function; acute stress exposure 
is known to enhance the encoding and consolidation of new memory traces while 
impairing memory retrieval (Roozendaal and McGaugh 2011). This effect is thought to 
be mediated by the actions of CORT and noradrenalin on plasticity in the basolateral 
amygdala (BLA). Experimental evidence from rodent studies report that arousal 
through noradrenergic activation of the BLA is a necessary prerequisite for CORT- 
mediated enhancement of memory function (Okuda et al. 2004). Stress-enhanced 
formation and storage of memory may contribute to the pathogenesis of psychiatric 
disorders resulting from a traumatic experience (further discussed in section Stress- 
related disorders of this chapter). 
The behavioral stress response: coping strategies
Stress coping is defined as the actions an individual undertakes to mitigate the effects 
of the stressor it encounters. The manner in which a stressor is coped with strongly 
affects its influence on the individual, and is also thought to determine the stressor’s 
potency for contributing to the pathogenesis of psychiatric disorders (Koolhaas et al. 
1999). Broadly, coping strategies can be divided into active (i.e., problem-focused) 
coping, and passive (i.e., emotion-focused) coping. Active coping strategies aim to 
remove the stressor or escape from it (fight/flight), while passive coping strategies 
(e.g., freeze) aim minimize harm from the stressor and conserve energy, potentially 
until an opportunity arises to fight or escape it (Lazarus 1993a). Adopting a coping 
style that suits the situation best can minimize the harmful effects of a stressor, 
whereas a maladaptive coping style can worsen the situation. Adopting a passive 
coping style in the face of a controllable stressor (i.e., one that can be avoided or 
escaped from) exacerbates its effects through unnecessarily prolonging exposure to 
it, while choosing an active coping style to confront an uncontrollable stressor (which 
cannot be avoided or escaped from) expends energy unnecessarily, thereby reducing 
the individual’s capacity to respond to situational changes. Therefore, it is not the 
general tendency in coping strategy, but rather the flexibility in coping style that 
seems to determine how stress coping defines resilience (Austenfeld and Stanton 
2004). Previous stressor coping experience may determine subsequent coping 
responses - e.g., an individual that has learned to cope passively in a certain situation 
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may have trouble adopting active coping strategies in the future, even if the context 
requires it - thereby decreasing coping flexibility and stress resilience (Homberg 2012, 
Nederhof and Schmidt 2012).
Stress-related disorders
Major depressive disorder
Major depressive disorder (MDD) is a debilitating mood disorder which is characterized 
by low mood, anhedonia, disturbed eating and/or sleeping patterns, reduced energy 
levels and in some cases even suicidal ideation (American Psychiatric and American 
Psychiatric Association 2013). MDD is one of the most prevalent and deleterious 
mental disorders across the world. In the majority of countries 8-12% of the population 
encounters a depressive episode during their lives (Andrade et al. 2003), and the 
global burden of disease caused by depressive disorders is the highest among all 
mental illnesses (Whiteford et al. 2013), with women having a higher risk of both onset 
and recurrence of the disorder (Kessler et al. 1993). Although the precise mechanisms 
behind the pathogenesis of depression remain elusive, much is already known about 
the factors that contribute to its development. The principal risk factors for depression 
can be divided into genetic and environmental categories, while some genetic and 
environmental factors only pose a risk in interaction with each other (Lesch 2004). 
These gene-environment interactions make up a promising new avenue of research 
that could well lead to new insights into the variation in susceptibility to depression 
that exists within the population. Furthermore, this type of research can provide 
opportunities for the development of novel therapeutic interventions. The wide range 
of risk factors contributing to depression and their interacting effects point to a 
heterogeneity in pathogenic mechanisms, which could warrant a more personalized 
approach in its treatment. This is urgent, considering that existing therapies are 
effective in a mere 50% of patients suffering from depression (Rush et al. 2006). 
Despite the ambiguity surrounding risk factors for developing MDD, it has long been 
clear that severe stress, both in early and later life, is an important contributor to MDD 
pathogenesis (Lazarus 1993b, Heim et al. 1997).
MDD is diagnosed according to the criteria stated in the fifth edition of the Diagnostic 
and Statistics Manual of Mental Disorders (DSM-5); these include:
- Subjectively reported or observed depressed mood
- Disinterest in activities and stimuli generally considered pleasurable (anhedonia)
- Significant gain or loss of body weight
- Insomnia or hypersomnia
- Psychomotor agitation or retardation
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- Fatigue, loss of energy
- Diminished self-worth, excessive and/or delusional self-blaming
- Cognitive impairment, indecisiveness
- Recurrent and pervasive thoughts of death, suicidal ideation
Five or more of these criteria must be present throughout a 2-week period, and the 
presence of either depressed mood or anhedonia is a necessary prerequisite for the 
diagnosis. The principal lines of treatment for MDD consist of pharmacological 
treatment, cognitive therapy and electroconvulsive therapy (American Psychiatric 
2013). The most commonly used pharmacological treatment consists of chronic 
administration of selective serotonin reuptake transmitters (SSRIs) (Reid and Barbui 
2010), which elevate the level of serotonin (5-HT) in the brain by preventing its reuptake 
(Sarkissian et al. 1990). 
With regards to the pathophysiology occurring in MDD, our understanding is currently 
limited. The monoamine hypothesis of depression states that its biological basis 
consists of a monoaminergic imbalance in the brain, specifically a deficiency of 
norepinephrine and the neurotransmitter 5-HT (discussed extensively below) 
(Hirschfeld 2000). This hypothesis was formulated on the back of experimental 
findings in users of the antihypertensive reserpine, which has the side effect of causing 
depression-like symptoms (Muller et al. 1955). These were found to be reversible by 
monoamine precursor supplementation, implicating reserpine’s effect on 5-HT levels 
as a mediator of these side effects (Carlsson et al. 1957). This finding led to the 
development of the presently used first line pharmaceutical treatment for depression; 
SSRIs. However, the limited efficacy of monoamine-focused pharmacological treatment 
of MDD has prompted the proposition of alternative and supplemental hypothesis for 
the pathogenesis of the disorder (Trivedi et al. 2006). It has been suggested that 
alterations in neural plasticity lie at the basis of the pathogenesis of depression, and 
that enhancing plasticity may mediate the efficacy of existing and novel therapeutic 
strategies (Pittenger and Duman 2008). Brain-derived neurotrophic factor (BDNF), an 
important signalling molecule in synaptic plasticity, appears to be decreased in 
patients suffering from MDD (Autry and Monteggia 2012), as well as animal models 
exerting a depressive-like phenotype (Duman and Monteggia 2006). In line with this, 
animal models of genetically downregulated BDNF exert depressive-like symptoms 
(Duman et al. 2007), and the beneficial effect of chronic SSRI administration on rats 
coincides with its influence on BDNF signalling (Duman 1998). Further supporting the 
plasticity hypothesis are enhancing effects of BDNF (Lee et al. 2002) and successful 
antidepressant treatment on synaptic plasticity and neurogenesis (Eisch and Petrik 
2012), i.e., the formation of new functional neurons in the dentate gyrus of the 
hippocampus. Reduction of hippocampal neurogenesis is proposed to lie at the basis 
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of the hippocampal atrophy that is observed in long-time sufferers of MDD (Campbell 
et al. 2004); an increase in neurogenesis is seen as a result of antidepressant treatment 
using electroconvulsive shock therapy (Rotheneichner et al. 2014), serotonin 
norepinephrine reuptake inhibitors (SNRIs) (Mostany et al. 2008) and SSRIs (where 
preventing the neurogenic effects disrupted their behavioral antidepressant effects) 
(Santarelli et al. 2003). Pharmacological treatment of depression using SSRIs needs to be 
sustained for several weeks before any benefits can be observed (2000); this proposed 
route of action of SSRIs (i.e.,  through enhanced neurogenesis) could explain this.
An entirely different approach to the treatment of MDD is targeting nutrition, specifically 
lipid intake. Omega-3 polyunsaturated fatty acids (n-3 PUFA’s) are dietary components 
that cannot be synthesized from other nutrients. Docosahexanoic acid (DHA) is crucial 
to healthy neuronal membrane physiology, and deficiencies in its intake affect signal 
transduction, monoamine neural transmission and the formation of the lipid rafts that 
compartmentalize cell membranes, separating integrated receptors, transporters and 
signalling molecules (Chalon 2006, Innis 2007). In addition, DHA stimulates synaptic 
plasticity and neurogenesis (Dagai et al. 2009). Low intake of dietary n-3 PUFA’s is 
associated with increased prevalence of depression (Golding et al. 2009), and dietary 
supplementation has been proposed as both a monotherapy for depression as well as 
a complementary therapy. However, therapeutic efficacy of n-3 PUFA supplementation 
for the treatment of MDD has been limited (Appleton et al. 2015); potentially, the 
mechanisms that mediate its beneficial effects are only relevant in a subset of MDD 
patients. 
Post-traumatic stress disorder
PTSD is a stress-related disorder that can arise after an individual experiences a severe 
traumatic event. It is considered an occupational disease for those working in 
professions that regularly deal with violence and trauma, such as military personnel 
on active duty, law enforcement and emergency responders. Reports of lifetime 
prevalence of PTSD are estimated to be around 3.3% for men and 8.5% for women 
(McLean et al. 2011). PTSD is diagnosed on the basis of the criteria as stated in the 
DSM-5 which include:
-  Exposure to a traumatic event personally or being witness to one, or learning of 
one occurring to a close friend or family member 
-  Experiencing intrusive memories, dreams, flashbacks related to the traumatic 
occurrence, and/or severe psychological / physiological reactions to internal or 
external cues related to the event
- Persistent avoidance of cues related to the event since its occurrence
-  Negative and/or aberrant cognition and emotionality since occurrence of the 
event, including trouble retrieving memories relating to the event, exaggerated 
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negative beliefs about oneself, others or the world, distorted cognitions pertaining 
to cause and consequence traumatic event (e.g. self-blaming), general negative 
emotional state, reduced interest in significant activities, detachment from others 
and/or inability to experience happiness or satisfaction
-  Significant changes in emotional reactivity and arousal since the event, including 
proneness to anger, self-destructive behavior, hypervigilance, increased startle 
response, trouble with mental focus and disturbed pattern of sleep
The symptoms must persist for at least one month, cause significant distress and/or 
deterioration of social/professional functioning to the individual, and must not be 
attributable to intoxication, substance abuse or another medical condition (American 
Psychiatric 2013). First line treatment of the disorder typically consists of cognitive 
behavioral therapy (CBT), eye movement desensitization and reprocessing (EMDR) 
and exposure therapy (Ursano et al. 2004), all of which appear to be equally effective 
(Bisson et al. 2013). Of these, CBT is a therapy aimed at identifying and correcting 
negative cognitive biases pertaining to the patients themselves, their trauma and their 
environment. EMDR, in contrast, is a trauma-focused therapy in which the senses are 
stimulated in multiple sensory dimensions (e.g., using directing visual and auditory 
attention to a discrete stimulus) while the patient focuses on their aversive memories. 
Although EMDR has been determined to be as effective as other first line therapies in 
treating PTSD, its underlying mechanisms remain relatively poorly understood 
(McGuire et al. 2014). Finally, exposure therapy focuses on extinguishing the 
physiological and emotional response to stimuli related to the trauma by repeatedly 
presenting them to the patient in a safe, therapeutic environment. This therapy is 
based on the theory that PTSD is caused by exacerbation and generalization of 
aversive associations between the trauma and stimuli present during the individual’s 
encounter with it; i.e., maladaptive persistence of a Pavlovian fear-conditioned 
association (further discussed in section Fear, anxiety disorders and 5-HTTLPR, Box 2) 
(Shin and Liberzon 2010). The primary first line pharmacological treatment of PTSD 
consists of SSRI administration (Cuijpers et al. 2013); while novel insights into the 
mechanistic underpinnings of PTSD have suggested a multitude of potential new 
avenues for pharmacological treatment of PTSD, most of these are still under 
investigation and not yet being put into clinical practice (Murrough et al. 2015, 
Mithoefer et al. 2016). For instance, a novel therapy consisting of trauma recollection 
followed by propranolol administration aims to destabilize and prevent reconsolida-
tion of trauma memory, and has proven somewhat successful (Kindt and van Emmerik 
2016). Furthermore, administration of CORT shortly after a traumatic experience has 
been shown to reduce the risk of developing PTSD (Schelling et al. 2006), whereas 
chronic low-dose CORT treatment seems to reduce intrusive symptoms in patients 
(Aerni et al. 2004).
 General introduction | 17
1
Findings from neuroimaging studies suggest that PTSD is characterized by a number 
of anatomical and physiological aberrations. These findings help to give credence to 
the fear conditioning hypothesis of PTSD, as many of these are located in brain regions 
and circuits that are involved in the regulation of Pavlovian fear associations; mainly 
the amygdala, the hippocampus and the prefrontal cortex (PFC) are implicated (Rauch 
et al. 2006). The amygdala, involved in emotional processing and vigilance (Davis 
1992), has been reported to be hyperactive in patients suffering from PTSD, both at 
rest (Chung et al. 2006), when exposed to aversive stimuli (Linnman et al. 2011), and 
during the acquisition of conditioned fear (Bremner et al. 2005). The hippocampus, 
which is generally understood to mediate the encoding and retrieval of episodic 
memory, serves to link the trauma to contextual cues in PTSD. Reduced activation of 
the hippocampus has been observed in PTSD patients during failed fear extinction 
recall (Milad et al. 2009). Moreover, reactivity of the ventromedial PFC (vmPFC), 
exerting inhibitory control over the amygdala (Quirk et al. 2000), to fearful faces and 
trauma-related stimuli is decreased in PTSD subjects (Shin et al. 1999, Phan et al. 
2006, Felmingham et al. 2010). Structural analysis show that both amygdala and 
hippocampus volume are decreased in PTSD patients, compared to healthy controls 
(Ahmed-Leitao et al. 2016). In addition, grey matter reductions were found in the mPFC 
of PTSD patients (Li et al. 2014). 
While PTSD is widely understood to be caused by severe trauma experience, not all 
individuals who experience a severe traumatic incident develop the disorder. 
Environmental and genetic factors greatly influence the risk for PTSD. Early life 
adversity, such as childhood abuse or neglect, has been designated to be an important 
risk factor for PTSD (Bremner et al. 1993). Similarly, severe stressful experiences during 
adult life, prior to the traumatic experience from which PTSD originates, enhance risk 
for PTSD as well as the severity of its symptoms (Breslau et al. 2008). Numerous 
genetic risk factors have also been identified for PTSD (see Smoller et al. for review 
(Smoller 2016)); in the interest of brevity, only the genetic variations in the 5-HTT linked 
polymorphic region (5-HTTLPR) will be discussed here.
Serotonin
Serotonin in MDD
Serotonin is a monoaminergic neurotransmitter that is synthesized from the amino 
acid L-tryptophan by the enzyme tryptophan hydroxylase (TPH) (Wang et al. 2002). 
Outside the central nervous system, serotonin serves regulatory functions in the gas-
trointestinal and cardiovascular system (Kaumann and Levy 2006, Tecott 2007). In the 
brain, it is an important modulator of neuronal signaling, and is involved in a plethora 
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of central nervous system functions such as cognition, sleep and emotionality. The 
role of 5-HT as a regulator of emotionality came to prominence when it was discovered 
that the efficacy of early antidepressants were mainly attributable to their effect on the 
brain metabolism of serotonin (Lapin and Oxenkrug 1969). Through the newly 
emergent practice of disease mechanism-driven drug design, the new antidepressant 
zimelidine was developed, which selectively reduced the reuptake of serotonin with 
the aim of enhancing circulating serotonin levels in the brain (Siwers et al. 1977). This 
entirely new class of antidepressant drugs, the SSRIs, has become a staple in the 
treatment of MDD, with fluoxetine as its most prominent example (Fuller et al. 1974). 
SSRI’s route of action is to reduce function of the serotonin transporter (5-HTT) by 
binding to it, thereby reducing the reuptake of 5-HT into synaptic boutons after neuro-
transmission (Marcusson and Ross 1990).
5-HTTLPR, stress and MDD
The establishment of serotonergic mechanisms in the pathogenesis and treatment of 
MDD has engendered interest for the influence of genetic variations in the serotonergic 
systems on the predisposition for mood disorders. It was found that a variable repeat 
sequence in the promotor of the gene that encodes the human 5-HTT, the 5-HTT linked 
polymorphic region (5-HTTLPR), determines its expression and function; the short (s) 
allele of 5-HTTLPR results in reduced transcription and function compared to the long 
(l) allele (Greenberg et al. 1999). As 5-HTT is the only transporter capable of transporting 
5-HT from the extracellular space back to the intracellular compartment, 5-HTT 
expression and function are expected to affect serotonergic signaling and thus 
emotionality (Smith et al. 2004). In line with this, carriers of low-functioning alleles of 
5-HTTLPR were found to display increased anxiety- and neuroticism-related traits 
(Lesch et al. 1996), but more pressingly, were also overrepresented in samples of 
patients suffering from MDD (Collier et al. 1996). The effect of 5-HTTLPR allelic variation 
on the risk for developing mood disorders appeared to be heavily modulated by 
traumatic experiences, especially early life stress; the risk of low-functioning variants 
of 5-HTTLPR for developing MDD is potentiated by early life adversity (Taylor et al. 
2006). This association has made 5-HTTLPR the prime example of a genetic factor that 
produces different outcomes depending on environmental factors, i.e., a gene x 
environment interaction. In particular, 5-HTTLPR is often used to illustrate vulnerability 
factors in the diathesis stress model. This model states that the likelihood to develop 
mood disorders as a result of stress is dependent on the presence of vulnerability and 
resilience factors; certain “diathesis” traits that may be genetic or other environmental 
factors that predispose for or protect against psychiatric illness. While converging 
evidence has indeed confirmed that low-functioning allelic variations of 5-HTTLPR 
interact with life adversity to increase vulnerability to mood disorders (Karg et al. 
2011), it was also proposed that the s-allele in fact enhances receptivity to positive 
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environmental factors as well (Belsky and Pluess 2009). In this ‘differential 
susceptibility’ model, low expressing variants of 5-HTTLPR reflect ‘plasticity’ rather 
than ‘susceptibility’, and actually increase an individual’s receptivity to positive 
environmental elements. Therefore, while adversity may produce poorer outcomes in 
these individuals compared to l-allele carriers, s-allele carriers may reap additional 
benefits from environmental enrichment and social support.
The s-allele as an environment-dependent vulnerability factor is exemplified by its 
effects on the neuroendocrine stress response. A meta-analysis has shown that the 
cortisol response to acute stressors is exaggerated in s-allele carriers, which was most 
pronounced in individuals with a history of severe life adversity (Miller et al. 2013). This 
link was proposed to be mediated by increased functional connectivity between the 
amygdala and hypothalamus (Alexander et al. 2012). However, as discussed previously, 
detrimental effects of a stressor on an individual are not only dependent on HPA axis 
homeostasis and reactivity, but also on the appropriateness and efficacy of the 
behavioral stress coping response to that stressor. Accumulating evidence suggests 
that differential preferences and tendencies in coping strategy may be a mechanism 
by which 5-HTTLPR modulates stress susceptibility. For example, trait worry, a form 
of anxiety predisposing one to - among other psychiatric illnesses - PTSD, is more 
prevalent in s-allele carriers (Bredemeier et al. 2014). In addition, S-allele carriers 
newly diagnosed with breast cancer exerted greater anxious preoccupation compared 
to their l-allele peers (Schillani et al. 2012). These genetic differences in stress (coping) 
responses seem to hinder responsivity to first-line behavioral cognitive therapies for 
both MDD and PTSD (Bryant et al. 2010). Drinking-to-cope, or alcohol consumption as 
a coping mechanism was reported less frequently as a motivation for consuming 
alcohol by carriers of low functioning allelic variants of 5-HTTLPR (Armeli et al. 2008). 
This is somewhat surprising, as these allelic variants are also associated with increased 
alcohol abuse (Thompson and Kenna 2016). In addition, 5-HTTLPR genotype affected 
the degree to which children internalized and externalized problems (Cline et al. 2015). 
In addition to its status as a risk factor for developing depression, the s-allelic variant 
of the 5-HTTLPR has also been shown to exacerbate the effects of severe combat-related 
trauma on the development of PTSD symptoms (Telch et al. 2015). However, other 
studies have found the s-allele to confer increased risk for PTSD only in the presence 
of pre-existing trauma experience (Xie et al. 2012, Gressier et al. 2013). In addition, 
preliminary data shows that first line therapeutic interventions to treat PTSD are 
ineffective in 5-HTTLPR s-allele carriers (Bryant et al. 2010), making the development 
of therapies specifically suiting the needs of this group of patients urgent.
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Stress coping in animal models of 5-HTTLPR
Evidently, coping strategies in humans are complex behaviors; the fact that their 
underlying mechanisms are as yet poorly described, makes it difficult to speculate how 
5-HTTLPR intercedes with them. By comparison, investigating stress coping behavior 
in animals is relatively straightforward; stressors can be more easily standardized in 
an experimental environment, the coping behavior of the subjects can be observed 
directly, and invasive methods of determining neural correlates are available. Work in 
animal models for genetically induced reduction of 5-HTT expression (either by 
complete knock-out (KO) of the gene or its partial knock-down (KD)) has replicated its 
earlier-mentioned interacting effect with (early) life stress in mediating vulnerability to 
stress-related mental disorders in humans (to some degree). A body of research has 
shown that 5-HTT heterozygous (5-HTT+/-) mice are more susceptible to the anxiogenic 
effects of early life stress than their wild type counterparts (Carola and Gross 2012). 
Reduction of 5-HTT expression enhanced the effect of unpredictable chronic mild 
stress exposure during adulthood, increasing feeding delay in a novelty-suppressed 
feeding assay and decreasing open arm time in the elevated plus maze test (Joeyen-
Waldorf et al. 2009). Similar results were observed after social stress in a resident 
intruder paradigm during adulthood, suggesting 5-HTT reduction potentiates vulnerability 
to stressors in the social as well as the physical dimension (Jansen et al. 2010). 
Moreover, social stress experience resulted in a greater increase in social avoidance in 
5-HTT+/- mice compared to wild types. However, in a remarkable example of early life 
and later life stress interaction with 5-HTT genotype, early life adversity bred resilience 
to later life inescapable shock-induced behavioral helplessness in 5-HTT+/-, but not in 
wild type or 5-HTT-/- rats. Interestingly, under both naïve and early life stress conditions, 
5-HTT-/- animals were more resilient to inescapable-shock induced escape deficits 
than wild type rats (van der Doelen et al. 2013). As yet, many aspects of the mechanisms 
by which variation in 5-HTT expression regulate stress sensitivity remains to be 
elucidated. Contrasting the exclusivity of its behavioral effects to 5-HTT+/- animals, 
maternal separation affected basal CORT levels in all genotypes except 5-HTT+/-; it 
lowered basal CORT in 5-HTT-/- rats and increased it in wild type animals (van der 
Doelen et al. 2014b). This implies that the altered stress coping and sequelae seen in 
these animals may be orchestrated by factors outside of the HPA axis.
Stressor controllability
Stressor controllability is a factor that profoundly affects the harmful persistent effects 
of stress exposure on an individual. An uncontrollable stressor (USt) is defined as a 
stressor that the individual cannot influence through its own behavior; the nature, 
severity, duration and frequency of the stressor are wholly determined by external 
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factors (i.e., beyond control). USt experience affects subsequent stressor coping 
behavior in a way that is generally considered maladaptive; an encounter with a severe 
USt is known to promote a persistent, more passive overall coping style, which can 
prevent an individual from coping with a stressor actively when the situation permits; 
a phenomenon known as learned helplessness (Overmier and Seligman 1967). The 
most prominent preclinical assay for investigating this phenomenon is the classical 
learned helplessness shock-escape test. Typically, such an assay begins with a 
prolonged inescapable foot shock experience, followed by behavioral challenge in the 
same environment in which the previously inescapable foot shocks can be escaped by 
shuttling across the cage (Box 1). While nearly all animals without prior stressor 
experience are able to acquire an (active) escape response, a prior USt experience 
instills escape learning deficits in a subset of animals (Seligman and Maier 1967).
While an escape learning deficit is the best known sequela of inescapable stress 
experience, it is part of a series of behavioral adaptations, which will from here on out 
be referred to as the “helpless” phenotype. These adaptations are persistent and 
trans–situational as they are be observed during behavioral assays that have little or 
no resemblance to the setting in which the stressor experience was obtained, unlike 
the sequelae of conditioned fear (Bouton and King 1983, Overmier 1996). The helpless 
behavioral phenotype includes increased acquisition of conditioned fear (Grahn et al. 
2000), impaired fear extinction learning (Baratta et al. 2007) and decreased social 
interaction (Short and Maier 1993); features that are induced by uncontrollable, but 
not controllable stressor experience. Investigating the effect that stressor controllabil-
ity has on its sequelae requires a behavioral assay in which control over the stressor 
is the only factor distinguishing the experimental group from the control group. For 
this purpose, the yoked triadic wheel turning assay was developed (Box 1), but different 
behavioral assays have also been used to study controllability; signaled two-way 
active avoidance vs. cued fear conditioning to pair a conditioned stimulus (CS) to an 
escapable or inescapable stressor (Box 1), respectively (Lee et al. 2008), and 
controllable and uncontrollable variants of the forced swim test (Brown et al. 2001). In 
another proposed method of providing control, restrained animals in the controllable 
stress group undergo shocks while having access to a piece of bark to chew on, 
providing them with an additional means of stress coping behavior, whereas animals 
in the uncontrollable stress group do not. This is an interesting take on controllability; 
while the animals in the controllable stress group have no control over actual exposure 
to the stressor (i.e. the restraint and the foot shocks), in the ability to chew they receive 
a means of exerting coping behavior, and indeed an effect of controllability is 
demonstrated (Helmreich et al. 2012). This raises the question of how to define con-
trollability, and to which degree findings in one paradigm can be generalized across 
others.
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Box 1  Triadic stress controllability assays
Various assays are used to determine the effect of stressor controllability in 
rodents. In all these assays, the controllable stress (CSt) and uncontrollable stress 
(USt) animal are exposed to stressors that are similar in dimension, predictability, 
intensity, and duration. However, the CSt animal can influence the stressor through its 
behavior, while the USt animal, although given the same behavioral options in the 
experimental environment, cannot influence the stressor. Animals in the unstressed 
control group are placed in the same experimental environment as their CSt and 
USt counterparts for the duration of the session, but are not exposed to the stressor. 
Occasionally, animals that remain in their home cage during stress testing are used 
as an additional control group, to account for any stress the “unstressed” control 
animals might endure (such as novelty exposure, or restraint in the case of wheel 
turning experiments).
A. Signaled operant active avoidance. In this paradigm, the CSt animal learns to 
escape and eventually avoid footshocks by shuttling over to the other side of the 
skinner box and nosepoking in response to the shock-predicting signal, which 
consists of a tone and/or light. Correct responding aborts or prevents foot shocks. 
Shock deactivation
A. Controllable stress
B.
C.
Uncontrollable stress Unstressed control
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Mechanisms mediating uncontrollable and controllable stress
The dorsal raphe nucleus (DRN), where 5-HT is synthesized and from where all 
serotonergic innervation originates, is a key brain region in orchestrating the effects 
of USt. In the absence of a severe stressor, DRN activity is suppressed through 
glutamatergic innervation originating from the vmPFC (Celada et al. 2001). However, 
USt causes activation of 5-HT immunoreactive neurons in the DRN (Berner et al. 1999) 
and elicits a large, immediate efflux of 5-HT from the DRN (Maswood et al. 1998), 
extending to the mPFC (Bland et al. 2003), BLA (Amat et al. 1998a), the ventral 
hippocampus and dorsal periaqueductal gray (Amat et al. 1998b). 5-HTergic projections 
originating from the DRN inhibit mPFC activity (Hajos et al. 2003) and promote 
reactivity of the amygdala (Baratta et al. 2016). 
The outflow of 5-HT is thought to contribute to the desensitization of the serotonin 
receptor 1A (5-HT1A) following USt (Rozeske et al. 2011). The presynaptic 5-HT1A 
receptor plays a central role in the negative feedback system that regulates 5-HT levels 
in the brain; presynaptic 5-HT1A binding to 5-HT reduces 5-HT release (Bonvento et al. 
1992) and inhibits 5-HTergic neuron firing (Sprouse and Aghajanian 1987). Considering 
The USt animal receives all shocks and signals that the CSt animal receives, but 
cannot influence the shocks by nose poking. The unstressed animal receives only 
the signals.
B. Signaled shuttle avoidance. Here, CSt animals learn to escape and eventually 
avoid footshocks by shuttling across to the other side of the skinner box twice 
in response to the shock-predicting signal which consists of a tone and/or light. 
A guillotine door separates the compartments between trials. Correct responding 
aborts or prevents foot shocks. Again, the USt animal receives all shocks and 
signals that the CSt animal receives, but cannot influence the shocks by shuttling. 
The unstressed animal receives only the signals.
C. Wheel turning stress escape. CSt animals receive unpredictable shocks which 
can be aborted by turning the wheel. The shocks are administered via a restraining 
electrode on the tail. Successfully aborting the shocks increases the amount of 
wheel turning required to abort the next trial. In this type of assay, the shocks are 
not signaled, nor can they be prevented by wheel turning. The USt animal receives 
all the shocks that the CSt animal receives and has access to a similar wheel, but 
turning it has no effect on shock exposure. The unstressed animal is restrained 
using the tail electrode for the duration of the session and does not receive shocks.
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the instrumental role of 5-HT in the mechanisms orchestrating the effects of control-
lability in stress, it is highly likely that they are modulated by genetic factors that 
influence 5-HT homeostasis, such as 5-HTTLPR.
Fear, stress-related disorders and 5-HTTLPR
Mechanisms of conditioned fear and extinction
The mechanisms that mediate the acquisition and extinction of classical Pavlovian 
fear conditioning are thought to be instrumental to the pathogenesis and treatment of 
PTSD, respectively (Rosen and Schulkin 1998) (Box 2). In the acquisition of a classical 
Pavlovian fear response, an unconditioned stimulus (US), i.e., severe negative event or 
trauma, is associated with a neutral stimulus (e.g., sight, sound, or environment), 
which becomes the conditioned stimulus (CS). Like Pavlov’s bell would cause a dog to 
salivate as it would to the presence of food, reencountering the CS will elicit a fear 
response as if the unconditioned stimulus itself were present. In PTSD, an association 
is formed between a trauma and environmental cues present at the time of the 
experience. This associative learning is mediated by the BLA, and is dependent on 
modulation of long-term potentiation through a Hebbian learning process (Johansen 
et al. 2011). The BLA receives inputs from brain regions that process and integrate 
sensory information, such as the hippocampus and the neocortex (McDonald 1998). In 
addition, it receives input directly from the auditory thalamus and auditory association 
cortex (Romanski et al. 1993). The former pathway provides more detailed sensory 
information that has been weighted for relevance and salience, while the latter 
pathway provides a more reflexive means for sensory information to access the fear 
system. Arrival of sensory information corresponding with a known threat subsequently 
activates projections from the BLA to the central nucleus of the amygdala (CeA). 
Activation of the CeA triggers the behavioral fear response, consisting of fear 
potentiated startle, freezing and changes in autonomic nervous system parameters, 
such as heart rate, blood pressure and body temperature via its projections to the 
hypothalamus, bed nucleus of the stria terminalis and brainstem (LeDoux et al. 1988, 
Fanselow 1994, Critchley et al. 2002).
Apart from the amygdala, cortical regions play an important role in the regulation and 
expression of fear. The prefrontal cortex can functionally be divided in the vmPFC and 
a dorsolateral area (dlPFC). Its analogs in rodents are the infralimbic (IL) and prelimbic 
(PrL) cortices, respectively. These regions serve opposite functions in the regulation of 
fear. Upon encountering a CS, glutamatergic projections from the PrL drive activation 
of the CeA, thereby promoting a fear response. If the CS has been (partially or 
completely) extinguished through non-reinforced encounters, the IL will be activated 
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when the CS is presented, stimulating the intercalated cell (ITC) region of the amygdala 
through excitatory innervation (Sotres-Bayon et al. 2006). The intercalated cells, in 
turn, inhibit activation of the CeA, decreasing the fear response. Successful extinction 
is dependent on plasticity occurring in the IL during non-reinforced CS presentation, 
and can be prevented by inhibiting protein synthesis after non-reinforced CS 
presentation (Santini et al. 2004). It should be noted that extinction of a conditioned 
fear response does not equal erasure of its memory trace; instead, the extinction and 
fear memory exist independently from one another and can be manipulated individually 
(Quirk 2002). Moreover, the IL controls fear by exerting inhibitory control over the PrL 
through a local GABAergic circuit (Saffari et al. 2016).
Perhaps relevant to the predisposing effect of life adversity for PTSD (Cabrera et al. 
2007), chronic stress is known to have profound effects on the anatomy and function 
of the hippocampus, PFC and amygdala. Reduction of hippocampal volume is a 
hallmark pathology of stress-related disorders, has been reported in those suffering 
from MDD and PTSD (Bremner et al. 1995, Sheline et al. 2002), and may be related to 
altered neuronal turnover and neuroplasticity in that brain region (Lucassen et al. 
2006, Malykhin and Coupland 2015). Similar volume loss accompanied by neuroplastic 
changes is observed in the PFC (Cerqueira et al. 2005), while chronic stress causes 
hypertrophy and increased dendritic arborization in the amygdala (Vyas et al. 2002).
The role of serotonin in fear mechanisms
While exposure to severe trauma is known to be the main causating factor in the 
development of PTSD, not all individuals that are confronted with it develop the 
disorder. Genetic factors are known to contribute to inter-individual variations in 
resilience to the effects of trauma. The 5-HTTLPR s-allele is known to potentiate the 
effect of severe trauma on the development of PTSD (Telch et al. 2015). In addition, 
preliminary evidence has shown that the s-allele diminishes the efficacy of cognitive 
behavior therapy, a first line treatment for PTSD (Bryant et al. 2010) (although 
conflicting reports exists, see Andersson et al. (Andersson et al. 2013)). The amygdala 
has been shown to be hyper-reactive in s-allele carriers (Munafo et al. 2008), while 
top-down control of cortical areas over it is reduced, as evidenced by the finding of 
reduced functional coupling between frontocortical regions and the amygdala 
(Pezawas et al. 2005). This has been proposed as a mechanism mediating the 
increased vulnerability in s-allele carriers to stress-related disorders, as these 
alterations suggest that impaired extinction of conditioned fear underlie the 
vulnerability to trauma seen in s-allele carriers. Acquisition of fear in cued fear 
conditioning has been reported to be stronger in carriers of the s-allele (Garpenstrand 
et al. 2001, Lonsdorf et al. 2009, Wendt et al. 2015), and to be potentiated by stressful 
life events (Hermann et al. 2012). Moreover, the s-allele was shown to potentiate the 
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Box 2  Acquisition and extinction of Pavlovian fear conditioning
Pavlovian fear acquisition and extinction processes are thought to be important in 
the pathogenesis and treatment of PTSD. These processes are studied in rodents 
by means of fear conditioning paradigms, as depicted below. In the paradigm 
discussed here and used throughout this thesis, a discrete, unfamiliar neutral 
signal (in this case, an auditory stimulus), the conditioned stimulus (CS), is paired 
to an aversive stimulus (in this case, a mild foot shock). This creates an aversive 
association with the CS, causing it to elicit a behavioral fear response upon 
subsequent re-exposure. This behavioral response to the CS subsides upon 
repeated non-reinforced presentations of the CS; this is called extinction of the 
conditioned fear response. Note that the context in which the US is encountered 
also elicits a fear response upon re-encountering it. To separate contextual 
associations from the CS contingency, evaluation of the response to the CS after 
conditioning in done in a novel, unfamiliar context. Variations in 5-HTT expression
are known to cause alteration in the regulation of fear. In 5-HTT-/- rats, this manifests 
as impaired recall of fear extinction.
A. Fear conditioning
B.
C.
Fear extinction learning Fear extinction recall
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reconsolidation of conditioned fear (Agren et al. 2012). However, no effects on the 
efficacy of extinction were found (Garpenstrand et al. 2001), although several studies 
have shown that the neural correlates of extinction, as determined through functional 
magnetic resonance imaging, are affected by the s-allele in interaction with stressful 
life events (Hermann et al. 2012, Klucken et al. 2013a, Klucken et al. 2015). In addition, 
increased severity of the fear response could be an important factor exacerbating 
the effects of trauma in 5-HTTLPR s-allele carriers (Garpenstrand et al. 2001, Klumpers 
et al. 2012).
Work in animal models has solidified the relation between variations in the expression 
of 5-HTT and abnormalities in the regulation of fear. 5-HTT-/- rats and mice have been 
repeatedly demonstrated to display impaired recall of conditioned fear extinction 
(Wellman et al. 2007, Nonkes et al. 2012a, Shan et al. 2014). Several studies report that 
extinction learning is however not impaired as a result of 5-HTT abolishment (Wellman 
et al. 2007, Nonkes et al. 2012a). Moreover, when an appetitive conditioned distractor 
stimulus was presented interspersed with shock-paired CS presentations throughout 
the extinction session, recall of extinction was markedly improved in 5-HTT-/- rats 
compared to those that had received neutral distractors, while distractor type had no 
effect in wild type animals (Nonkes et al. 2012a). This lends credence to the notion that 
A. Schematic outline of a cued fear conditioning experiment. CS and US are paired by 
(usually multiple) presentations of the CS (tone) ending with a US (mild foot shock) 
in a familiarized environment. Subsequently, non-reinforced presentations of the 
CS are given in a novel context.
B. The behavioral freezing response across conditioning and extinction. To determine 
in response to the CS, defined as the absence of all motion except for that needed 
for respiration. Freezing increases quickly during conditioning and then decreases 
gradually through nonreinforced presentations of the CS.
C. Simplified model of the prefrontal and amygdala circuitry involved in fear 
conditioning and extinction. Acquisition and extinction of conditioned fear responses 
are dependent on interactions between the prelimbic (PrL) and infralimbic cortices 
and the basolateral and central nuclei of the amygdala. Acquisition is dependent 
on plasticity in the amygdala, while plasticity in the IL cortex mediates extinction. 
During extinction, the original fear memory is not degraded; instead, behavior 
during nonreinforced CS exposure is determined by competing responses from the 
IL and the Prl/BLA.
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reduced 5-HTT expression in fact enhances sensitivity to all external stimuli, both 
negatively and positively valenced (Homberg and Lesch 2011). This is further 
substantiated by the finding of increased reactivity of the BLA to appetitive conditioning 
in s-allele carriers (Klucken et al. 2013b).
The mechanisms at a molecular/cellular level underlying altered regulation of fear 
resulting from variations in 5-HTT expression are still poorly understood. Serotonin is 
involved in the mechanisms of conditioning, expression and extinction of fear in a 
multitude of ways, offering many possible routes of action by which altered serotonergic 
homeostasis resulting from variations in 5-HTT expression can interfere with fear 
regulation. Activation of serotonergic neurons in the DRN is seen in response to 
aversive physical stimuli, but also after expression of conditioned fear (Spannuth et al. 
2011). 5-HT release is also gradually enhanced in the DRN and BLA in response to fear 
memory retrieval, peaking around 30 minutes after CS exposure (Zanoveli et al. 2009). 
Consequentially, acute administration of the SSRI citalopram, which elevates the 
serotonin level in the amygdala (Bosker et al. 2001), enhances the fear-potentiated 
startle response (Browning et al. 2007), while chronic administration does not (Grillon 
et al. 2009), and has even been reported to reduce the behavioral fear response to 
conditioned stimulus presentation in rats (Burghardt et al. 2004). This effect of chronic 
administration was found to be mediated through N-methyl-D-aspartic acid (NMDA) 
receptor unit 2B (NR2B) downregulation (Burghardt et al. 2013); fear learning  and 
extinction both depend on activation of NMDA receptors in BLA, and specifically 
blocking subunit 2B has been demonstrated to impair these types of learning 
(Rodrigues et al. 2001). Furthermore, freezing in response to a fear CS is diminished 
when serotonergic inputs into the BLA are selectively lesioned by local intracerebral 
injection of 5,7 –dihydroxytryptamine (Izumi et al. 2012).
Serotonin in neural development
Influences of variations in 5-HTT expression on neural development may offer 
supplemental or even alternative explanations for their effect on fear regulation. 
Regional expression of 5-HTT varies greatly throughout development, but is much 
more prominent during than after gestation, when expression is mostly restricted to 
the DRN and to axon terminals of projection neurons originating from it (Zhou et al. 
2000). Selective, transient blockage of 5-HT reuptake  during development produces 
an anxious and emotional phenotype that has many similarities to that seen in animals 
characterized by genetically induced (i.e., chronic) reduction of 5-HTT expression 
(Ansorge et al. 2004, Glover and Clinton 2016). The effects of prenatal reduction of 
5-HTT function on brain anatomy are most prominent in the somatosensory cortex; 
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5-HTT-/- rodents show reduced anatomical definition of somatosensory “barrel fields”, 
neuronal columns that serve an important function in the processing of tactile 
information, and as a result show impaired performance in gap crossing assays 
(Persico et al. 2001). Similar, but less pronounced effects were reported in rodents 
after neonatal SSRI exposure (Lee 2009). In addition, it is probable that altered 
development contributes to the structural abnormalities seen in corticolimbic 
connectivity as well. 5-HTTLPR genotype affects the structural integrity of the 
uncinated fasciculus, an important white matter tract connecting the PFC to the 
amygdala, thought to be instrumental in suppression conditioned fear responses 
(Pacheco et al. 2009). This might cause impaired functional connectivity between PFC 
and amygdala in s-allele carriers as well (Heinz et al. 2005). Examining the neuronal 
morphology in relevant brain regions of 5-HTT-/- mice uncovered aberrant neuronal 
morphology in the IL, but not the BLA, indicating that 5-HT availability affects 
morphology on the neuronal level as well (Wellman et al., 2007). These findings imply 
that besides the effects of acutely altered serotonin signaling in response to stress, 
developmental effects of altered serotonergic signaling contribute to this phenotype 
in 5-HTT knockout models as well, although it is not clear to what extent. 
Aim and outline of this thesis
Genetically-induced variation of 5-HTT has been demonstrated to modulate the risk for 
developing psychiatric disorders such as MDD and PTSD. This association seems to be 
mediated by altered susceptibility to stress. What is perceived as 5-HTTLPR-deter-
mined stress resilience in population-wide studies may in reality be reflective of 5-HTT 
expression dependent differences in stress coping tendencies and adaptability, and 
variation in the acquisition, extinction and expression of conditioned fear responses, 
which may develop during severely stressful experiences and lead to psychiatric 
disorders, such as PTSD. Although there is initial evidence suggesting that 5-HTTLPR 
affects stress coping, it is not known precisely to what degree the relation between 
5-HTT expression and stress susceptibility is dependent on the nature of the stressor 
and appropriateness of the coping response. Moreover, the effect of 5-HTT expression 
on the ability to flexibly adapt the coping style to situational demands has not been 
explored. In addition, experimental data from animal models strongly implicate 
serotonergic mechanisms in the modulating effects of a stressor’s controllability on its 
impact; this suggests that factors affecting 5-HT homeostasis, such as 5-HTTLPR, 
could alter the effects of control over the stressor. Furthermore, the question remains 
to what degree developmental abnormalities contribute to impaired stress resilience 
in carriers of low-expressing variants of 5-HTTLPR and corresponding animal models. 
Finally, it remains to be investigated whether nutritional interventions targeting the 
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intake of essential fatty acids have an impact on the emotional and depressive-like 
behavioral profile of rodents lacking 5-HTT. 
In chapter 2, we investigate how full and partial abolishment of 5-HTT affects the 
extinction and extinction recall of conditioned fear across development by subjecting 
5-HTT-/-, 5-HTT+/- and wild type rats to a fear conditioning and extinction paradigm. 
Subsequently, we assess glutamate decarboxylase (GAD) 65 and 67 positive cell 
populations in the infralimbic cortex and the amygdala, to determine how the 
development of fear extinction relates to variations in inhibitory cell populations in 
these brain regions. In chapter 3 we examine whether severe uncontrollable stress 
affects fear expression in a 5-HTT expression dependent manner by exposing 5-HTT-/- 
and wild type rats to a restrained tail shock paradigm and then assessing fear 
extinction and extinction recall. In chapter 4, we explore whether the neural 
underpinnings of the effects of controllable and uncontrollable stress are 5-HTT 
expression dependent by subjecting 5-HTT-/- and wild type animals to a triadic yoked 
active avoidance paradigm, wherein animals undergo either signaled active avoidance 
learning, receive the same quantity of signaled shocks in an inescapable setting, or 
receive only signals. Subsequently, we measure activation in the prelimbic and 
infralimbic cortices by determining c-Fos immunoreactivity, and serotonergic activation 
in the DRN by assessing co-expression of 5-HT and c-Fos immunoreactivity in that 
region. In chapter 5 we investigate 5-HTT dependent stress coping flexibility. In order 
to learn whether and how the prior acquisition of a passive coping response to a 
stressor affects subsequent learning of an active coping response to it, we subject 
5-HTT-/- and wild type animals to a fear or sham conditioning paradigm, and then a 
signaled active avoidance paradigm using the fear conditioned stimulus to predict 
oncoming shocks. Following these procedures, we assess the behavioral coping 
response to this stimulus in a novel, neutral environment. Finally, in chapter 6, we 
investigate whether the emotional and depressive-like behavioral pattern of 5-HTT-/- 
rats is affected by dietary supplementation with n-3 PUFA’s by performing various 
emotionality-related behavioral assays on 5-HTT-/- and wild type animals after 
prolonged intake of either a diet rich in DHA and eicosapentanoic acid (EPA) or a 
control diet.
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Abstract
Adolescence is a developmental phase characterized by emotional turmoil and 
increased risk-seeking behavior. Evidence from neurodevelopmental studies suggests 
that during adolescence the amygdala, an important brain region for driving anxiety 
and fear-driven behavior, develops more quickly than the medial prefrontal cortex 
(mPFC), the brain area controlling the amygdala’s activity. Altered function of the mPFC 
– amygdala circuit is thought to be important factor in the pathogenesis of many 
anxiety disorders. Several aspects of the adolescent behavioral phenotype are shared 
with carriers of the 5-HTTLPR short allele, which confers reduced expression of the 
serotonin transporter (5-HTT) in the brain, which clears serotonin from the extracellular 
space. Prefrontal control over the amygdala is reduced in 5-HTTLPR s-allele carriers, 
which could be due to increased availability of serotonin affecting the development of 
limbic areas and the cortical regions that exert control over them. This raises the 
question whether and how the regulation of fear processes develops differently across 
adolescence as a result of reduced 5-HTT expression. To address this question we 
tested serotonin transporter knockout (5-HTT-/-) rats, heterozygous (5-HTT+/-) and 
wildtype rats of preadolescent, adolescent and adult age for cued fear extinction and 
extinction recall, which critically depend on a well-functioning mPFC-amygdala circuit, 
and are known to be impaired in adult 5-HTT-/- rats. We quantified inhibitory neuron 
populations in the IL (the rat analog of the human mPFC) and basolateral amygdala 
(BLA), regions known to be functionally active in gating fear and extinction. We find 
that the impaired recall of conditioned fear that characterizes preadolescent and adult 
5-HTT-/- rats is transiently normalized during adolescence. Moreover, during all phases 
of development IL inhibitory neuron populations are reduced in 5-HTT-/- rats, while the 
number of inhibitory neurons in the BLA was not altered. As IL inhibitory cells regulate 
the activity of a cortical area that directs the fear response via inhibition of the 
prelimbic cortex (PrL), this reduction may contribute persistence of conditioned fear 
seen in 5-HTT-/- rats, although its stability across development suggests it is not 
related to the transient improvement of fear extinction seen during adolescence. The 
improvement of fear extinction recall during adolescence suggests corticolimbic 
development is paced or executed differently in 5-HTT-/- rats.
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Introduction
Adolescence is a period of physical and brain maturation that is characterized by an 
increase in pervasive fears and risky behaviors, and coincides with the emergence of 
anxiety and other affective disorders (Pine et al. 1998, Dahl 2004, Steinberg 2005, 
Somerville and Casey 2010, Somerville et al. 2010a, Somerville et al. 2010b, Britton et 
al. 2011). Recent data implicates organizational changes of the cognitive control 
circuitry regulating emotional behavior in this vulnerability during adolescence. More 
specifically, there is evidence for relative immaturity of the prefrontal cortex (PFC) and 
its top-down control over subcortical areas mediating emotion and motivation such as 
the amygdala, which’ development precedes that of the PFC. According to the 
developmental mismatch hypothesis, the delayed maturation of the PFC in comparison 
to the amygdala results in a temporary imbalance between emotion and its regulatory 
processes (Heller et al. 2016). However, there are substantial individual differences in 
this transient “imbalance” in function of cortical and subcortical regions during 
adolescence, and the underlying mechanisms and factors influencing the maturation 
process are not yet clear. As the PFC-amygdala circuit is dysfunctional in anxiety 
disorders (Shin and Liberzon 2010) that frequently emerge during adolescence and 
often persist into adulthood (Kim-Cohen et al. 2003), the understanding of the 
maturation of the PFC-amygdala circuit in healthy subjects is expected to inform the 
pathophysiology of stress-related neuropsychiatric disorders. 
Cortical–subcortical connectivity has been shown to be essential for the learning and 
recall of extinction of conditioned fear, which is known to depend on successful 
suppression of amygdala activation by the infralimbic (IL) cortex (Sotres-Bayon et al. 
2006). As such, fear extinction is a behavioral marker that reflects the cortical-subcor-
tical developmental imbalance in both humans and rodents; importantly, fear 
extinction appears to be diminished in adolescents, compared to pre-adolescents and 
adults, of both species (McCallum et al. 2010, Pattwell et al. 2012). Inhibitory signaling 
plays an important role in the regulation of fear and anxiety. While the IL is most known 
for inhibiting the fear response in the central amygdala (CeA) after successful fear 
extinction via its excitatory projections to the intercalated cells of the amygdala, it has 
recently become apparent that the IL through a local GABAergic circuit also inhibits 
the prelimbic cortex (PrL), responsible for activating the CeA (Saffari et al. 2016), which 
may be another route through which the IL exerts control over fear. The excitability of 
the basolateral amygdala (BLA), the amygdalar subnucleus responsible for maintaining 
the learned fear-association (LeDoux et al. 1990), is also regulated by inhibitory 
signaling of local GABAergic interneurons, a mechanism by which fear and anxiety are 
attenuated (Ehrlich et al. 2009). Patients suffering from post-traumatic stress disorder, 
a disorder of aberrant fear extinction, are characterized by abnormalities in GABAergic 
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signaling within the prefrontal cortex (Michels et al. 2014), implicating these local 
inhibitory circuits in its pathology. However, as of yet, their exact contribution to the 
impaired fear extinction in adolescents remains to be investigated. 
Interestingly, the adolescent behavioral and supposed neural phenotype shows 
striking similarities to that seen in carriers of the low activity variant short (s) allele of 
the serotonin transporter linked polymorphic region (5-HTTLPR). Adult s-allele carriers, 
which presumably display increased extracellular serotonin levels, show increased 
acquisition (Garpenstrand et al. 2001) and reduced extinction (Klucken et al. 2013a) of 
conditioned fear, together with amygdala hyper-reactivity (Hariri et al. 2002), and 
attenuated anatomical and functional coupling between the mPFC and amygdala 
(Pezawas et al. 2005, Pacheco et al. 2009). Thus, the behavioral and brain phenotypes 
seen in adult carriers of the s-allele of the 5-HTTLPR may also imply a cortical-subcor-
tical functional imbalance. Serotonin acts as a neurotrophic factor during development, 
and variations in serotonin availability occurring due to limited availability of 5-HTT are 
thought to affect the development of circuits involved in the regulation of emotional 
behavior (Gaspar et al. 2003, Homberg et al. 2010c, Witteveen et al. 2013). This poses 
the hypothesis that 5-HTTLPR may affect the development of the cortical-subcortical 
circuit, such that the transitions from preadolescence to adolescence and from 
adolescence to adulthood are altered in 5-HTTLPR s-allele carriers.
Serotonin transporter knockout (5-HTT-/-) rats are used as a model organism for the 
5-HTTLPR s-allele in humans, and show many phenotypical similarities, both adaptive 
and maladaptive, to s-allele carriers (see Homberg et al. (Homberg and Lesch 2011)). 
Similar to humans and rodents during adolescence and adult 5-HTTLPR s-allele 
carriers, 5-HTT-/- rats display impaired recall of extinction of conditioned fear (Nonkes 
et al. 2012a). Since the level of 5-HTT influences neuronal development in a multitude 
of ways (Homberg et al. 2010c), it is possible that development of prefrontal and 
amygdala inhibitory circuits are altered, potentially influencing the fear extinction 
recall deficit seen in 5-HTT-/- rodents across developmental stages. 
Here, we employ a fear extinction paradigm to evaluate how differential 5-HTT 
expression affects the development of fear extinction learning and recall across 
adolescence using the serotonin transporter knockout (5-HTT-/-) and heterozygous 
(5-HTT+/-) rat, and compare them to wildtype animals (5-HTT+/+). We then quantify the 
population of inhibitory cells in the IL and BLA by measuring the number of cells 
expressing the inhibitory markers glutamic acid decarboxylase 65 and 67 (GAD65/67) 
to assess development of the IL’s capacity to inhibit fear through the PrL and the BLA’s 
capacity to regulate the amygdala’s excitability. 
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Methods
Animals
All experiments were approved by the Committee for Animal Experiments of the 
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, and all 
efforts were made to minimize animal suffering and to reduce the number of animals 
used. Serotonin transporter knockout rats (Slc6a41Hubr) were generated on a Wistar 
background by N-ethyl-N-nitrosurea (ENU)-induced mutagenesis (Smits et al. 2006b). 
Experimental animals were derived from crossing heterozygous 5-HT transporter 
knockout (5-HTT+/-) rats that were outcrossed for at least twelve generations with 
wildtype Wistar rats obtained from Harlan Laboratories (Horst, The Netherlands). Ear 
punches were taken at the age of 21 days after weaning for genotyping, which was 
done by Kbiosciences (Hoddesdon, United Kingdom. Male adult 5-HTT-/-, 5-HTT+/- and 
wildtype rats entered the experiment at p24 (preadolescent), p35 (adolescent) or p70 
(adult). The adult animals were housed in pairs, while the adolescent and preadolescent 
animals were housed three per cage, in open cages. All animals had ad libitum access 
to food and water. A 12-hr light-dark cycle was maintained, with lights on at 08.00 AM. 
All behavioral experiments were performed between 08.00 AM and 18:00 PM.
Apparatus
A 30.5 cm x 24.1 cm x 21 cm operant conditioning chamber (Model VFC-008, Med 
Associates) was used for fear conditioning and sham conditioning. The box was 
housed within a sound-attenuating cubicle and contained a white LED stimulus light, 
a white and near infrared house light, as well as a speaker capable of producing an 85 
dB 2.8 kHz tone. The metal grid floor of the apparatus was connected to a scrambled 
shock generator (model ENV-412, Med Associates) configured to deliver shocks at 0.6 
mA intensity. Fear extinction and extinction recall were tested in a novel context. The 
novel context consisted of a 25 cm x 25 cm x 30 cm Plexiglas cage, the bottom of which 
was covered with a +/- 0.5 cm thick layer of black bedding. In this context, 85 dB 
(measured at the center of the floor) 2.8 kHz auditory stimuli were delivered through a 
set of external speakers. 
Procedure
On the day on which the animals entered the experiment (p24 for the preadolescent 
group, p35 for the adolescent group and p70 for the adult group) the animals were 
habituated to the conditioning context for 10 minutes. 24 hours after habituation, 
animals were given a cued fear conditioning session. Fear conditioning began with a 
two minute habituation period, followed by 5 instances of a 30 second 85 dB 2.8 kHz 
auditory stimulus co-terminating with a 1 second 0.6 mA foot shock, followed by a 1 
minute inter-trial interval. 24, 48 and 72 hours after conditioning, fear extinction and 
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two sessions of extinction recall were given, respectively. In each of these sessions, 
rats were exposed to a 2 minute habituation period, after which 24 20-second 
presentations of the auditory stimulus were given, with an inter-trial interval of 5 
seconds. Sessions were recorded and freezing was automatically assessed by a 
software program. For the conditioning and the habituation to the fear conditioning 
chamber, the apparatus was cleaned before and after each animal using a tissue 
slightly dampened with 70% EtOH. Water was used for cleaning in between the 
extinction and extinction recall sessions.
Assessment of behavior
For assessing the time spent freezing during the extinction learning and both the 
extinction recall sessions, we used the Ethovision 9.0 behavioral software package 
(Noldus Information Technology B.V., Wageningen, the Netherlands). Freezing was 
determined using the Activity Monitor feature of the software package. The threshold 
for pixel change between frames was set between 0.05% and 0.09% (depending on 
the specific camera in use, but not different between groups). Automatic assessment 
was compared to manually scored samples, as made by a trained observer blind to the 
genotype of the animal, and proved to be a reliable assessment of freezing behavior 
(correlation between manual and automatic outcomes: r = 0.7397).
GAD65/67 immunostaining
The immunostaining procedure was adopted from Olivier et al. (2008) and Nonkes et 
al. (2010) (Olivier et al. 2008, Nonkes et al. 2010). 90 minutes following either the 
extinction learning session or the second extinction recall session, anesthetized rats 
were perfused transcardially with 0.1 mol/l PBS, pH 7.3, followed by 400 ml 4% para-
formaldehyde dissolved in 0.1 mol/l phosphate buffer (PB), pH 7.2. Subsequently, the 
brains were removed from the skull and postfixed overnight in 4% paraformaldehyde 
at 4°C. Before sectioning, the brains were cryoprotected with 30% sucrose in 0.1 mol/l 
PB. Forty micrometer thick brain sections were cut on a freezing microtome, and 
collected in six parallel series in 0.1 mol/l PBS containing 0.1% sodium azide. One 
series from each rat was used for every staining. The free-floating sections were 
washed three times in PBS and preincubated with 0.3% perhydrol (30% H2O2, Merck, 
Darmstadt, Germany) for 30 min. After washing three times in PBS the sections were 
presoaked for 30 min in an incubation medium consisting of PBS with 0.1% bovine 
serum albumin and 0.5% Triton X-100. The sections were then incubated with goat 
anti-GAD65/67, 1:2000 (Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) 
overnight on a shaker, at room temperature, and consecutively incubated for 90 min at 
room temperature with biotinylated donkey-anti-goat (Jackson Immuno Research 
Laboratories, West Grove, Pennsylvania, USA) diluted 1 : 1500 in incubation medium 
for 90 minutes and for 90 min at room temperature with ABC-elite, diluted 1:800 in PB 
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(Vector Laboratories, Burlingame, California, USA). Between incubations, sections 
were rinsed three times with PBS. The GAD65/67–antibody peroxidase complex was 
made visible using 3,3-diaminobenzidine tetrahydrochloride staining. Sections were 
incubated for 10 min in a chromogen solution consisting of 0.02% 3,3-diaminobenzi-
dine tetrahydrochloride and 0.03% nickel–ammonium sulfate in 0.05 mol/l Tris-buffer 
(pH 7.6), and subsequently for 10 min in chromogen solution containing 0.006% 
hydrogen peroxide. This resulted in a blue–black staining. Then, the sections were 
rinsed three times in PBS and mounted on gelatin chrome alum-coated glass slides, 
dried overnight in a stove at 37 °C, dehydrated in an increased series of ethanol, 
cleared in xylene, embedded with Entellan (Merck) and coverslipped.
Quantification
Numbers of GAD65/67-immunopositive cells were quantified using the software 
program Fiji ImageJ, a public domain image-processing program (http://rsb.info.nih.
gov/ij/) (Schindelin et al. 2012). Cells were counted in the IL in equally framed sections 
across groups at 2.20 from Bregma at ×40 magnification using an Axio Imager.A2 
microscope (Zeiss, Oberkochen, Germany). BLA GAD65/67 immunoreactivity was 
measured in sections at -1.88 or -1.80 from Bregma at ×40 magnification. The results 
for each subject are expressed as the total amount of cells counted in each section.
Statistics
All statistical analyses were performed using SPSS Statistics version 24.0 (SPSS Inc., 
IBM, Armonk, NY, USA). Data are presented as mean ± standard error of the mean 
(SEM). Behavioral and immunohistochemical data were analyzed using two-way 
analysis of variance (ANOVA) and repeated-measures ANOVA, respectively, with 
genotype and age (preadolescent, adolescent, adult) as between-subject factors. 
When appropriate, subsequent Bonferroni post hoc tests were performed to further 
specify genotype effects. Probability p values of less than 0.05 were considered 
significant.
Results
Freezing behavior
Basal anxiety. To measure baseline anxiety, we assessed freezing during the two minute 
stimulus free period preceding the extinction learning session. Freezing in response to 
the novel context was significantly affected by age (F(2, 309) = 42.182, p < 0.001), but not 
genotype (F(2, 309) = 0,737 p = 0.473), and no significant genotype x age interaction 
was found (F(4, 309) = 0.581, p = 0.677). Bonferroni post-hoc analysis revealed that 
adolescent animals froze more upon novel context exposure than adult animals 
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(p = 0.02), while preadolescent animals froze more than adolescent and adult 
animals (p < 0.01).  
Fear extinction across sessions. Freezing in response to the CS+ decreased across 
the three extinction sessions (F(2,141) = 168.046, p < 0.001), indicating that exposure to 
the non-reinforced CS was successful in diminishing the conditioned fear response. 
Session # did not significantly interact with genotype (F(4, 141) = 0.761, p = 0.544) or age 
(F(4, 141) = 2.251, p = 0.068), nor did we find a genotype x age x session interaction 
(F(8, 141) = 1.367, p = 0.215), indicating that the learning effect of extinction training 
and recall across sessions was not age- or genotype-dependent. However, over all 
sessions together we did find main effects of genotype (F(2,141) = 8.509, p < 0.001)), age 
(F(2,141) = 6.123, p = 0.003) and a trend-level significant genotype x age interaction 
(F(4,141) = 2.032, p = 0.093). Examining freezing across sessions per age group revealed 
significant overall genotype effects in the preadolescent (F(2,44) = 5.566, p = 0.007) 
and adult groups (F(2,45) = 6.324, p = 0.004) (driving the main effect of genotype), but 
not the adolescent group (F(2,52) = 0.405, p = 0.668). Bonferroni post hoc testing 
revealed that these genotype effects were driven by differential freezing of 5-HTT-/- 
rats compared to both 5-HTT+/- and wildtypes in the preadolescent group (p = 0.007 
and p = 0.034 respectively) and differential freezing in 5-HTT-/- animals compared to 
5-HTT+/- (p = 0.003), but not wildtype animals (p = 0.226) in the adult group (Figure 1). 
Freezing was significantly affected by age in 5-HTT-/- rats (F(2, 35) = 5.735, p = 0.007), 
but not in 5-HTT+/- (F(2, 71) = 2.123, p = 0.127) or wildtype animals (F(2,37) = 0.214, 
p = 0.809). Within the 5-HTT-/- group, adolescent animals froze less compared to 
preadolescent animals (p = 0.007), and a trend-level significant decrease was found 
compared to adult animals (p = 0.053). Freezing between preadolescent and adult 
animals was not different (p = 0.657).
Fear extinction learning. In the extinction learning session, total freezing during all cue 
presentations was significantly affected by genotype (F(2, 309) = 3.090, p = 0.047) and 
age (F(2, 141) = 4.367, p = 0.013), but no genotype x age interaction was observed 
(F(4, 309) = 0.352, p = 0.842). Exploration of the genotype effect through Bonferroni 
post-hoc revealed that 5-HTT-/- animals froze more during the extinction learning 
session than 5-HTT+/- animals (p = 0.004), but not wildtype animals (p = 0.107). 
Freezing in 5-HTT+/- and wildtype animals was not significantly different (p = 1.000). 
Remarkably, in this population consisting of all three 5-HTT genotypes, adolescent 
animals froze less than preadolescent (p = 0.003) and adult animals (p = 0.010), while 
these latter age groups did not differ in freezing from one another (p = 1.000), an effect 
that is likely to be mainly driven by the findings of improved extinction and recall in 
5-HTT-/- rats.  We analyzed within-session extinction learning by assessing the 
development of freezing behavior during the extinction learning session by dividing its 
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Figure 1  Fear conditioning behavioral data across extinction learning and the two 
extinction recall sessions. (A, B, C) Fear extinction recall is impaired in preadolescent 
5-HTT-/- rats, then normalized in this genotype during adolescence, to be impaired 
again in adulthood. Data are expressed as mean % of time spent freezing during 
stimulus presentations ± standard error of the mean. $ indicates a significant effect 
of session number (p < 0.05), < indicates a significant effect of genotype (5-HTT-/- vs. 
5-HTT+/- and wildtype, p < 0.05); > indicates a significant effect of genotype (5-HTT-/- vs. 
5-HTT+/-, p < 0.05). Group sizes: 5-HTT+/+ preadolescent n = 13 - 25 , adolescent n = 10 
- 25, adult n = 17 - 35; 5-HTT+/- preadolescent n = 26 - 51, adolescent n = 35 - 79, adult 
n = 16 - 31; 5-HTT-/- preadolescent n = 10 - 25 , adolescent n = 10 - 17, adult n = 18 - 30.
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24 trials into 6 blocks of 4 cue presentations and analyzing freezing through 2-way 
repeated measures ANOVA using trial block #, age and genotype as factors. An overall 
significant effect of trial block # was found (F(2, 309) = 295.241, p < 0.001), indicating 
successful extinction learning. Trial block # interacted significantly with genotype 
(F(4, 309) = 6.903 p < 0.001) and age (F(4, 309) = 3.704, p = 0.001), but no genotype x age 
x trial block was detected (F(8, 309) = 0.620, p = 0.825) (Figure 2).  
First fear extinction recall. Total freezing during the first extinction recall session was 
used as a behavioral indicator of the recall of the extinction memory acquired during 
the first fear extinction learning session. We observed a genotype x age interaction for 
this parameter (F(4, 141) = 2.731, p = 0.032), which appeared to be driven by a significant 
effect of genotype in the preadolescent (F(2, 48) = 6.145, p = 0.004), but not the 
adolescent (F(2, 52) = 1.401, p = 0.255) and adult animals (F(2, 48) = 2.328, p = 0.108). The 
genotype effect in the preadolescent group was driven by 5-HTT-/- rats, which froze 
significantly more than 5-HTT+/- (p = 0.009) and wildtype (p = 0.006) animals, while 
freezing was not different between 5-HTT+/- and wildtype animals (p = 1.000). 
Second fear extinction recall. We found a genotype x age interaction in freezing 
behavior during the second extinction recall session (F(4, 141) =2.968, p = 0.022). Here, 
we found a significant effect of genotype in the preadolescent (F(2, 46) = 5.754, 
p = 0.006) and the adult group (F(2, 48) = 6.537, p = 0.003), but not in the adolescent 
animals (F(2, 52) = 0.137, p = 0.873). 5-HTT-/- rats froze more than 5-HTT+/- and wildtype 
animals in both the preadolescent (p = 0.009 and p = 0.006 respectively) and the 
adult (p = 0.005 and p = 0.024 respectively) age groups, while freezing between 
5-HTT+/- and wildtype animals was not different in either age group (p = 1.000 in both 
age groups).
GAD65/67 immunoreactivity
Infralimbic cortex. The number of GAD65/67 immunopositive cells in the IL was 
significantly affected by genotype (F(2, 36) = 9.747, p < 0.001), but not age (F(2, 36) = 
2.226, p = 0.123), and no genotype x age interaction could be detected (F(4, 36) = 0.663, 
p = 0.622). Further analysis of the genotype effect revealed that the number of cells 
expressing GAD65/67 was significantly reduced in 5-HTT-/- animals compared to 
5-HTT+/- (p = 0.001) and wildtype animals (p = 0.002), while the latter two genotypes 
did not differ from one another (p = 1.000). 
Basolateral amygdala. No effects of genotype (F(2, 36) = 1.574, p = 0.221) or age (F(2, 36) 
= 1.291, p = 0.287) were found in the number of GAD65/67 immunopositive cells in the 
BLA, but an interaction between these factors was found to be trend-level significant 
(F(4, 36) = 2.239, p = 0.084). Exploring this effect using a one way ANOVA revealed a 
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genotype effect in the adolescent (F(2, 12) = 3.952, p = 0.048) but not the preadolescent 
(F(2, 12) = 0.888, p = 0.437) or adult groups (F(2, 12) = 0.528, p = 0.603). Within the 
adolescent group, a trend-level significant increase in GAD65/67 immunoreactivity 
was seen in 5-HTT+/- over wildtype animals (p = 0.052), while 5-HTT-/- GAD65/67 
immuno reactivity in the BLA was not different from that in 5-HTT+/- (p = 0.267) or 
wildtype animals (p = 1.000).
Figure 2  Fear extinction learning. (A) Freezing during the 2-minute stimulus free 
baseline period preceding extinction learning decreased across age in all genotypes. 
(B,C,D) Fear extinction learning is impaired in preadolescent 5-HTT-/- rats, then 
normalized in this genotype during adolescence, to be impaired again in adulthood. 
Data are expressed as mean % of time spent freezing during the baseline period (A) or 
mean % of time spent freezing during stimulus presentations (B,C,D) ± standard error 
of the mean. ^ indicates a significant effect of age (p < 0.05), $ indicates a significant 
effect of trial block number (p < 0.05), + indicates a significant trial block number x 
genotype interaction (p < 0.05), < indicates a significant effect of genotype (5-HTT-/- vs. 
5-HTT+/- and wildtype, p < 0.05). Group sizes: 5-HTT+/+ preadolescent n = 25, adolescent 
n = 25, adult n = 35; 5-HTT+/- preadolescent n = 51, adolescent n = 79, adult n = 17; 
5-HTT-/- preadolescent n = 31, adolescent n = 25, adult n = 30.
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Discussion
Here, we confirm that fear extinction recall is impaired in 5-HTT-/- rats, an established 
and oft replicated phenomenon (Schipper et al. 2011a, Schipper et al. 2011b, Nonkes 
et al. 2012a, Shan et al. 2014), in addition to finding impaired extinction learning in 
this genotype. Strikingly, an effect of age on fear extinction recall was seen only in 
Figure 3  GAD65/67 immunoreactivity in the IL and BLA. A) IL GAD 65/67 immuno-
reactivity is significantly reduced in preadolescent, adolescent and adult 5-HTT-/- 
animals. B) BLA GAD 65/67 immunoreactivity is not different in 5-HTT-/- rats across all 
developmental phases. < indicates a significant effect of genotype (5-HTT-/- vs. 5-HTT+/- 
and wildtype, p < 0.05), ~ indicates a trendline significant genotype x age interactions 
(p = 0.084), { indicates a trendline significant effect of 5-HTT+/- vs wildtype animals 
(p = 0.052). Group size: n = 5 (all genotype / age combinations).
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5-HTT-/- rats, which enjoyed a transient normalization (i.e., improvement) of fear 
extinction recall during adolescence. Augmented fear extinction learning seems to be 
responsible for the improved fear extinction observed in 5-HTT-/- rats during adolescence. 
The number of GAD65/67 positive cells, indicative of inhibitory circuit function, was 
decreased in the IL of 5-HTT-/- rats, regardless of age, while no clear effect of age or 
genotype were seen on the number of GAD65/67 positive cells in the BLA. 
A number of developmental abnormalities arising from 5-HTT abolishment have been 
described in literature. The development of several motor and sensory functions, 
namely reflexes, motor coordination and olfactory discrimination, is delayed in 5-HTT-/- 
rats, but normalized upon reaching adulthood. Remarkably, other deficiencies seen in 
adult 5-HTT-/- animals, i.e., impaired object recognition, object directed behavior and 
sensorimotor gating, do not arise until after adolescence (Kroeze et al. 2016). The 
present results suggest that the abnormal emotional profile seen in 5-HTT-/- rats is 
subject to a nonlinear developmental trajectory as well, implying that 5-HTT 
abolishment influences neural maturation depending on the developmental phase 
and locus. The finding of transiently alleviated recall of fear extinction during 
adolescence in 5-HTT-/- rats suggests that the pacing of development of cortical and 
subcortical regions may be altered in this genotype. Congruent with our findings, a 
study in 5-HTT-/- mice has demonstrated that increased anxiety, another hallmark trait 
of the 5-HTT-/- rodent phenotype, is not present during adolescence (Sakakibara et al. 
2014). Also the typically observed increased spine density in the BLA in adult 5-HTT-/- 
and 5-HTT+/- animals was not observed in adolescence in the same study (Sakakibara 
et al. 2014), which is in line with the behavioral phenotype. Furthermore, IL (but not 
PrL) spine density was increased in adolescent and adult 5-HTT-/- rats compared to 
wildtypes (Sakakibara et al. 2014), suggesting a relative reduction of the BLA – IL 
imbalance during adolescence in 5-HTT-/- animals. However, at the same time aberrant 
dendritic branching is observed in the PrL of adult 5-HTT-/- mice (Wellman et al. 2007), 
complicating the picture. These altered spine densities may be directly related to 
abnormalities in serotonin levels during development as serotonin plays a critical role 
in the pruning of synapses; a “trimming” of excess synaptic connections that occurs 
throughout development (Gaspar et al. 2003). Pruning is prevalent in cortical areas 
during adolescence (see Brenhouse et al. for review (Brenhouse and Andersen 2011)) 
and the IL inputs to the BLA are specifically pruned during late adolescence (Cressman 
et al. 2010). Alterations in neuronal morphology are thought to contribute to the 
network abnormalities seen in a variety of psychiatric and developmental disorders 
(Penzes et al. 2011). In addition, altered connectivity between regions may affect 
neural network function. In addition, a prenatal diminishing of 5-HTT expression 
through a pharmacological intervention influences expression of a number of genes 
that regulate nervous pathway myelination in the brain (Kroeze et al. 2015). 5-HTTLPR 
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s-allele carriers show altered functional connectivity between cortical-subcortical 
connectivity (Fang et al. 2013) and abnormalities in white matter structure. It remains 
to be determined to which degree abnormalities in the development of tracts that 
physically connect IL and BLA resulting from 5-HTT abolishment contribute to the 
findings reported here.
The inhibitory neuron population in the IL is reduced in 5-HTT-/- rats across all age 
groups. These cells are known to be functionally active in a local cortical circuit with 
the PrL, and contribute to the regulation of the expression of conditioned fear via 
the attenuation of the excitability of PrL. Reduced inhibition of the PrL may drive 
generalized anxiety seen in 5-HTT-/- rodents (Olivier et al. 2008), but may also be a 
causative factor of the reduced efficacy of fear extinction observed in this genotype. 
However, as the reduction in inhibitory neurons appears to remain stable across 
development from preadolescence to adulthood, it seems unlikely that altered 
development of local prefrontal inhibitory circuits contributes to the remarkable 
development of fear- and extinction behavior seen in these animals.
This study does not replicate findings from other studies that suggest fear extinction 
recall deficits in adolescent animals and humans with normal 5-HTT expression 
(McCallum et al. 2010, Pattwell et al. 2012), as our results indicate that in wildtype 
animals fear extinction recall is not significantly affected by age (F(2,35) = 0.214, 
p = 0.809). Differences in details of the experimental procedures may crucially 
determine whether an effect of age presents itself. For instance, the experiments may 
differ in the degree to which contextual cues from the conditioning session are present 
during the extinction, which determines the additional involvement of the hippocampus 
on fear expression and extinction (Maren et al. 2013). We do corroborate the findings 
of another earlier study, in which extinction learning was found to be similar between 
adolescent and adult C57BL/6J mice (Hefner and Holmes 2007). This variability in the 
reported findings necessitates additional investigation towards the exact circumstances 
under which adolescent fear extinction (recall) is impaired. 
Some limitations of the study require attention. First, animals that had undergone one 
and three days of fear extinction were pooled to determine the number of GAD65/67 
positive neurons in the IL and BLA to obtain sufficient statistical power for a comparison. 
Since GAD65/67 expression is influenced by recent fear conditioning, it is possible that 
levels of expression were affected by this variation in time between conditioning and 
sacrifice of the animal. However, all GAD65/67 positive cells were included in the 
assessment regardless of expression level; given the high signal to background ratio 
of the DAB-Ni, variations in expression due to the varying recency of fear conditioning 
is unlikely to have affected the findings. In addition, in the absence of data describing 
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the total number of neurons present in the IL, the possibility that the reduction in 
GAD65/67 immunoreactivity in 5-HTT-/- rats reflects a lower overall neuron count 
cannot be fully excluded. Furthermore, housing conditions varied between the age 
groups; although no animals were kept in isolation, preadolescent and adolescent 
animals were housed with more cage mates than adults for practical and ethical 
reasons. Although this aspect is often overlooked in animal research concerning stress 
and psychiatric illness, social elements in housing conditions have been shown to 
influence emotional behavior (Hunter 2014), and social factors are known to be 
especially influential and instrumental to psychiatric wellbeing during adolescence 
(Crone and Dahl 2012).
In conclusion, the present findings show that the influence of genetic reduction of 
5-HTT expression on the development of fear extinction recall manifests in a non-linear 
pattern, temporarily normalizing during adolescence, to become deficient again at 
adulthood. This discovery raises as many questions as it answers; delayed or aberrant 
maturation of cortical or subcortical regions or interconnecting tracts is a likely cause, 
but exploiting this finding for therapeutic benefit will require further specification of 
their nature and functional implications. The involvement of brain-derived neurotrophic 
factor (BDNF) in particular is an interesting avenue to explore in this regard, since it 
contributes to the development of the IL and its expression is dependent on 
serotonergic influences (Homberg et al. 2014). In addition, anatomical and functional 
development of excitatory neurons in the IL projecting to the amygdala are of interest 
for future study. As it stands, the data suggest that reduced inhibitory signaling within 
the IL is a potential cause for the impaired control over the amygdala seen in individuals 
with reduced expression of 5-HTT, but the finding of consistently reduced inhibitory 
neuronal populations in the IL across developmental phases implies the transient 
alleviation of the extinction recall deficit during adolescence has a different neural 
correlate.
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Abstract
Life stress increases risk for developing stress-related mental disorders like 
post-traumatic stress disorder (PTSD), and more prominently so in carriers of the 
5-HTTLPR short-allele, an allelic variant that confers reduced expression of the 
serotonin transporter. Findings from animal models have shown that severe 
inescapable stressor (IS) experience has a detrimental effect on the extinction of fear, 
a memory updating mechanism critical for adequate fear/trauma recovery and 
necessary for the successful treatment of PTSD. This effect is mediated by an elevation 
of serotonin levels resulting from IS. Accordingly, serotonin transporter knockout 
(5-HTT-/-) rats and mice show compromised extinction (recall) of conditioned fear. This 
raises the expectation that IS will exacerbate the fear extinction (recall) deficit. To test 
this, we assessed whether IS differentially affects fear extinction and extinction recall 
in 5-HTT-/- rats and wildtype controls. Surprisingly, IS experience improved fear 
extinction recall in 5-HTT-/- rats to the point where it was indistinguishable from that of 
wildtype animals, while wildtypes were unaffected by IS. Thus, 5-HTT-/- rats evidently 
were more sensitive to the effects of the stressor than wildtypes, although the 
behavioral consequences presented themselves as adaptive. These results focus 
attention on the under-investigated adaptive, potentially even beneficial sequelae of 
stress on fear memory in reputedly stress-sensitive individuals, which may eventually 
yield new avenues of therapy.
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Introduction
Stress has long been understood to play a role in the development of psychiatric 
disorders, even if the underlying mechanisms still mystify us. For example, severe life 
adversity has been linked to increased risk for developing post-traumatic stress 
disorder (PTSD). A large body of evidence suggests that the serotonergic system plays 
a role in mediating these detrimental effects of stress. For instance, genetic variation 
in serotonin transporter (5-HTT) expression is known to alter stress sensitivity in humans, 
non-human primates and rodents, with genetic variants conferring a reduction in 
function (such as the 5-HTTLPR s-allele) exacerbating the effects of stressful life 
experiences on the incidence of PTSD {Gressier, 2013 #2272}. Critically, traumatic life 
events modulate the strength and neural basis of fear acquisition and extinction in 
a 5-HTT dependent manner, potentially underlying this increased vulnerability to 
psycho pathology (Hermann et al. 2012, Klucken et al. 2013a). As fear acquisition and 
extinction processes are key in respectively the development and treatment of PTSD 
(Shin and Liberzon 2010), understanding 5-HTT – stress interactions is essential for 
the development of therapeutic interventions attuned to these individuals. This is 
especially urgent given that 5-HTTLPR s-allele carriers show poor response to cognitive 
behavioral therapy, a first line treatment for PTSD (Bryant et al. 2010).
Rodent models of 5-HTT deficiency, modeling both the neurodevelopmental and 
neuro physiological effects of reduced 5-HTT function, are characterized by a behavioral 
profile of generalized anxiety (e.g. (Mohammad et al. 2016), and impaired fear extinction 
memory recall (e.g. (Wellman et al. 2007)), modeling symptoms of stress-related 
psycho pathology. While 5-HTT abolishment results in a wide array of anatomical and 
physiological changes and adaptations in the brain, perhaps the most prominent of 
these is a constitutive sevenfold increase in extracellular serotonin (Homberg et al. 
2007a). This is relevant, given that acute inescapable stress (IS) potentially impairs 
fear extinction (Baratta et al. 2007) potentially by increasing dorsal raphe nucleus 
(DRN) serotonergic signaling and subsequently serotonin release in the basolateral 
amygdala (BLA) (Amat et al. 1998a). Expression of conditioned fear is associated with 
phasic elevation of BLA serotonin (Zanoveli et al. 2009), and terminating serotonergic 
inputs into the amygdala reduces the expression of conditioned fear, but only in IS 
experienced mice (Baratta et al. 2016). Since 5-HTT is of vital importance in the 
clearance of serotonin from the extracellular space, the detrimental effects of IS on 
fear extinction are likely affected by 5-HTT expression (Jasinska et al. 2012), and 
IS-induced fear extinction impairment is expected to be exacerbated in those with 
inherited 5-HTT down-regulation, explaining the 5-HTTLPR related clinical findings for 
PTSD.
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To investigate how the effects of IS on fear extinction are modulated by a pre-existing 
state of high extracellular 5-HT, we assessed fear extinction and extinction recall in 
both naïve and IS-experienced 5-HTT-/- rats and their wildtype (5-HTT+/+) counterparts 
(Homberg et al. 2007a). We subjected adult males of both genotypes to IS consisting 
of one session of 100 unpredictable tail shocks of randomized duration under restraint 
(n5-HTT-/- = 20, n5-HTT+/+ = 19), or a control manipulation (n5-HTT-/- = 20, n5-HTT+/+ = 16), 
followed by a cued fear conditioning paradigm 48 hours later. 24 and 48 hours after 
fear conditioning, animals were re-exposed to the fear conditioned stimulus to measure 
fear extinction learning and recall by means of behavioral freezing.
Methods
Animals
All experiments were approved by the Committee for Animal Experiments of the 
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, and all 
efforts were made to minimize animal suffering and to reduce the number of animals 
used. Serotonin transporter knockout rats (Slc6a41Hubr) were generated on a Wistar 
background by N-ethyl-N-nitrosurea (ENU)-induced mutagenesis. Experimental 
animals were derived from crossing heterozygous 5-HT transporter knockout (5-HTT+/-) 
rats that were outcrossed for at least twelve generations with wild-type Wistar rats 
obtained from Harlan Laboratories (Horst, The Netherlands). Ear punches were taken 
at the age of 21 days after weaning for genotyping, which was done by Kbiosciences 
(Hoddesdon, United Kingdom). We tested male adult 5-HTT-/- and 5-HTT+/+ rats which 
ranged from 16 to 24 weeks of age. The animals were housed in pairs, in open cages. 
All animals had ad libitum access to food and water. A 12-hr light-dark cycle was 
maintained, with lights on at 08.00 AM. All behavioral experiments were performed 
between 08.00 AM and 18:00 PM.
Apparatus
IS tail shocks were given in a triadic chamber (large) measuring 18.3 × 11.4 × 18.5 cm 
with grid floors (Med Associates, St. Albans, VT, USA). The grid floors were covered 
with vinyl to minimize injury to the animal. Shocks were delivered by a shock generator 
(model ENV-412, Med Associates). A 30.5 cm x 24.1 cm x 21 cm operant conditioning 
chamber (Model VFC-008, Med Associates) was used for fear conditioning and sham 
conditioning. The box was housed within a sound-attenuating cubicle and contained a 
white LED stimulus light, a white and near infrared house light as well as a speaker 
capable of producing an 85 dB 2.8 kHz tone. The metal grid floor of the apparatus was 
connected to a scrambled shock generator (model ENV-412, Med Associates) 
configured to deliver shocks at 0.6 mA intensity. Fear extinction and extinction recall 
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were tested in a novel context. The novel context consisted of a 25 cm x 25 cm x 30 cm 
Plexiglas cage, the bottom of which was covered in a +/- 0.5 cm thick layer of black 
bedding. In this context, 85 dB (measured at the center of the floor) 2.8 kHz auditory 
stimuli were delivered through a set of external speakers.
Procedure
The timeline of the procedure is displayed in Figure 1. Animals in the IS group were 
restrained by the tail in the triadic chamber using disposable finger electrodes, under 
which electrolytic gel was applied. 100 shocks of increasing intensity (30 shocks at 
0.8 mA, 30 shocks at 1.0 mA, 40 shocks at 1.2 mA) and of randomized duration 
(1 – 30 seconds, 5 seconds average) were given on a variable interval schedule 
ranging from 50 to 70 seconds (60 seconds average). The IS procedure took 2 hours. 
Control animals were restrained by the tail (while they were still able to move all limbs) 
for 2 hours in the apparatus using disposable finger electrodes, but were not given 
shocks. 24 hours after IS or restraint, animals were habituated to the fear conditioning 
environment for 10 minutes. The house light was on during habituation and conditioning. 
For the fear conditioning itself, after a two minute habituation period, a 30 second 
 85 dB 2.8 kHz auditory stimulus co-terminated with a 1 second 0.6 mA foot shock, 
followed by a 1 minute inter-trial interval. A total of 5 of these tone – shock pairings 
were given. 24 hours and 48 hours after conditioning, fear extinction and extinction 
recall were tested, respectively. After a 2 minute habituation period, 24 20-second 
presentations of the auditory stimulus were given, with an inter-trial interval of 
5 seconds. Conditioning and extinction sessions were recorded and freezing was 
manually assessed by a trained observer who was blind to genotype and treatment. 
For the IS or control procedures, the conditioning and the habituation to the fear 
conditioning chamber, the apparatus was cleaned before and after each animal using 
a tissue slightly dampened with 70% EtOH. Water was used for cleaning during the 
extinction and extinction recall. Due to equipment malfunction, the conditioning 
session could be recorded only for half the animals of each group.
Statistical analysis
Data are presented as mean ± standard error of the mean (SEM). All statistical analyses 
were performed using IBM SPSS Statistics version 20.0 (SPSS Inc., Chicago, Illinois, 
USA). Effects of genotype and treatment were analyzed using a 2-way ANOVA (F). 
Significant genotype x treatment interactions were further explored using post hoc 
Student’s t-tests. Probability p-values below 0.05 were considered significant.
54 | Chapter 3
Fi
gu
re
 1
  
E
xp
er
im
en
ta
l 
ou
tl
in
e.
  
Al
l a
ni
m
al
s 
un
de
rw
en
t 
ha
bi
tu
at
io
n 
to
 t
he
 f
ea
r 
co
nd
iti
on
in
g 
ap
pa
ra
tu
s,
 f
ea
r 
co
nd
iti
on
in
g,
 f
ea
r 
ex
tin
ct
io
n 
le
ar
ni
ng
 a
nd
 fe
ar
 e
xt
in
ct
io
n 
re
ca
ll 
te
st
in
g 
re
sp
ec
tiv
el
y 2
4,
 4
8,
 7
2 
an
d 
96
 h
ou
rs
 a
fte
r I
S,
 w
hi
ch
 co
ns
is
te
d 
of
 10
0 
un
pr
ed
ic
ta
bl
e 
ta
il 
sh
oc
ks
 u
nd
er
 re
st
ra
in
t, 
or
 a
 c
on
tr
ol
 m
an
ip
ul
at
io
n 
co
ns
is
tin
g 
of
 t
w
o 
ho
ur
s 
of
 re
st
ra
in
t i
n 
th
e 
be
ha
vi
or
al
 a
pp
ar
at
us
 u
se
d 
fo
r t
ai
l 
sh
oc
k 
ad
m
in
is
tr
at
io
n.
 Inescapable stress alleviates fear extinction recall deficits in 5-HTT-/- rats | 55
3
Results
Analyzing freezing behavior during cue presentation in the fear conditioning session 
using 2-way ANOVA analysis yielded no effect of genotype (F(1,36) = 0.021, p = 0.884), 
IS (F(1, 36) = 0.707, p = 0.406), or genotype x IS interaction (F(1, 36) = 0.1358, p = 0.716) 
(Figure 2A). Moreover, no effects of genotype (F(1,71) = 0.108, p = 0.744), IS (F(1,71) = 
1.222, p = 0.273) or genotype x IS interactions (F(1,71) = 0.26, p = 0.873) were observed 
in time spent freezing during extinction training (24 hours post-conditioning) (Figure 2B). 
However, we observed a significant genotype x IS interaction in freezing during the 
presentation of the conditioned stimulus in the extinction recall test (48 hours 
post-conditioning) (F(1,74) = 3.967, p = 0.050). Exploring this effect using post hoc 
t-tests revealed that in line with earlier reports (Wellman et al. 2007), stress naïve 
5-HTT-/- animals displayed impaired retention of conditioned fear extinction compared 
to 5-HTT+/+ animals (t(1,38) = 2.969, p = 0.005). No difference was found in freezing 
during CS presentation in the extinction recall test between IS-exposed and control 
5-HTT+/+ rats (t(1,36) = 0.318, p = 0.752), but, surprisingly, IS improved extinction 
retention in 5-HTT-/- animals (t(1,38) = 3.437, p = 0.001) (Figure 2C).
Figure 2  Fear conditioning and extinction. A. Behavioral freezing during stimulus 
presentations in the fear conditioning session. Freezing increased across trial blocks 
but was not significantly affected by genotype, stress or genotype x stress interaction.
 
A
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Figure 2  Continued. B. Behavioral freezing in response to the conditioned stimulus 
24 hours after fear conditioning per block of 4 stimulus presentations. Freezing 
decreased across the trial blocks but was not affected by genotype, stress or genotype 
x stress interactions. C. Behavioral freezing in response to the conditioned stimulus 24 
hours after the fear extinction learning session per block of 4 stimulus presentations. 
Impaired fear extinction recall in 5-HTT-/- rats was normalized by IS experience. Data 
are expressed as mean percentage of the duration of stimulus presentation spent 
freezing ± SEM. #, significant effect of trial block # (p < 0.001). *, significant genotype x 
stress interaction (p < 0.05)
B
C
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Discussion
Here, we show that severe IS normalizes the typically impaired recall of fear extinction 
memory in 5-HTT-/- rats, whereas extinction recall in 5-HTT+/+ animals was unaffected 
by a history of acute stress exposure. Successful recall of extinction memory of 
conditioned fear is a critical adaptive response in the face of changing environmental 
conditions. Accordingly, normalized freezing during the extinction recall test indicates 
that 5-HTT-/- animals successfully updated the contingency of the fear conditioned 
stimulus from signifying the onset of danger to a neutral cue. The fact that the 
behavioral effects of IS were limited to the extinction recall session suggests that IS 
improved consolidation or retrieval of extinction memory, but not extinction learning 
itself, in a manner dependent on serotonin transporter expression. 
These results are in striking contrast with majority of studies reporting on detrimental 
effects of IS experience on the extinction of conditioned fear. A single session of 
exposure to uncontrollable foot shocks has been shown to potentiate the acquisition 
of fear in several rodent models for PTSD (e.g. (Rau et al. 2005, Herrmann et al. 2012)). 
Several others reported IS to increase fear acquisition and impair fear extinction 
learning, using an acute stress paradigm similar to the one used here (Maier 1990, 
Grahn et al. 2000, Baratta et al. 2007). Here, we demonstrate that this inescapable 
stressor may also produce adaptive behavioral effects and improve fear extinction 
recall depending on serotonin transporter genotype. It is possible that the enhancing 
effects of IS on the acquisition of fear in wild type animals were obscured by a ceiling 
effect in our experiment, as the conditioning paradigm used here induced a maximal 
level of freezing upon exposure of the first CS presentations during the extinction 
learning session. Furthermore, differences in baseline behavior and stress-sensitivity 
between Sprague Dawley rats predominantly used to describe effects of the IS tail 
shock paradigm utilized by Baratta et al. and the Wistar rats used here may have 
played a role as well. Upon repeated stress exposure rats were found to display normal 
fear acquisition and extinction learning, but impaired extinction recall (Knox et al. 
2012). Yet, other studies reported that chronic IS (repeated restraint), administered 48 
hours before fear conditioning, enhanced the acquisition of conditioned fear, impaired 
extinction learning (Hoffman et al. 2014), and hindered extinction recall (Miracle et al. 
2006) in (wildtype) rats. As acute and chronic stressors exert effects through very 
different neural mechanisms, and repeated stress exposure causes a wide arrange of 
(mal)adaptations (McEwen 2004), it is expected that the chronicity of the stressor and 
the duration between stressor exposure and the assessment of fear conditioning and 
extinction behavior crucially affect the precise nature of the interaction between stress 
experience and the regulation and expression of conditioned fear. 
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Previous experiments have demonstrated 5-HTT-/- rats to be resilient to the detrimental 
effect of IS on subsequent escape learning (van der Doelen et al. 2013). In that study, 
animals with compromised 5-HTT availability displayed stress resilience, and were 
found to be even more resistant to IS-induced escape deficits than control animals 
when they had undergone early life stress (maternal separation). Similar instances of 
adaptive behavioral sequelae of stress have been reported previously, albeit much 
more emphasis is put on its maladaptive behavioral consequences. Cortisol for 
example, a highly important neuroendocrine mediator of the stress response, is known 
for its detrimental effects on hippocampal function upon chronic exposure and its 
acute impairing effects on memory retrieval (Wingenfeld and Wolf 2014). However, at 
the same time it acutely enhances the encoding and the consolidation of emotional 
memory (Roozendaal et al. 2009), prioritizing the storage of emotional memories 
benefiting the survival of the individual. Furthermore, a moderate amount of life stress 
contributes to resilience and improves psychiatric wellbeing, yet a high amount of life 
stress experience clearly predicts increased risk for developing psychiatric disorders 
(Seery et al. 2010).
A key feature of 5-HTT abolishment is a profound constitutive enhancing effect on the 
level of extracellular 5-HT in the brain (Homberg et al. 2007c). Pharmacological 
interventions that aim to alter extracellular 5-HT levels, such as selective serotonin 
reuptake inhibitors (SSRIs), have previously been described to alter the regulation of 
conditioned fear. Interestingly, acute and constitutive increases in extracellular 5-HT 
have an opposite effect on the acquisition of fear, with acute administration of the SSRI 
citalopram enhancing it and chronic administration reducing it (Burghardt et al. 2004). 
This reduction appears to be mediated through downregulation of N-methyl-D-aspar-
tate (NMDA) receptor subunit NR2b in the amygdala (Burghardt et al. 2013), which is 
instrumental in the physiology of fear acquisition (Rodrigues et al. 2001). However, 
reduced 5-HTT function throughout development (as present in 5-HTT-/- animals) 
seems to exert differential effects; NR2b levels in the amygdala were found to be 
similar in 5-HTT-/- and wild-type animals (Karel et al., in press), implying that 
mechanisms  by which chronic SSRI exposure modulates fear   do not mediate fear 
extinction deficits in 5-HTT-/- rats. In addition, acute treatment with the SSRI fluoxetine 
potentiated freezing in a signaled shock escape assay (Greenwood et al. 2008). In 
5-HTT-/- rats, however, high central 5-HT levels are seen in conjunction with extinc-
tion-resistant conditioned fear and improved signaled shock escape / avoidance 
(Shan et al. 2014, Schipper et al. 2015). Potentially, alterations in neural development 
that result from genetic ablation of 5-HTT contribute to this apparent inconsistency. In 
particular, genetic abolishment of 5-HTT resulted in altered development of the 
serotonergic projections from DRN to PFC (Witteveen et al. 2013), which are functionally 
relevant in mediating the behavioral effects of stress (Waselus et al. 2011). Furthermore, 
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5-HTT abolishment has been shown to induce desensitization of 5-HT1a autoreceptors 
in the DRN at baseline (Homberg et al. 2008). 5-HT1a desensitization has also been 
found to be a requirement for IS-induced behavioral despair to occur (Rozeske et al. 
2011), but remarkably has also been theorized to mediate the therapeutic effects of 
SSRIs (Millan 2003). 
The mechanisms underlying our findings remain to be investigated. As the elevation in 
serotonin in response to IS is thought to be a key mediator of its behavioral effects 
(Amat et al. 2006), future studies must address how serotonin transporter expression 
affects this exact serotonergic response. However, although the increased release of 
serotonin in the target regions of the DRN, modulating fear memory processes, is of a 
transient nature (Amat et al. 1998a), the effects of IS persist past the duration of their 
initial elevation of 5-HT. The IS-induced transient rise in serotonin levels is thought to 
cause desensitization of the 5-HT1a receptor in the DRN itself, which has been 
demonstrated to amplify subsequent serotonergic responses to new challenges 
(Rozeske et al. 2011). Putatively, serotonergic receptors in DRN-projection sites are 
affected as well; the 5-HT2c receptor in the amygdala is of particular interest due to its 
modulatory role in fear memory consolidation (Baratta et al. 2016). Yet, although data 
from the amygdala are not available, both PFC and hippocampal 5-HT2c receptor 
populations in 5-HTT-/- and wild type rats were similar in quantity and post-translation-
al editing (Lyddon et al. 2010). Additional studies are needed to determine the role of 
altered serotonin receptor function in both the impaired retention of extinction 
memory in 5-HTT-/- animals, but importantly, also in its alleviation through IS 
experience. It is also possible that factors that lie outside the direct influence of the 
serotonergic system contribute to the differential effects of IS on fear regulation. 
5-HTT-/- rats have been reported to feature a number of functional adaptations in the 
hypothalamic-pituitary-adrenal axis, an important regulatory system of the stress 
response (van der Doelen et al. 2013, van der Doelen et al. 2014a, van der Doelen et al. 
2014b, van der Doelen et al. 2015, van der Doelen et al. 2016). Among these, the finding 
of increased mineralocorticoid (MR) receptor expression in the mPFC and decreased 
glucocorticoid receptor (GR) expression in the dlPFC may be especially relevant in this 
context (van der Doelen et al. 2014a). GRs in the mPFC contribute to the consolidation 
of memory (Barsegyan et al. 2010), and expression levels have been shown to increase 
in male rats in response to stress (Karandrea et al. 2002, Wang et al. 2012), potentially 
contributing to stress-enhanced memory consolidation. mPFC MRs seem to serve 
functions in the retrieval of fear memory (Souza et al. 2014) and are downregulated 
following stress (Wang et al. 2012). It is tempting to speculate that IS provokes 
adaptations in corticosteroid receptor expression in the 5-HTT-/- brain, to make it 
resemble that of wild type animals. However, it is currently not known what sort of 
adaptations in the localization and expression of these receptors may have resulted 
60 | Chapter 3
from IS in the 5-HTT-/- animals, and additional studies are required to explore their role 
in post IS fear regulation.
As a limitation of this study, it should be noted that while the control group did not 
receive shocks during the control manipulation, they were restrained by the tail like 
the IS group. While a single session of restraint is not expected to affect fear acquisition 
or extinction in a cued fear conditioning paradigm (Cordero et al. 2003), it is possible 
that 5-HTT-/- rats were more sensitive to this stressor. However, as behavior during fear 
extinction learning and recall in the control animals was similar to that seen in previous 
assessments of fear extinction in 5-HTT-/- rats (e.g. (Nonkes et al. 2012a)), it is unlikely 
that the single restraint session greatly impacted behavior in the control group.
Before designating the adaptations in the regulations of fear behavior that result from 
IS in 5-HTT-/- rats as strictly beneficial, further study is necessary. It is presently not 
known whether the improvements in extinction recall seen in 5-HTT-/- are of an 
enduring or transient nature, what mechanisms underlie them, and whether they are 
part of a larger array of (mal)adaptive behavioral effects. Abolishment or diminution of 
5-HTT expression has been shown to enhance cognitive flexibility in a wide range of 
species, and in a wide range of settings; whether and how these benefits of reduced 
5-HTT expression are affected by IS in the 5-HTT-/- animals remains to be investigated. 
Though it may be premature to suggest to implement measures similar to the ones 
employed here (i.e., stress exposure) to improve treatment success in psychiatric 
practice, “shock to the system” approaches to treating depression and anxiety have 
been suggested previously and may indeed be of merit in combating these disorders, 
particularly in 5-HTTLPR s-allele carriers, which typically poorly respond to cognitive 
behavioral therapy. For instance, it has been proposed that sky-diving may provide 
therapeutic benefits (van Roekel et al. 2016). While our understanding of the 
phenomenon and its relation to psychiatric disorders has a long way to go still, our 
findings lend credence to the notion that Paracelsus’ adage “the dose makes the 
poison” may apply to stress (or its molecular mediators), and that we may be able to 
wield its adaptive properties for therapeutic benefit before long. 
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Abstract
Variations in serotonin transporter (5-HTT) expression have been associated with 
altered sensitivity to stress. Since controllability is known to alter the impact of a 
stressor through differential activation of the medial prefrontal cortex (mPFC) and 
dorsal raphe nucleus (DRN), and that these regions are functionally affected by genetic 
5-HTT down-regulation, we hypothesized that 5-HTT expression modulates the effect 
of controllability on stressor impact and coping. Here, we investigated the effects of a 
signaled stress controllability task or a yoked uncontrollable stressor on behavioral 
responding and mPFC and DRN activation.  5-HTT-/- rats proved better capable of 
acquiring the active avoidance task than 5-HTT+/+ animals. Controllability determined 
DRN activation in 5-HTT+/+, but not 5-HTT-/-, rats, whereas controllability-related 
activation of the mPFC was independent of genotype. These findings suggest that 
serotonergic activation in the DRN is involved in stress coping in a 5-HTT expression 
dependent manner, whereas mPFC activation seems to be implicated in control over 
stress independently of 5-HTT expression. We speculate that alterations in serotonergic 
feedback in the DRN might be a potential mechanism driving this differential stress 
coping.
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Introduction
The etiology of stress-related disorders is complex and poorly understood, but stress 
is one factor which certainly plays a role in its pathogenesis. However, the impact of a 
stressor depends on the vulnerability of the individual - as conferred by genetic factors - 
as well as properties relating to the stressor itself. Elucidating the neural mechanisms 
mediating such gene-environment interactions will increase our understanding of the 
disorders, and may lead to opportunities for the development of new therapeutic 
strategies.
An important category of genetic factors determining individual vulnerability is those 
influencing the expression of the serotonin transporter (5-HTT). Human carriers of the 
short (s) allelic variant – displaying reduced 5-HTT transcription and expression – 
have been shown to be more anxious (Lesch et al. 1996) and extra vulnerable to 
stress-related mental disorders, such as major depression (Lesch and Gutknecht 
2005). In order to study this genetic variant and the vulnerability it confers with regards to 
affective disorders, serotonin transporter knockout (5-HTT-/-) mice and rats have been 
developed (Bengel et al. 1998, Smits et al. 2006b). These animals are characterized by 
altered susceptibility to various stressors. Data from mouse models have – for instance – 
revealed increased anxiety-like behavior in response to a chronic resident intruder 
paradigm in mice with reduced expression of 5-HTT (Bartolomucci et al. 2010, Jansen 
et al. 2010). Furthermore, repeated social defeat stress was shown to impair fear 
extinction learning in 5-HTT deficient mice (Narayanan et al. 2011), and brief exposure 
to predator odor was shown to induce long-lasting anxiogenesis in the light-dark box 
and elevated plus maze assays in 5-HTT-/- mice selectively (Adamec et al. 2006). 
Moreover, exaggerated epinephrine responses have been noted in response to stress 
(Tjurmina et al. 2002), while hypothalamic–pituitary–adrenal axis responsivity seems 
to be unaffected by altered 5-HTT expression (Jansen et al. 2010).
However, all these studies addressed the interaction between 5-HTT signaling and 
stressors that were in fact uncontrollable. A yet unexplored facet of 5-HTT-dependent 
stress sensitivity is how it is modulated by this exact controllability of the stressor. 
Control over a stressor (as reviewed by Maier et al. (Maier et al. 2006)) diminishes 
its impact, such that the typically stress-induced behavioral phenotype that is 
characterized by neophobia, increased expression of fear behavior, and increased 
anxiety, does not occur in response to controllable stress. These features have also 
been reported in naïve 5-HTT rodents (Kalueff et al. 2010). Uncontrollable stress 
activates serotonergic neurons in the dorsal raphe nucleus (DRN), while mPFC 
activation during controllable stress is known to inhibit DRN activation (Amat et al. 
2005). It has been demonstrated that serotonin depletion in the mPFC increases active 
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stress coping (Andolina et al. 2013), suggesting that prefrontal serotonin levels play an 
important role in steering the behavioral response to controllable stress. Because 
intracellular prefrontal serotonin levels are reduced in 5-HTT-/- rats (Homberg et al. 
2007b) (while extracellular serotonin levels are increased in 5-HTT-/- mice; see 
(Mathews et al. 2004, Shen et al. 2004)), it is plausible that these animals cope more 
actively with stressors, when they are controllable. 
To evaluate how 5-HTT genotype affects coping with a controllable stressor, and if 
stress controllability affects serotonergic signaling in the DRN and activity of the mPFC 
in response to stress in a 5-HTT expression dependent manner, we exposed 5-HTT-/- rats 
and their wild-type counterparts to a self-designed triadic controllability experiment. 
Previous studies had already shown that 5-HTT-/- rats show persistent ‘maladaptive’ 
freezing in response to signaled uncontrollable stressors in a fear conditioning 
paradigm (Schipper et al. 2011a). Here, using a similar stressor (i.e., signaled foot 
shock), we tested whether these animals show ‘adaptive’ active responding when 
comparable signaled stressors are controllable. For an equal measure of controllable 
and uncontrollable stressor exposure we subjected rats to either a signaled controllable 
stress (CSt) paradigm, or a yoked uncontrollable stress (USt) paradigm in which the 
timing and intervals of the given stressors were matched to those of active avoidance 
participants, but no actual control was given. Afterwards, activation of serotonergic 
neurons in the DRN was assessed by evaluating co-expression of immediate early 
gene c-Fos and 5-HT through immunohistochemistry. To explore genotype differences 
in mPFC activity during controllable and uncontrollable stressor exposure, we also 
determined neuronal activation in the infralimbic (IL) and prelimbic (PrL) subareas of 
the mPFC using c-Fos immunohistochemistry. 
Results and Discussion
In our triadic controllability experiment rats were first trained in one chamber of a 
shuttlebox. Upon presentation of a conditioned stimulus/signal the animals were 
enabled to avoid or escape a foot shock by active nose poking (Figure 1a). Once the 
response criterion of a genotype group average of 70% avoidance responding was 
met for both genotypes, the rats switched to a two-chamber setting and the paradigm 
was repeated, with the additional requirement of shuttling over to the opposite 
shuttlebox compartment before an avoidance or escape nosepoke response could 
be made. Repeated measures ANOVA analysis revealed a significant genotype effect 
in the number of avoidance responses (F(1,15)= 5.486, p < 0.05) in the two-chamber 
paradigm, with 5-HTT-/- animals displaying more avoidance responses than wild-types 
(Figure 1b). No effect of genotype was seen in the number of escape responses (F(1,15) = 
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0.459, p > 0.05, Figure 1c). 5-HTT-/- animals responded also significantly faster to 
the cue than 5-HTT+/+ animals (F(1,15) = 5.333, p < 0.05) (Figure 1d). These data show 
that 5-HTT-/- rats, in line with what we hypothesized, display enhanced avoidance 
acquisition and lower response latency in a signaled controllable stress test. Similar 
results were obtained in the one-chamber training; these data are presented in 
Supplementary Figure 1. 
Intuitively, this observation of improved acquisition of avoidance behavior under 
controllable stress conditions might seem at odds with the pattern of heightened 
basal emotional behavior found in both 5-HTT-/- rats and mice, and their increased 
sensitivity to uncontrollable stress (Kalueff et al. 2010). A previous study reported on 
impaired shock escape in unstressed 5-HTT-/- mice in an unsignaled single session 
shock escape assay (Lira et al. 2003). Potentially, differences in the experimental 
Figure 1  Active avoidance behavioral assay. (A) Outline of a signaled stress controllability 
session. During 14 trials, animals were presented with a compound stimulus, consisting 
of illumination of the nose-poke hole and a constant tone. During the first 60 seconds 
of this signal (i.e., the avoidance period), animals were able to nose-poke to avoid 
shocks. The cue would be discontinued immediately and the trial would move on to 
the intertrial interval phase; this was considered an avoidance response. If animals 
failed to respond during the avoidance phase, a 1 s 0.6 mA scrambled foot shock was 
administered, followed by another foot shock every 10 seconds until 10 foot shocks 
were administered or the animal responded. If an animal nose-poked during this 
period, the compound stimulus and foot shocks were discontinued immediately and 
the trial moved on to the intertrial interval; this was considered an escape response. 
Failure to respond during this phase was considered a non-response.
A
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Figure 1  Continued. (B) Development of avoidance responses during the two-chamber 
sessions. (C) Development of escape responses across daily sessions did not differ between 
genotypes in the two-chamber test. (D) Mean nose-poke response latency across daily 
sessions was significantly lower in 5-HTT-/- rats during the two-chamber sessions. 
Sessions were 24 hours apart. Data are expressed as mean ± SEM. * indicates a significant 
effect of genotype (p > 0.05), & or && indicates a significant effect of session (p < 0.05 
or p < 0.01, respectively), + or ++ indicates a significant genotype by session interaction 
(p < 0.05 or p < 0.01, respectively). $ indicates a significant genotype effect in a single 
session (p > 0.05, Student’s t-test).
B
C
D
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(signaled vs. unsignaled) and behavioral (multiple vs. single session) set-ups may 
determine the differences in stress coping responses. We here show that 5-HTT-/- rats 
display enhanced coping behavior in a controllable stress setting. Possibly, this improved 
active stress coping is facilitated by the improved cognition seen in these animals, 
as evidenced by the findings of enhanced reversal learning and extra-dimensional set- 
shifting (Nonkes et al. 2011, Nonkes et al. 2012b); elevated awareness of environmental 
cues could contribute to increased performance in the present behavioral task.
Ninety minutes after conclusion of the last behavioral session the rats were transcardially 
perfused. We also included a control treatment (CT) group which was exposed to the 
same handlings and signals as the controllable stress and uncontrollable stress 
groups, but not the foot shocks. Brains were used for c-Fos (recent neuronal activity 
marker) and 5-HT fluorescence immunostaining in the DRN (Figure 2a,b), and c-Fos 
immunostaining in the mPFC (Figure 3a). In the DRN, we found a significant genotype 
x stressor interaction (F(2,42) = 5.3, p < 0.01) for 5-HT+c-Fos co-expressing neurons 
(Figure 2c). 5-HTT+/+ rats exposed to controllable stressors showed more double-labeled 
neurons compared to controllable stress exposed 5-HTT-/- subjects (t(1,7.8) = -3.1, p < 0.05). 
Bonferroni-corrected posthoc analysis revealed significant differences between 
controllable and uncontrollable stressor exposed 5-HTT+/+ rats (p < 0.05) and between 
controllable stress exposed 5-HTT+/+ and control 5-HTT+/+ rats (p < 0.01). Thus, 
controllable stress, but not uncontrollable stress, increased activation of serotonergic 
neurons in 5-HTT+/+ rats, which was not observed in 5-HTT-/- rats. Serotonergic 
activation of subdivisions of the DRN is specified in Supplementary Figure 2. 
The inhibitory 5-HT1A autoreceptors in the DRN potentially play a role in this observation. 
It has been reported that their purported function, namely autoinhibition of 5-HTergic 
signaling, is still intact and in fact hyperresponsive in 5-HTT-/- mice (Araragi et al. 
2013), although 5-HT1a mRNA was found to be decreased (Li et al. 2000). This finding 
suggests that changes in within-DRN signaling may contribute to the altered activity of 
serotonergic neurons in 5-HTT-/- animals in response to controllable stressors, although 
further specification of signaling in the DRN after stressor exposure would be necessary 
to elaborate on this. It should be noted that the DRN is a heterogeneous area in terms 
of cellular make-up (Calizo et al. 2011), and additional information on the inhibitory or 
excitatory nature of the activated cells could also contribute to a better understanding 
of how the local network within the DRN is affected by 5-HTT abolishment.
Another noteworthy aspect of the present findings is the lack of increased serotonergic 
activity in the DRN following uncontrollable stressor exposure in either genotype, as 
has been reported previously by others (Amat et al. 2005, Liu et al. 2009). However, 
the chronic component in this experiment (i.e., animals were exposed to uncontrollable 
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Figure 2  Activation of serotonergic neurons was assessed through measuring 5-HT + 
c-Fos co-localization. (A) Co-localization was assessed in the region depicted here, in 
coronal sections corresponding to -8.00 mm from Bregma. The fluorescence channel 
corresponding to c-Fos is displayed as green, 5-HT is colored red. (B) Close-up view of 
a 5-HTergic neuron co-localizing with a c-Fos immunoreactive nucleus (black arrow), 
non co-localizing 5-HTergic neuron (white arrow) and non co-localizing c-Fos positive 
nucleus (striped arrow) as visualized in combined Cy3 (red) and Alexa488 (green) 
signal (left panel), Cy3 signal only (middle panel) and Alexa488 signal only (right 
panel). 
A
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stressors for 10 consecutive days) may be of critical importance here, and makes 
comparisons with findings from experiments using acute stressors difficult. Repetition 
of the stressor may have caused a habituation-like effect on serotonergic circuitry in 
the DRN, thereby diminishing the effect of the stressor on the serotonergic response. 
Such habituation of activation has been observed in multiple studies wherein neuronal 
activation in the DRN or serotonin release after acute and chronic stress was compared 
(Stamp and Herbert 2001, Price et al. 2002, Hajos-Korcsok et al. 2003). 
To investigate whether differential serotonergic signaling in 5-HTT+/+ and 5-HTT-/- rats 
related to distinct activation of the mPFC in response to controllable and uncontrollable 
stress, we next analyzed c-Fos expression levels in this region, divided into the IL and 
PrL cortices (Figure 3a). A two-way ANOVA revealed a significant main effect of stressor 
(F(2,43) = 27.23, p < 0.01), but no significant effect of genotype (F(1,43) = 0.08, NS) or 
genotype x stressor interaction effect (F(2,43) = 0.25, NS) on the density of c-Fos 
immunopositive nuclei in the PrL subregion of the mPFC (Figure 3b). Similarly, in the IL, 
a significant main effect of stressor (F(2,41) = 7.99, p < 0.01), but no effect of genotype 
(F(1,41) = 0.35, NS), or genotype x stressor interaction (F(2,41) = 0.30, NS) was found 
(Figure 3c). Bonferroni posthoc analysis showed that neuronal activation in the IL and 
PrL was significantly higher in the CSt group than in the USt and CT groups (p < 0.01 in 
Figure 2  Continued. (C) Co-localization of 5-HT and c-Fos immunoreactivity was increased 
in 5-HTT+/+ rats, but only after controllable stress. Data are expressed as mean number 
of co-localizations ± SEM. CSt, controllable stress. USt, uncontrollable stress. CT, control 
treatment. * indicates a significant effect of genotype (p < 0.05), ¥ or ¥¥ indicates a 
significant effect of stress (p < 0.05 or p < 0.01 respectively). + indicates a significant 
genotype by stress interaction (p < 0.05).
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Figure 3  Neuronal activation in the mPFC was measured by quantifying c-Fos immuno-
reactivity. (A) Density of c-Fos immunoreactive nuclei was determined in the IL and PrL 
regions of the mPFC in coronal sections between -4.20mm and -2.20mm distance from 
Bregma. The density of c-Fos immunoreactivity in the IL region (B) as well as the PrL 
region (C) was increased after exposure to controllable, but not uncontrollable stressors, 
in both genotypes. Data are expressed as number of c-Fos positive nuclei detected 
per 10.000 pixels + SEM. CSt, controllable stress. USt, uncontrollable stress. CT, 
unstressed control. ¥¥ indicates a significant effect of stress (p < 0.01). $ indicates that 
a significant difference was found between two stress conditions in Bonferroni posthoc 
analysis (p > 0.01).
A
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both comparisons), while it did not differ between USt and CT conditions (non-signifi-
cant in both comparisons). These data show that the mPFC is activated after exposure 
to controllable stressors, but not uncontrollable stressors, in 5-HTT+/+ and 5-HTT-/- rats 
alike. The finding of increased c-Fos expression in the mPFC only in our controllable 
stress group is consistent with other reports of recruitment of prefrontal regions during 
controllable stressor experience (Amat et al. 2005, Liu et al. 2009, Moscarello and 
LeDoux 2013). The lack of a genotype effect on recent mPFC activation could be 
explained by the similar performance of the genotypes during the final behavioral 
session.
To test the relationship between the behavioral and brain activation data under 
controllable stress conditions, we next tested for any significant correlations between 
behavioral outcomes obtained during the last session of the double-chamber signaled 
controllable stress test, as well as mean response latency across all session and im-
munohistochemical data from the DRN (5-HT + c-Fos co-expressing cells) and the 
mPFC (c-Fos positive nuclei) (Table 1). While correlations between these behavioral 
parameters and IL / PrL activation could not be detected in either genotype, avoidance 
behavior during the last test session correlated positively with activation of 
serotonergic neurons in the DRN in 5-HTT+/+, but not in 5-HTT-/- rats. This indicates that 
the lower performance of 5-HTT+/+ rats in this task was accompanied by increased 
activity of serotonergic neurons in 5-HTT+/+ rats, whereas performance seemed 
unrelated to activity of serotonergic neurons in 5-HTT-/- rats. Mean escape latency 
during the last behavioral session correlated with serotonergic DRN activation as well 
in these animals. In sum, whereas there seemed to be a clear link between DRN activity 
and behavior under conditions of controllable stress and behavioral output in terms of 
active avoidance task performance in the 5-HTT+/+ rats, no such associations were 
found in the 5-HTT-/- rats. 
Figure 3  Continued.
C
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It seems remarkable that, although 5-HTT-/- animals have repeatedly been shown to 
suffer from impaired extinction of conditioned fear responses (Wellman et al. 2007, 
Schipper et al. 2011a), they excel at acquiring the escape and avoidance responses to 
the ‘conditioned stimulus’ that predicts the incoming stressor in our experiment. 
Apparently, 5-HTT-/- rats were able to overcome their impairment in the presence of 
operant control over the foot shock stress, implying that the possibility to control 
stress takes precedence over a conditioned stimulus predicting uncontrollable stress. 
In our experimental set up the conditioned stimulus contingency is gradually updated 
from a danger signal towards a stimulus that signals controllability, and secondary, 
Table 1  The relation between activation of serotonergic neurons in the DRN  
and behavioral markers of stress controllability task performance was investigated 
through comparing Pearson correlation outcomes between genotypes. 
Genotype 5-HTT-/- 5-HTT+/+  
5-HT + c-Fos 
double  
labeled cells
5-HT + c-Fos 
double  
labeled cells
Significance of 
comparison
Escape latency 
during the final 
session
Pearson Correlation 0.085 0.808
0.100
Sig. (2-tailed) 0.841 0.015
Mean escape 
latency
Pearson Correlation 0.095 0.732
0.186
Sig. (2-tailed)  0.824  0.039
Avoidances 
during the last 
session
Pearson Correlation -0.251 -0.648
0.418
Sig. (2-tailed)  0.549  0.083
Non-responses 
during the last 
session
Pearson Correlation -0.087 0.858
0.030
Sig. (2-tailed)  0.837  0.006
c-Fos density  
in IL
Pearson Correlation 0.389 0.542
0.757
Sig. (2-tailed)  0.341 0.165 
c-Fos density 
in PrL
Pearson Correlation 0.456 0.131
0.569
Sig. (2-tailed)  0.257  0.758
Comparisons of correlations between genotypes were made using two-tailed Fisher r-to-z analysis. 
Behavioral markers correlated with serotonergic activation in the DRN in 5-HTT+/+, but not 5-HTT-/- rats.
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safety. This process may resemble extinction of the fear-predicting value of the 
conditioned stimulus in cued fear-extinction paradigms. Given that fear extinction is 
mediated by the mPFC (see Quirk et al. for review (Quirk et al. 2000)), genotype 
differences in IL / PrL neuronal activity in response to controllable stress exposure in 
our task could be expected. However, the improved performance of the 5-HTT-/- 
animals was not reflected in increased neuronal activation in these mPFC subareas, 
nor did performance in the behavioral test correlate with IL / PrL neuronal activation. 
Improved signaled active avoidance acquisition was previously shown to correspond 
with altered behavior-dependent ∆FosB protein expression in the mPFC of behaviorally 
inhibited Wistar Kyoto rats (Perrotti et al. 2013), although the use of a chronic neuronal 
activation marker in this study (Nestler 2001) prevents direct comparison. 
Some limitations to this study should be mentioned. First of all, freezing and locomotion 
were not measured during the behavioral proceedings; therefore we cannot exclude 
differences in mobility contributed to the genotype effects found in the acquisition of 
avoidance behavior. However, alterations in 5-HTT expression are reported not to 
influence general locomotion in rats (Homberg et al. 2007a), although modest effects 
have been reported in mice (Kalueff et al. 2007). Secondly, because successful 
avoidances prevented shock administration and 5-HTT-/- animals acquired the task 
more effectively, 5-HTT+/+ received more shocks during most sessions (Supplementary 
Figure 3).  Therefore, it is possible that the findings of 5-HTergic activation in the DRN 
were affected by differences in shock quantity between genotypes. Furthermore, the 
readout of neuronal activation in the mPFC carries some ambiguity, as a lack of 
co-labeling for cell-type leaves open the possibility that different stress conditions or 
genotypes favor recruitment of different neuronal populations.
Conclusion and future directions
Although genetic 5-HTT down-regulation is known to be associated with poor stress 
resilience and persistent negative emotional behavior, 5-HTT-/- rats were shown to 
outperform their wild-type counterparts during the acquisition of a signaled 
controllable stress task. We did not include 5-HTT+/- rats in this experiment, which is 
regarded as a closer model for 5-HTTLPR s-allele carriers in terms of gene dose-depen-
dency. Since the s-allele has been associated with increased trait anxiety (Lesch et al. 
1996), and has been linked to the emergence of affective disorders in these individuals 
(Lesch and Gutknecht 2005), most research has focused on poor stress resilience. 
However, in line with our findings, it has also been demonstrated that healthy s-allele 
carriers display improved active avoidance (Finger et al. 2007). Evolutionary biology 
predicts that the high prevalence of the 5-HTTLPR s-allele reflects overall positive or 
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adaptive effects of this s-allele (Homberg and Lesch 2011). Improved coping with 
(signaled) controllable stress may reflect such an adaptive effect.
Although present and other findings strongly suggest that stressors drive the DRN 
differently in animals with compromised 5-HTT expression, more work is needed to 
elucidate what mechanisms are at the basis of this. Further characterization of the 
neuronal activation in the mPFC and DRN after CSt and USt, including identifying the 
type of neurons being activated through co-staining for inhibitory and excitatory 
markers, as well as the circuits they connect to through tracer imaging, will help clarify 
how the development and function of the mPFC and DRN depend on 5-HTT expression. 
Moreover, functional manipulations of the serotonergic circuits in these regions, 
using optogenetic or pharmacological interventions, could demonstrate their functional 
involvement in mediating the behavioral effects observed in the present paradigm. 
Furthermore, assessing 5-HT1a receptor expression, function and ligand binding 
qualities in naïve and stressed 5-HTT-/- animals will inform us on the role of both the 
autoreceptors in the DRN and the heteroreceptors in the mPFC in driving the stress 
response and its persistent consequences. Moreover, assessing emotional and 
cognitive behavioral parameters within a certain time interval after CSt and USt will 
reveal the transsituational and persistent impact of stressor controllability on emotion 
regulation and cognitive functioning. Finally, it remains unclear to what degree the 
effects of 5-HTT abolishment on active avoidance behavior and associated control-
lability-dependent DRN activation effects are mediated through acute alterations in 
5-HTergic neurotransmission in adult life, or through altered 5-HT-mediated neuro-
development (Gaspar et al. 2003, Kinast et al. 2013). Additional experiments using 
conditional 5-HTT knockdown models are necessary to dissociate these effects.
Materials & Methods
Animals
All experiments were approved by the Committee for Animal Experiments of the 
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, and all 
efforts were made to minimize animal suffering and to reduce the number of animals 
used. Serotonin transporter knockout rats (Slc6a41Hubr) were generated on a Wistar 
background by N-ethyl-N-nitrosurea (ENU)-induced mutagenesis (Smits et al. 2006b) 
and have been described previously (Homberg et al. 2007a). Experimental animals 
were derived from crossing heterozygous 5-HT transporter knockout (5-HTT+/-) rats 
that were outcrossed for at least twelve generations with wild-type Wistar rats 
obtained from Harlan Laboratories (Horst, The Netherlands). Ear punches were taken 
at the age of 21 days after weaning for genotyping, which was done by Kbiosciences 
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(Hoddesdon, United Kingdom). Since stress sensitivity in females is dependent on 
their estrous cycle phase (Devall et al. 2015), we here restricted ourselves to the 
gender with the most robust and stable stress response. All animals had ad libitum 
access to food and water. A 12-hr light-dark cycle was maintained, with lights on 
at 08.00 AM. All behavioral experiments were performed between 08.00 AM and 
18:00 PM.
Apparatus
A 40.6 cm (width) x 15.9 cm (depth) x 21.3 cm (height) rectangular shuttlebox (model 
ENV-010MD, Med Associates, St. Albans, VT, USA), was used, which was split into two 
identical chambers by an automated door and housed within a sound-attenuating 
cubicle. Each compartment was equipped with a circular nose-poke hole of 2.5 cm 
circumference containing an infrared detection mechanism and a white LED light, as 
well as a speaker capable of producing an 85 dB 2.8 kHz tone. Eight infrared beams 
were installed in order to detect the position of the animal. The grid floor of the 
apparatus was connected to a scrambled shock generator (model ENV-412, Med 
Associates).
Yoked triadic controllability design
The signaled active avoidance paradigm is briefly detailed in Figure 1a. For an in-depth 
description we refer to the Supplementary methods. In order to differentiate 
controllable and uncontrollable stressors, responses from the controllable stress test 
were recorded and used to create “yoked” uncontrollable stress groups; these rats 
were exposed to foot shocks and signals of the same duration and intervals as rats 
from the controllable stress group. Since these animals were not able to influence the 
stressor with their behavior, no behavioral parameters were recorded for this group. 
The animals that were subjected to this yoked paradigm are referred to as the 
uncontrollable stress (USt) group. The USt treatment was performed after the active 
avoidance behavioral proceedings of the CSt group. We included a control treatment 
group to dissociate the effect of controllability from the effects of the stressor. The 
animals belonging to this control group were exposed to the same visual and auditory 
signals of the controllable paradigm, but not the foot shocks. Uncontrollable stress 
and control rats were individually matched to rats of their own genotype from the 
controllable stress group in terms of the number of shocks administered (uncontrollable 
stress only) and time spent in the shuttle box. This paradigm differs in several key 
aspects from classic wheel-turning paradigms that have been employed to determine 
the influence of controllability of stressors, such as predictability(Weiss 1968), 
methods of shock administration, freedom of movement and method of control over 
the stressor. The triadic yoked element is transferred fully intact from that paradigm, 
however; every animal from the controllable stress group was matched up with an 
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animal from the uncontrollable stress group and one from the control treatment group 
of its own genotype, ensuring that controllability of the stressor was the only aspect in 
which the treatment of animals from the controllable and uncontrollable groups 
differed.
Immunohistochemistry
Ninety minutes after conclusion of the last behavioral session, rats were anesthetized 
and perfused transcardially with 0.1 M phosphate buffered saline (PBS), and 
subsequently by 4% paraformaldehyde in 0.1 M PBS. Brains were collected, post-fixed 
in the same fixative for 30 minutes and subsequently stored in 0.1 M PBS at 4 °C until 
sectioning. Before sectioning brains were put in a 30% sucrose in 0.1 M PBS solution. 
When brains were saturated (and had sunk) (~2 days) 40 μm thick coronal sections 
were frozen and cut on a sliding microtome (Microm HM 440 E, Thermo Fisher Scientific 
Inc., Waltham, MA, USA). Sections were stored at 4 °C in 0.1 M PBS with 0.01% NaN3 
(antimicrobial) until use. DRN sections were then stained for 5-HT and c-Fos, and mPFC 
sections were stained for c-Fos. A detailed description of the staining and quantification 
protocols can be found in the Supplementary Methods.
Statistical analysis
All statistical analyses were performed using SPSS Statistics version 17.0 (SPSS Inc., 
Chicago, IL, USA). Data are presented as mean ± standard error of the mean (SEM). 
Behavioral and immunohistochemical data was analyzed using a repeated-measures 
analysis of variance (ANOVA) and a two-way ANOVA, respectively, with genotype and 
stress (uncontrollable stress, controllable stress, control (no stress)) as between-sub-
ject factors. When appropriate, subsequent Bonferroni posthoc tests were performed 
to further specify genotype or stress condition effects, or Student’s t-tests to explore 
interacting effects. Probability p values of less than 0.05 were considered significant. 
Pearson’s correlations were used to assess relations between behavioral and immu-
nohistochemistry outcomes, and compared across genotypes using Fisher r to z-trans-
formation.
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Abstract
Stressors can be actively or passively coped with, and adequate adaption of the 
coping response to environmental conditions can reduce their potential deleterious 
effects. One major factor influencing stress coping behavior is serotonin transporter 
(5-HTT) availability. Abolishment of 5-HTT is known to impair fear extinction but 
facilitate signaled active avoidance (AA). Flexibility in adapting coping behavior to the 
nature of the stressor shapes resilience to stress-related disorders. Therefore, we 
investigated the relation between 5-HTT expression and ability to adapt a learned 
coping response to changing environmental conditions. To this end, we first established 
and consolidated a cue-conditioned passive fear response in 5-HTT-/- and wildtype 
rats. Next, we used the conditioned stimulus (CS) to signal oncoming shocks during 
signaled AA training in 5-HTT-/- and wildtype rats to study their capability to acquire an 
active coping response to the CS following fear conditioning. Finally, we investigated 
the behavioral response to the CS outside of the AA training context. To this end, we 
exposed the animals to the CS in a novel environment and measured freezing and 
exploration. We found that fear conditioned and sham conditioned 5-HTT-/- animals 
acquired the signaled AA response faster than wildtypes, while prior conditioning 
briefly delayed AA learning in both genotypes. Subsequent exposure to the CS outside 
the AA training context elicited reduced freezing in 5-HTT-/- compared to wildtype rats. 
This indicates that their improved AA performance resulted in a weaker residual 
passive fear response to the CS in a novel context. Fear conditioning prior to AA 
training did not affect freezing upon re-encountering the CS, although it did reduce 
exploratory behavior in 5-HTT-/- rats. We conclude that independent of 5-HTT signaling, 
prior fear conditioning does not greatly impair the acquisition of subsequent active 
coping behavior when the situation allows for it. Abolishment of 5-HTT results in a 
more active coping style when the CS is encountered in a novel context after AA 
learning. This is partially undone when the 5-HTT-/- animals are fear conditioned to the 
CS prior to AA learning.
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Introduction
Stress is recognized as one of the foremost contributors to the development of 
psychiatric disorders such as posttraumatic stress disorder (PTSD) and major 
depression (MD). However, large inter-individual variation exists in vulnerability to 
stress; not all individuals who are faced with severe trauma succumb to anxiety or 
mood disorders. The capability of an individual to appropriately adapt one’s coping 
response to a stressor has a great influence on its potentially deleterious sequelae. 
Therefore, it has been proposed that varying levels of stress susceptibility may in part 
be mediated by differences in stress coping strategies (Veenema et al. 2003). Stress 
coping is defined as the actions an individual undertakes to reduce the impact of a 
stressor. Coping can be done either actively in an effort to remove the stressor, or 
passively by conserving energy while enduring a stressor. It has been suggested that 
both styles can be adaptive or maladaptive and thus can confer resilience or 
vulnerability. Whether a stress coping style is adaptive depends on its appropriate-
ness to the exact environmental setting; stress coping flexibility has been proposed as 
an important factor in resilience (Homberg 2012, Nederhof and Schmidt 2012). 
Certain genetic factors modulating serotonergic neurotransmission are known to 
affect stress coping behavior, and thereby influence vulnerability to stress-induced 
psychopathology. The short (s) allelic variant of the serotonin transporter linked 
polymorphic region (5-HTTLPR) is thought to compromise the availability of the 
serotonin transporter (5-HTT) in the brain (although conflicting evidence exists as well 
(Willeit and Praschak-Rieder 2010)). The s-allele is well known for increasing 
susceptibility to MD in conjunction with the presence of early life adversity (Taylor et al. 
2006, Karg et al. 2011), and to PTSD following severe trauma (Gressier et al. 2013). 
Since associations between 5-HTTLPR and these stress-related disorders have been 
found exclusively in the presence of previous stressful life experience it is likely that 
modulation of coping behavior is key to understanding these gene x environment 
interactions (Markus 2013). This is further supported by the finding that 5-HTT binding 
is influenced by prior adverse experience in depressed subjects (Miller et al. 2009). 
Several studies point out differences in stress coping behavior between 5-HTTLPR s- 
and long (l)-allele carriers. Trait worry, a coping style that constitutes a cognitive focus 
on undesirable future outcomes that predisposes one to - among other psychiatric 
illnesses - PTSD (Holeva and Tarrier 2001, Berenbaum 2010), is more prevalent in 
s-allele carriers (Bredemeier et al. 2014). In line with this, greater anxious preoccupation 
was observed in s-allele carriers newly diagnosed with breast cancer compared to 
their l-allele peers (Schillani et al. 2012). Furthermore, coping style has been shown to 
be a mediator in the interaction between 5-HTTLPR genotype and stress regarding the 
susceptibility to MD (Wang et al. 2016). For both MD and PTSD these genetic differences 
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in stress (coping) responses also seem to hinder responsivity to first-line behavioral 
cognitive therapies (Bryant et al. 2010). Although the mechanisms directing these 
alterations in stress coping behavior and resilience are not fully understood, it is 
known that genetic variations in 5-HTT expression result in functional adaptations of 
the hypothalamic-pituitary-adrenal axis. The 5-HTTLPR s-allele is associated with 
increased basal levels of the stress hormone cortisol (Wankerl et al. 2010), and 
increased cortisol response to stress (Way and Taylor 2010). Furthermore, serotonin 
plays an important role in the neural circuits involved in managing fear learning, 
expression and extinction (Bocchio et al. 2016).
Work in animals with genetically altered levels of 5-HTT has solidified the association 
between serotonin and stress coping strategy, though many of the underlying 
mechanisms remain unclear. 5-HTT-/- animals display impaired extinction memory, 
and thus prolonged expression of a passive stressor coping response (i.e., freezing) in 
a cued fear conditioning paradigm (Wellman et al. 2007, Schipper et al. 2011a, Shan 
et al. 2014). At the same time, 5-HTT abolishment was shown to improve the acquisition 
of an active stressor coping task, signaled active avoidance (AA) (Schipper et al. 2015). 
The discrepancy between impaired fear extinction and improved AA performance in 
5-HTT-/- animals is peculiar, as overcoming the freezing response induced by the 
shock-predicting signal is a prerequisite to proactively respond to it. During initial 
unsuccessful AA trials, signal–shock pairings induce conditioned freezing. The animal 
then has to overcome this conditioning in order to subsequently avoid or escape the 
shock (Lazaro-Munoz et al. 2010, Moscarello and LeDoux 2013). While successful fear 
extinction is dependent on updating the contingency of the conditioned stimulus (CS) 
by passive exposure to it, signaled AA learning allows the individual to reevaluate the 
CS contingency by actively interacting with it. Therefore, AA could be considered the 
“controllable” counterpart of fear extinction, in the sense that it could achieve a 
behavioral outcome similar to fear extinction training (i.e., reduced freezing to a CS 
presentation) by altering the coping response elicited by the CS. 
Here, we further explore whether the updating of a passive coping stimulus contingency 
to an active one is modulated by 5-HTT expression. To this end, we assessed signaled 
AA performance in previously fear conditioned and sham conditioned 5-HTT-/- and 
wildtype rats, using the CS to signal incoming shocks during AA. We then measured 
freezing in response to the CS in a novel environment to evaluate the effects of 5-HTT 
genotype on the carry-over of the conditioned fear response to different environmental 
conditions (Figure 1). Using fear conditioning, we induce a pre-existent behavioral 
freezing response to the CS. This is expected to reduce the ability to acquire an active 
coping response (i.e., impair AA learning), due to the animals having to overcome their 
acquired freezing response to the CS in order to respond actively to it. Therefore, 
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we hypothesized that AA performance would decrease in both genotypes as a result 
of prior fear conditioning. We expected that 5-HTT-/- rats would be relatively resistant 
to these effects of prior fear conditioning, as they have previously been demonstrated 
to be resilient to stressor induced escape learning deficiencies (van der Doelen et al. 
2013). Consequently, we expected a greater freezing response to the CS after AA 
learning in a novel context in wildtype animals, since improved AA learning of 5-HTT-/- 
rats would strengthen the active coping contingency of the CS and reduce their fear 
response.
Methods and materials
Animals
Serotonin transporter knockout rats (Slc6a41Hubr) were generated on a Wistar 
background by N-ethyl-N-nitrosurea (ENU)-induced mutagenesis (Smits et al. 2006b) 
as described previously (Homberg et al. 2007a). Experimental animals were derived 
from crossing heterozygous 5-HT transporter knockout (5-HTT+/-) rats that were 
outcrossed for at least twelve generations with wild-type Wistar rats obtained from 
Harlan Laboratories (Horst, The Netherlands). Ear punches were taken at the age of 
21 days after weaning for genotyping, which was done by Kbiosciences (Hoddesdon, 
United Kingdom). Since stress sensitivity in females is dependent on their estrous 
cycle phase (ter Horst et al. 2012, Devall et al. 2015), we here restricted ourselves to the 
gender with the most stable stress response, i.e., males. Twenty homozygous knockout 
(5-HTT-/-) and twenty wildtype animals were used for this experiment; half of each 
group received fear conditioning before signaled AA training, while the remaining 
animals received sham conditioning. All animals had ad libitum access to food and 
water and were housed in pairs in standard Makrolon type 3 open cages. A 12-hr 
light-dark cycle was maintained, with lights on at 08.00 AM. For consistency with 
previous experiments performed in this rat line (e.g. (Schipper et al. 2011a, Shan et al. 
2014, Schipper et al. 2015)), all behavioral experiments were performed between 
08.00 AM and 18:00 PM. At the time of entering the experiments, the animals were 
between 12 and 20 weeks old. All experiments were approved by the Committee for 
Animal Experiments of the Radboud University, Nijmegen, The Netherlands, 
(application # RU-DEC 2013-149) and all efforts were made to minimize animal suffering 
and to reduce the number of animals used.
Fear conditioning
A 30.5 cm x 24.1 cm x 21 cm operant conditioning chamber (Model VFC-008, Med 
Associates) was used for fear conditioning and sham conditioning. The box was 
housed within a sound-attenuating cubicle and contained a white LED stimulus light, 
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a white and near infrared house light as well as a speaker capable of producing an 
85 dB 2.8 kHz tone. The metal grid floor of the apparatus was connected to a scrambled 
shock generator (model ENV-412, Med Associates) configured to deliver shocks at 
0.6 mA intensity. Animals were habituated to the fear conditioning chamber for the 
duration of 10 minutes, 24 hours prior to conditioning. For the conditioning and 
habituation, the apparatus was cleaned before and after each animal using a tissue 
slightly dampened with 70% EtOH. The house light was on during habituation and 
conditioning. For the fear conditioning itself, after a two minute habituation period, a 
30 second 85 dB 2.8 kHz auditory stimulus (the CS) co-terminated with a 1 second 
0.6 mA foot shock, followed by a 1 minute inter-trial interval. A total of 5 of these tone 
– shock pairings were given. For the sham conditioning groups, the foot shock was 
omitted.
Signaled active avoidance
A rectangular shuttlebox (model ENV-010MD, Med Associates, St. Albans, VT, USA), 
consisting of two 20.3 cm x 15.9 cm x 21.3 cm compartments, was used for AA learning. 
It was divided into two identical chambers by an automated door and housed within a 
sound-attenuating cubicle. Each compartment was outfitted with a speaker capable of 
producing an 85 dB 2.8 kHz tone. Eight infrared beams were installed in order to detect 
the position of the animal. The metal grid floor of the apparatus was connected to 
a scrambled shock generator (model ENV-412, Med Associates), configured to deliver 
shocks at 0.6 mA intensity. All animals underwent five AA sessions, each consisting of 
31 trials, on a single day, the day after fear conditioning or sham conditioning. Each 
trial consisted of an avoidance phase, an escape phase, and a one minute inter-trial 
interval phase, in that exact order. During the avoidance phase, an 85 dB, 2.8 kHz tone 
(i.e., the CS) sounded continuously, and the door opened, enabling the animal to 
escape through the door and terminate the trial by breaking the infrared detection 
beams at the other end of the shuttlebox. If the animal failed to do so within 15 seconds, 
the escape phase would begin, during which a 0.5 second 0.6 mA foot shock was 
administered every second. The shocks and the CS would continue until the animal 
escaped to the opposite compartment or until 15 seconds (and thus 15 shocks) had 
passed. A session lasted 40 – 60 minutes, depending on AA performance and the 
inter-session interval was one hour, making the total AA procedure last 7 – 9 hours. 
Each session began and ended with a 2 minute stimulus free period. Avoidance, 
escape, and response latency were assessed automatically through laser beam 
detection during every session, while freezing during stimulus presentation, defined 
as the absence of all movement except that necessary for respiration, was assessed 
by a trained observer blind to the experimental condition of the animal from digital 
video recordings of the last session. In between sessions, the apparatus was cleaned 
using a tissue slightly dampened with 70% EtOH.
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Post AA training CS exposure
The day after AA, all animals were exposed to the CS used in the prior sessions 
delivered in a novel, distinctive context. The novel context was located in a different 
experimental room from the conditioning and AA environments, and consisted of an 
unfamiliar 25 cm x 25 cm x 30 cm Plexiglas cage, the bottom of which was covered in 
a +/- 0.5 cm thick layer of black bedding. In this behavioral chamber, 85 dB (measured 
at the center of the floor) 2.8 kHz auditory stimuli (i.e., the CS) could be delivered 
through a set of external speakers. After a 2 minute habituation period, 24 20 second 
presentations of the CS were given, with an inter-trial interval of 5 seconds. The chamber 
was cleaned using water between animals to create olfactory cues distinctive from 
those during the prior experiments. The session was recorded and freezing during 
stimulus presentation was manually assessed by a trained observer who was blind 
to genotype and treatment. In addition, exploration of the chamber was assessed using 
the computer program Ethovision v9.0 (Noldus Information Technology, Wageningen, 
the Netherlands), which determined the distance moved by tracking the animals’ 
movement in digital video recordings of the behavioral session.
Statistics
Data are presented as mean ± standard error of the mean (SEM). All statistical analyses 
were performed using IBM SPSS Statistics version 20.0 (SPSS Inc., Chicago, Illinois, 
USA). Effects of genotype, conditioning, and session/trial number were analyzed using 
repeated measures ANOVA. Probability p-values below 0.05 were considered significant.
Results
Active avoidance (AA)
When assessing the total number of avoidances throughout the entire five-session 
procedure, we found a significant effect of genotype (F(1,35) = 5.555, p = 0.024), with the 
5-HTT-/- rats making significantly more avoidance responses than wildtypes (Figure 2A). 
No effects of conditioning (F(1,35) = 0.527, p = 0.473), nor genotype x conditioning 
interactions (F(1,35) = 0.579, p = 0.452) could be detected. A significant effect of session 
number was found for both 5-HTT-/- (F(1,19) = 5.636, p < 0.001) and wildtype (F(1,18) = 
9.489, p = 0.001) animals, in the absence of a genotype x session number interaction 
((F(1,35) = 0.947, p = 0.416)), indicating that the number of avoidances made increased 
significantly across AA sessions for both genotypes, reflecting AA learning. Similar 
results were found in the mean response time across all active avoidance sessions, 
with 5-HTT-/- animals responding significantly faster than wildtype animals (F(1,35) = 
4.644, p = 0.038) in the absence of effects of conditioning (F(1,35) = 0.354, p = 0.555) or 
genotype x conditioning interaction effects (F(1,35) = 0.472, p = 0.472, Figure 2B). AA 
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Figure 2  Active avoidance behavior. (A) Avoidance responses increased across AA 
sessions, and 5-HTT-/- rats made significantly more avoidance responses during the 
AA sessions. (B) Response time decreased across sessions, and was significantly lower 
in 5-HTT-/- rats. (C) Response time during the first AA session increased as a result of 
prior fear conditioning, but the effect did not persist past the first block of 5 trials. 
5-HTT-/- rats responded significantly faster in all but one session.
A
B
C
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response time decreased significantly across sessions in both 5-HTT-/- (F(1,19) = 5.609, 
p = 0.003) and wildtype rats (F(1,18 = 10.482, p < 0.001) without a significant genotype 
x session interaction (F(1,35) = 0.593, p = 0.593), again reflecting AA learning. However, 
conditioning significantly increased AA response time during the first block of five 
trials of the first AA session (F(1,35) = 7.614, p = 0.009), but not in the remaining blocks 
Figure 2  Continued. (D) Foot shock exposure during AA decreased across session 
and was not significantly affected by genotype or treatment.  (E) No effects of genotype 
or fear conditioning were found in freezing during the last AA session. FC, fear 
conditioning; SHAM, sham conditioning. Data are expressed as mean ± S.E.M, freezing 
during AA session five was expressed as a percentage of the time during which the 
stimulus was presented. & indicates a significant effect of genotype on the overall 
number of avoidance responses and mean response time across all AA sessions, and 
the mean response time per trial block and across all trial blocks of the first AA session 
(p < 0.05). * indicates a significant effect of treatment on the first trial block of the first 
AA session (p < 0.05). + indicates a significant effect of session or trial number across 
all blocks / trials on every outcome (p < 0.05).
A
B
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of that session (Figure 2C). The data for the incidence of shock exposure during AA 
sessions correspond with those for the number of successful avoidances made 
subtracted from the number of trials per session (n=31), as a foot shock was initiated 
each time an animal failed to make an avoidance. The time exposed to foot shocks 
during AA per session decreased across sessions (F(1,35) = 17.684, p < 0.001), but was 
not affected by genotype (F(1,35) = 1.346, p = 0.254), treatment (F(1,35) = 0.651, p = 0.425) 
or displayed a genotype x treatment interaction (F(1,35) < 0.001, p = 0.993) (Figure 2D).
As a measure of passive coping behavior, the percentage of time spent freezing during 
active avoidance trials was assessed during the final session. No significant effects of 
genotype (F(1,35) = 1.376, p = 0.249), nor conditioning (F(1,35) = 0.250, p = 0.620), nor 
interactions between them (F(1,35) = 0.767, p = 0.387) were found regarding freezing 
behavior during active avoidance (Figure 2E). Freezing did however significantly 
decrease across the trials of the last session (F(1,35) = 4.064, p < 0.001), in both 5-HTT-/- 
(F(1,19) = 2.943, p = 0.002) and wildtype rats (F(1,18) = 2.318, p = 0.016), indicating 
successful acquisition of an active coping response to the stressor in the absence of a 
trial x genotype interaction (F(1,35) = 0.794, p = 0.585). Correlational analyses revealed 
that (in both genotypes) the amount of freezing correlated positively with response 
time in both genotypes (5-HTT-/-; r = 0.744, p < 0.001, wildtype; r = 0.745, p < 0.001), 
whereas it correlated negatively with the number of avoidance responses made during 
the session (5-HTT-/-; r = -0.691, p = 0.001, wildtype; r = -0.669, p = 0.002), indicating 
competing (i.e., passive vs. active) response strategies.
Post AA training CS exposure
In the novel environment, freezing behavior was first of all measured during the two 
minute pre-stimulus (i.e., habituation) period, serving as a measurement of baseline 
(novelty-induced) anxiety. We found that baseline freezing levels to a novel context 
were significantly higher in wildtype rats compared to 5-HTT-/- rats (F(1,35) = 7.219, 
p = 0.011, Figure 3A), whereas no effects of conditioning (F(1,35) = 2.118, p = 0.154), nor 
genotype x conditioning interaction (F(1,35) = 0.033, p = 0.856) were found. Subsequent 
CS-induced freezing across all trials was also found to be significantly higher in 
wildtype animals (F(1,35) = 5.050, p = 0.031), while no conditioning effects (F(1,35) = 
1.527, p = 0.225) nor genotype x conditioning interactions (F(1,35) = 0.407, p = 0.528) 
were observed (Figure 3B). Freezing decreased significantly across trials (F(1,35) = 
13.560, p < 0.001), in both 5-HTT-/- (F(1,19) = 7.724, p < 0.001) and wildtype rats (F(1,18) = 
6.937, p < 0.001) in the absence of a trial x genotype interaction (F(1,35) = 0.794, p = 
0.585), suggesting similar extinction of the behavioral freezing response to the CS in 
both genotypes. CS-induced freezing during the post AA CS exposure session 
correlated positively with the total response time across all active avoidance sessions, 
in 5-HTT-/- (r = 0.508, p = 0.022), but not in wildtype rats (r = 0.178, p = 0.466).
92 | Chapter 5
Figure 3  Freezing behavior during presentation of the CS in a novel context 24 hours 
after AA training. (A) In the 2-minute period before stimulus presentation, wildtype 
animals displayed significantly more freezing compared to 5-HTT-/- animals. (B) During 
the 24 stimulus presentations of the extinction session, wildtype rats froze significantly 
more than 5-HTT-/- rats. Data are expressed as mean percentage of time (of the 2 minute 
baseline period or 20 second cue presentation) spent freezing ± S.E.M. & indicates 
a significant effect of genotype on time spent freezing during the stimulus free baseline 
period and across all trials of the post AA CS exposure (p < 0.05). + indicates a 
significant effect of trial number on time spent freezing during CS exposure after AA 
training (p < 0.05).
A
B
 5-HTT knockout reduces passive coping following active retraining of fear | 93
5
Figure 4  Locomotion during exposure to (the CS in) a novel context. (A) Locomotion 
during the 2-minute stimulus free period before CS presentation was significantly 
higher in 5-HTT-/- rats. (B) Fear conditioning prior to AA training significantly reduced 
locomotion during CS presentation in 5-HTT-/- rats, but not in 5-HTT+/+ rats. Data are 
expressed as total distance moved in centimeters during a given time period (2 minute 
baseline period or 20 second CS presentation) ± S.E.M. $ indicates a significant gene 
x environment interaction in total distance moved across all trials of the post AA CS 
exposure (p > 0.05). & indicates a significant effect of genotype on distance moved 
during the stimulus free baseline period and across all trials of the post AA CS exposure 
(p < 0.05). + indicates a significant effect of trial number and # indicates a significant 
effect of conditioning in 5-HTT-/- rats (p > 0.05 on distance moved during the post AA 
CS exposure (p < 0.05).
A
B
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Furthermore, 5-HTT-/- animals exhibited significantly more locomotion in the novel 
context during the stimulus free baseline period of the post AA CS exposure (F(1,35) = 
20.712, p < 0.001) (Figure 4A). During the subsequent CS exposures, a gene-environ-
ment interaction was found in locomotion (F(1,35) = 7.696, p = 0.009), driven by a 
reduction in locomotion during CS presentation due to prior conditioning in 5-HTT-/- 
(F(1,18) = 6.377, p = 0.021), but not wildtype rats (F(1,17) = 1.592, p = 0.224), signifying 
that prior conditioning reduced exploration of the novel environment only in 5-HTT-/- 
animals (but to similar levels as observed in wildtypes) (Figure 4B). In addition, an 
overall effect of trial number was found, indicating that exploration increased across 
trials (F(1,35) = 8.385, p > 0.001). Locomotion during the post AA CS exposure correlated 
with negatively with freezing in wildtype (r = -0.625, p = 0.004), but not in 5-HTT-/- rats 
(r = -0.307, p = 0.188).
Discussion
Here, we set out to test whether prior fear conditioning and the acquisition of a passive 
stress coping strategy interferes with subsequent acquisition of an active stress 
coping response in an AA task in a 5-HTT dependent manner. In addition, we assessed 
to what degree this passive-active stress coping interaction influenced the fear 
response outside of the original training context. Results confirm our previous finding 
that abolishment of 5-HTT in rats improves signaled AA learning (Schipper et al. 2015). 
However, fear conditioning prior to CS-signaled AA training only briefly impeded AA 
learning performance in 5-HTT-/- and wildtype animals. Moreover, prior fear conditioning 
did not influence freezing behavior during subsequent re-exposure to the CS in a novel 
context. However, it did reduce exploration in 5-HTT-/- rats to the level of wildtype rats 
in this setting. These findings counter our hypotheses that the acquired passive coping 
response (i.e. freezing behavior) would strongly interfere with the subsequent 
acquisition of an active coping response, and that changes in stress coping resulting 
from it would be more pronounced in wildtypes. Furthermore, 5-HTT-/- rats were shown 
to exhibit less freezing at baseline and to the CS in a novel context, indicating that the 
advantage of these animals during AA acquisition translates to reduced passive fear 
expression beyond the AA context. 
Contrary to our expectations, prior fear conditioning (i.e., pairing the CS to brief 
inescapable foot shocks inducing a passive stress coping response) to the CS prior to 
CS-signaled AA training, had only minor effects on AA acquisition, in both 5-HTT-/- and 
5-HTT+/+ rats. Effects of prior conditioning were seen only in the first trials of the first 
session. This indicates that the new contingency of the stimulus acquired during those 
first trials quickly superseded the passive coping contingency that was attributed to it 
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during conditioning. Previous work has shown that exposure to a severe unpredictable, 
inescapable stressor induces an inflexible and generalized passive coping response 
known as learned helplessness (LH) (Overmier and Seligman 1967, Seligman and 
Maier 1967). However, the quantity and intensity of the foot shocks given in the LH 
paradigms exceed those given during the conditioning session in the present 
experiment by a large margin (e.g. (Baratta et al. 2007, Schulz et al. 2010)). This 
difference with LH in stressor intensity, as well as its predictability (Machida et al. 
2013), may in fact crucially determine the generalization of its sequelae to other 
settings. Indeed, LH paradigms have been shown to not only affect subsequent 
acquisition of escape behavior, but also anxiety, fear extinction, and social parameters 
(for review see (Maier et al. 2006)) in paradigms which have little to no similarity to the 
context or proceedings of the LH assay. This indicates that the persistent behavioral 
consequences of LH are not solely mediated by the neural correlates of fear 
conditioning, but constitute a much broader range of physiological adaptations. Here, 
we aimed at potential disturbance of AA acquisition by targeting a passive coping 
response to a specific conditioned stimulus to measure the influence of 5-HTT 
expression on the ability to adapt a learned stress coping style to suit changing 
environmental conditions.
We show that 5-HTT genotype modulated signaled AA learning, with 5-HTT-/- acquiring 
the task faster than 5-HTT+/+ rats, regardless of prior fear conditioning. In a previous 
study, we also observed improved AA in 5-HTT-/- rats, but the presently used AA 
paradigm differs in many key aspects (Schipper et al. 2015); the temporal distribution 
of the training sessions (all sessions same day vs. separate days), and the method of 
behavioral responding (crossover vs. nose poke). Replication of this finding suggests 
generally improved active stress coping in 5-HTT-/- rats. We have also found a similar 
advantage for 5-HTT-/- rats using a signaled lever press shock avoidance paradigm 
(unpublished findings), but not in instrumental food conditioning experiments (Nonkes 
et al. 2012a). This suggests that improved learning is specific to aversive learning 
paradigms. Successful signaled AA learning is dependent on the suppression of the 
(passive) fear response induced by presentation of the AA stimulus (foot shock) 
following unsuccessful avoidance trials (Moscarello and LeDoux 2013). 
Finally, presentation of the CS in a novel context after fear conditioning and signaled 
AA training yielded lower freezing in 5-HTT-/- compared to wildtype animals. AA 
performance during the final AA training session was not different between genotypes 
(F(1,35) = 2.678, p = 0.110), nor was the number of shocks received by both genotypes 
during the final AA session (F1,35) = 1.450, p = 0.236). Yet, the resulting stimulus 
contingency produced a reduced passive fear response in 5-HTT-/- animals, which 
generalized to a novel environment. This is supported by the correlational data 
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showing that CS-induced freezing in the novel context was associated with AA 
performance in 5-HTT-/- (better performance predicted less freezing), but not wildtype 
animals. 
The novel environment in which the post AA CS exposure took place induced an 
increased freezing (and reduced locomotive) response in wildtype animals, which may 
suggest either generalization of fear across contexts or induction of generalized 
anxiety. The increase in freezing in wildtype animals presumably resulted from AA, as 
it was not affected by prior fear conditioning in this study, and was not found previously 
in fear conditioned animals prior to fear extinction in a novel context (Nonkes et al. 
2012a). As fear generalization is a key feature of anxiety disorders like PTSD (Lopresto 
et al., 2016), this may suggest controllable stressors are less likely to induce anxiety 
disorders in individuals with genetically reduced expression of 5-HTT.
While freezing behavior induced by post AA CS presentation was not affected by fear 
conditioning prior to AA training, it significantly reduced the typically increased 
exploratory behavior (as assessed by general locomotion) observed in non-condi-
tioned 5-HTT-/- animals to levels comparable to wildtype animals. Thus, fear 
conditioning experience did not severely impair CS signaled AA learning in 5-HTT-/- 
rats, but it reduced the exploration of a new environment upon encountering the fear 
conditioned stimulus in these animals, reflecting some residual fear. Exploration of 
the environment may indicate that the animals are primed to interact with the CS and 
the environment, as they had done during AA training, even though the novel context 
provides no direct means of doing so. Apparently, prior association of the CS with 
passive stress endurance (obtained during fear conditioning) influenced coping 
behavior extending beyond AA training in 5-HTT-/- but not wildtype rats. Possibly, 
similar effects on exploratory behavior may be present in wildtype animals, but the 
high levels of freezing (and thus low exploration) observed in wildtype animals upon 
CS exposure during post AA CS presentation may obscure the measurement of such 
effects. Our data indeed suggest that high freezing interferes with locomotion in 
wildtypes, given the strong negative correlation between these behaviors present in 
this genotype.
A few limitations of the study require mention. First, since freezing during the first 
active avoidance session was not assessed, we cannot claim that the increased AA 
response time caused by conditioning in the first AA session was accompanied by 
increased freezing. However, given our previous experiences with the exact same 
conditioning procedure (Schipper et al. 2011a, Nonkes et al. 2012a, Shan et al. 2014), 
we expect the re-exposure to the stimulus to robustly induce a passive coping (i.e., 
freezing) response in these animals. Second, it is possible that the increased baseline 
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anxiety in wildtype animals observed post AA in a novel context affected freezing 
during the CS presentations, where wildtypes also exerted higher freezing. Remarkably, 
we previously reported lower novelty-induced freezing in wildtype rats after solely fear 
conditioning (Shan et al. 2014). Naïve 5-HTT-/- rodents normally display more anxi-
ety-related behaviors and reduced exploration in anxiety-assays in a novel 
environment, such as the elevated plus maze and open field test (Kalueff et al. 2010, 
Mohammad et al. 2016). Therefore, the additional AA training (and thus altered stressor 
experience in terms of severity and controllability) in the present experiments has 
likely affected the behavioral reaction to novel environments. Third, sex-specific 
effects of 5-HTT on stressor coping transfer were not assessed here as we considered 
these beyond the scope of this study. Stress coping behavior has been demonstrated 
to be sex-dependent (e.g. (Gruene et al. 2015)), as have the risks of developing 
stress-related psychiatric disorders (see e.g. (Bromet et al. 2011, Shansky 2015). 
Therefore, future studies will have to determine whether the findings reported here 
can be generalized across sexes. Finally, it remains to be investigated whether the 
behavioral coping responses resulting from passive-active CS retraining are 
CS-specific, or if they are subject to fear generalization, one of the hallmark symptoms 
of PTSD. Therefore, coping responses during stimulus-free periods and during 
presentation of stimuli of various degrees of similitude should be assessed in future 
studies.
To conclude, in line with our suggestion that 5-HTT-/- rats have a greater tendency to 
cope actively than passively with signaled stressors, 5-HTT-/- animals are better able 
to suppress their passive coping response to the CS after gaining control over it. 
However, conditioned fear resists effective extinction in 5-HTT-/- animals when 
environmental conditions do not provide opportunities for active stress coping 
(Wellman et al. 2007, Schipper et al. 2011a, Shan et al. 2014) . Our findings of reduced 
freezing in response to CS exposure following AA-training advocate that behavioral 
therapy focused on adopting an active coping strategy may supplant or supplement 
extinction therapy to combat fear extinction impairments induced by variation in 
5-HTT expression. We therefore propose further investigation to elucidate the 
therapeutic potential of approaching psychiatric treatment of trauma with an emphasis 
on engendering active coping, thereby reducing fear. Furthermore, we recommend an 
increased focus on coping style flexibility when assessing the influence of genotype 
– stress interactions on vulnerability and resilience.
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Abstract
The aim of this study was to investigate the effects of a mixed dietary intervention on 
behavioral symptoms in serotonin transporter knockout (5-HTT-/-) rats modeling 
the human 5-HTT length polymorphic region short-allele. Twenty female 5-HTT-/- and 
19 wild-type (5-HTT+/+) rats were fed for 3 months on a mixed polyunsaturated fatty 
acid (PUFA) diet comprising n-3 PUFAs, B vitamins and phospholipids, or an isocaloric 
control diet, and a subgroup was subsequently tested in an array of anxiety-related 
behavioral tests. All brains were harvested and immunostained for doublecortin, 
a neurogenesis marker. In addition, hippocampal volume was measured. 5-HTT-/- rats 
on the control diet displayed increased anxiety-related behavioral responses, and 
impaired fear extinction. These effects were completely offset by the mixed PUFA diet, 
whereas this diet had no behavioral effect in 5-HTT+/+ rats. In parallel, dentate gyrus 
doublecortin immunoreactivity was increased in 5-HTT-/- rats fed on the control diet, 
which was reversed by the mixed PUFA diet. Hippocampal volume was unaffected 
by the mixed PUFA diet in 5-HTT-/- subjects, whereas it increased in 5-HTT+/+ rats. 
We conclude that a mixed n-3 PUFA diet ameliorates anxiety-related symptoms in a 
genotype-dependent manner, potentially by normalizing neurogenesis. We suggest 
that such a mixed diet may serve as an attractive adjuvant to treat anxiety in 5-HTT 
length polymorphic region short-allele carriers.
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Introduction
Anxiety and depression are leading causes of disease burden in the United States 
(Kessler et al. 2005). As 50% of the patients do not respond to first drug treatment, 
suffering is prolonged and medical costs increased (Bystritsky 2006). Therefore, the need 
for alternative treatments for those showing treatment resistance is high. 
Affective disorders are associated with disturbances of the serotonergic system (Mann 
1999, Gordon and Hen 2004, Lesch and Gutknecht 2005). Because the 5-HT transporter 
(5-HTT) is solely responsible for reuptake of 5-HT from the synaptic cleft (Kriegebaum 
et al. 2010), changes in 5-HTT expression and/or function have profound consequences 
for the availability of 5-HT in the extracellular space and emotional control. For 
example, the low activity (short; s) variant of the 5-HTT length polymorphic region 
(5-HTTLPR) in humans, is well-known for its association with anxiety-related 
personality traits (Lesch et al. 1996), and increased risk for depression due to early-life 
stress (Caspi et al. 2003, Caspi et al. 2010). These behavioral manifestations correlate 
with amygdala hyper-reactivity, amygdala and hippocampus hyper-perfusion, and 
alterations in volume (Canli et al. 2006, Canli and Lesch 2007). It is possible that a 
‘gain of function’ in these limbic nodes results in decreased stress-resilience (Young 
et al. 2008). 5-HTTLPR genotype also influences the decrease in hippocampal volume 
typically seen in prolonged affective disorders, although some ambiguity remains 
with regard to the precise nature of this effect (Bremner et al. 1995, Taylor et al. 2005, 
Canli et al. 2006, Frodl et al. 2008). 
Meta-analyses have revealed that 5-HTTLPR short (s)-allele carriers respond relatively 
poor to selective serotonin reuptake inhibitors (SSRIs) (Lesch and Gutknecht 2005, 
Stein et al. 2006, Serretti et al. 2007), a staple in the treatment of affective disorders 
(Stein et al. 1998). SSRIs may exert their effects through alterations in adult hippocampal 
neurogenesis (Santarelli et al. 2003), potentially via altered 5-HT1A signaling (Wang et 
al. 2010). The association between the s-allele and neurogenesis remains to be 
assessed, but the ‘gain of function’ concept suggests that SSRI mechanisms of action 
work out differently in s-allele carriers.
Recently, nutrients like n-3 poly-unsaturated fatty acids (n-3 PUFA’s) and B-vitamins 
have gained interest for their influence on mood-related disorders; an inverse relation 
was demonstrated between n-3 PUFA intake and prevalence of anxiety and depression 
(Hibbeln et al. 2006, Sanchez-Villegas et al. 2007, Lin et al. 2010), and increased intake 
improved the outcome of regular antidepressant therapy (Nemets et al. 2002). 
Increasing the n-3/n-6 PUFA ratio in the neuronal membrane beneficially affects 
membrane fluidity (Suzuki et al. 1998), which, in turn, facilitates neuronal signaling by 
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increasing ion channel availability (Zimmer et al. 2000), or increasing 5-HT1A receptor 
density (Levant et al. 2008) and binding affinity (Farkas et al. 2002). Vice versa, n-3 
PUFA deficiency may negatively affect serotonin neurotransmission (Chalon 2006). 
Additionally, n-3 PUFA’s have been associated with changes in hippocampal 
neurogenesis in rodents (Kawakita et al. 2006, Cao et al. 2009, He et al. 2009, Dyall 
et al. 2010), and the intake of B-vitamins is inversely related with the risk for depression 
(Hibbeln et al. 2006, Skarupski et al. 2010). Finally, vitamin B9 (folate) increases 
the synthesis of s-adenosyl methionine (SAMe). SAMe is a methyl donor in central 
membrane phospholipid synthesis (Hirata and Axelrod 1980) and exerts antidepressant 
properties (Bressa 1994), also in SSRI-resistant depressed patients (Papakostas et al. 
2010). 
Since nutrients may help to compensate deficits reported for s-allele carriers, we 
hypothesized that a mixed diet of n-3 PUFAs, phospholipids and B-vitamins has 
beneficial effects in 5-HTTLPR s-allele carriers. To test this hypothesis, we used female 
serotonin transporter knockout (5-HTT-/-) rats and wild-type (5-HTT+/+) controls. 
Similar to human s-allele carriers, these animals show increased anxiety and depres-
sion-like symptoms (Kalueff et al. 2010). The higher prevalence of affective disorders 
among women compared to men (Hausken et al. 2010, Hollingworth et al. 2010) was 
our rationale for choosing female rats. After being fed either a mixed PUFA diet or a 
control diet, the animals were subjected to a series of anxiety-related tests (elevated 
plus maze, social interaction test, fear extinction). Because neurogenesis is implicated 
in depression, SSRI, and n-3 PUFA effects (Kawakita et al. 2006, Cao et al. 2009, He et 
al. 2009, Dyall et al. 2010), we also addressed the neurobiological correlates of 
genotype and diet effects using immunohistochemical staining for the neurogenesis 
marker doublecortin (DCX) (Brown et al. 2003). In addition, we measured hippocampal 
volume, as n-3 PUFA consumption may increase hippocampal volume (Venna et al. 
2009).
Materials and Methods
Animals
Serotonin transporter knockout rats (Slc6a41Hubr) were generated by N-ethyl-N-nitro-
sourea-induced mutagenesis (Smits et al. 2006a). Female experimental animals were 
derived from crossing heterozygous 5-HTT knockout (5-HTT+/-) rats that were 
outcrossed with commercial (Harlan, Ter Horst, The Netherlands) wild-type Wistar rats 
for at least eight generations. All animals were housed two per cage in a temperature 
(21 ± 10C) and humidity-controlled room (45-60% relative humidity), and had ad libitum 
access to water and food until testing. A 12/12 h light–dark cycle was maintained, with 
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lights on at 08.00 a.m. All experiments were approved by the Committee for Animal 
Experiments of the Radboud University Nijmegen Medical Centre, Nijmegen, The 
Netherlands (application # 2009-095), and performed in compliance with European 
Communities Council Directive 86/609/EEC. All efforts were made to minimize animal 
suffering and to reduce the number of animals used.
Diets
From the age of 65 days the animals were fed for 3 months with either a control diet or 
a mixed PUFA diet (Research Diet Services, Wijk bij Duurstede, The Netherlands) 
before behavioral studies started. The diets were continued during behavioral testing 
and in the week before sacrifice. Both diets were AIN-93M based (Reeves et al. 1993), 
isocaloric and identical with respect to their protein, carbohydrate, fiber, and mineral 
content. Differences between the diets are summarised in Table 1. The diets were 
stored at -200C, and used within the expiration date.
Experimental groups
We used four groups of animals: 1] 5-HTT+/+ rats on control diet, 2] 5-HTT-/- rats on 
control diet, 3] 5-HTT+/+ rats on mixed PUFA diet, and 4] 5-HTT-/- rats on mixed PUFA 
diet. All groups consisted of 10 animals, except 5-HTT+/+ rats on mixed PUFA diet 
Table 1  Diet contents.  
Control Mixed PUFA
5% Fat
Soy oil 1.90
Coconut oil 0.90 0.10
Corn oil 2.20 1.87
Fish oil 3.03
Extra’s
Soy lecithin 0.755
Pyridoxine 0.00328
Folic acid 0.00067
Overview of the differences between the two isocaloric diets that were used in the current study. 
In contrast to the control diet, the mixed PUFA diet provided the combination of n-3 PUFA’s (fish oil), 
phospholipids (soy lecithin) and increased levels of B-vitamins (pyridoxine and folic acid). Values are 
expressed as g / 100g diet.
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(9 animals). In order to determine whether the behavioral experiments influenced 
hippocampal neurogenesis, 5 rats of each group were used in the behavioral 
experiments and immunohistochemistry and 5 were used exclusively for immunohisto-
chemistry. Because no differences in DCX immunostaining and hippocampal volume 
were detected (Table 2), the two groups were pooled for these parameters. 
Behavior
In general, the behavior observer was trained and unaware of the genotype and diet 
group of the animals. Behavioral tests were performed in the order of mention, from 
least stressful to most stressful, with at least 48 hours between tests.
Elevated plus maze 
The maze was elevated to a height of 50 cm with two open (50×10) and two enclosed 
arms (50×10×40) arranged such that the arms of the same type were opposite to each 
other. The illumination intensity measured in the open arms was 80 lux. Rats were 
placed in the center of the maze for a free exploration period of 5 minutes, as described 
earlier (Olivier et al. 2008). The movements and position of the animals were recorded 
and registered automatically using Ethovision® 3.1 software (Noldus Information 
Technology B.V., Wageningen, The Netherlands). Results were expressed as the mean 
Table 2  Neurogenic effects of behavioral tests.  
p-value t df
Neurogenesis
5-HTT+/+ control diet 0.99 0.02 6
5-HTT+/+ mixed n-3 PUFA diet 0.99 0.02 7
5-HTT-/- control diet 0.69 0.42 7
5-HTT-/- mixed n-3 PUFA diet 0.78 0.29 8
Hippocampal volume
5-HTT+/+ control diet 0.19 1.5 6
5-HTT+/+ mixed n-3 PUFA diet 0.09 2.0 6
5-HTT-/- control diet 0.14 1.7 6
5-HTT-/- mixed n-3 PUFA diet 0.41 0.87 8
Overview of statistical comparisons of neurogenesis and hippocampal volume data between groups of 
participants and non-participants of behavioral tests.
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of time spent in the open arms, and total distance moved. Results were expressed as 
the mean of time spent in the open arms, closed arm entries, and total distance moved.
Social interaction test
Social interaction was measured in a test cage (50 x 50 x 75 cm ((l x w x h)) which had 
transparent walls and was filled with sawdust (2 cm). The experimental room was 
illuminated by a 25-W fluorescent red light, mounted 60 cm above the test cage. 
Twenty-four hours before the test, the female rats were habituated to the test cage 
during 10 minutes. Social interaction pairs were designed such that both rats were 
genotype and diet matched, and that rats from the same litter or home cage were not 
paired. Thus, there were types of rat pairing: 5-HTT-/- and 5-HTT-/- fed on control diet, 
5-HTT-/- and 5-HTT-/- fed on mixed PUFA diet, 5-HTT+/+ and 5-HTT+/+ fed on control diet, 
and 5-HTT+/+ and 5-HTT+/+ fed on mixed PUFA diet. On the test day, test pairs were 
isolated for 2 hours prior to the test to increase in the amount of social behavior, and 
subsequently tested for 15 minutes. Behavior of the animals was recorded on video 
tape. Using Observer 4.0 (Noldus Information Technology, Wageningen, The Netherlands), 
frequencies and durations of the following behaviors were scored: contact: sniffing or 
licking any body part of the test partner; self-grooming: forepaw licking, face washing, 
scratching, body grooming and genital grooming; no contact: none of these behaviors. 
Behavior was assessed per individual animal. Animals were used only once. 
Forced swim test
Cylindrical glass tanks (50 cm long×18 cm in diameter), filled to a depth of 30 cm with 
water at 25(±1)°C, were used. After a 15-min water experience on day 1, the subjects 
were tested 24 h later in the water cylinders for 5 min. The movements of the rats were 
videotaped for offline measurement of the duration of immobility (s). The behavioral 
variable ‘immobility’ was defined as follows: making no movements for at least 2 s or 
making only those movements that were necessary to keep the nose above the water. 
Active climbing, diving and swimming along the wall were scored as mobility (s). The 
results of the forced swim test are not shown in the results section because several 
rats had to be excluded from the test for lodging themselves between the cylinder 
walls, a strategy that results in misleading values for immobility and swimming data. 
After exclusion of these rats the groups had become too small for reliable statistical 
analysis.
Pavlovian fear conditioning and extinction (recall)
Conditioning was conducted in a home-made chamber with transparent walls and a 
metal rod floor. A camera was mounted on the top of the chamber. After habituation to 
the chamber the animals received a conditioning session consisting of a 120 second 
acclimation period (baseline measurement), three pairings (60–120 s variable inter- 
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stimulus interval) of the conditioned stimulus (CS) (30 s, 80 dB, 3 kHz tone) and the 
unconditioned stimulus (US) (1 second, 0.6 mA scrambled footshock), in which the US 
was presented during the last 2 seconds of the CS (home-made freezing program). 
After a 120 seconds no-stimulus consolidation period the rats were returned to their 
home cage. 24 hours later, initial CS-recall and subsequent CS-extinction (test 1) was 
measured in a novel context and room. After a 120 second acclimation period (baseline 
measurement), the rats received five 30 second CS presentations (60-120 seconds 
variable interstimulus interval). The same procedure was repeated 24 (test 2) and 48 
(test 3) hours later. Freezing (no visible movement except respiration) was scored 
using Observer 4.0 (Noldus Information Technology). Freezing was summed up in 
each session, and extinction recall during test 2 and 3 was expressed as % of freezing 
during test 1.
Immunohistochemistry
Immunostaining 
The procedure was adopted from (Olivier et al. 2008, Nonkes et al. 2010). One week 
following the last behavioral test (when potential immediate effects of stress were 
expected to be ‘washed out’), anesthetised rats were perfused transcardially with 0.1 
mol/l PBS, pH 7.3, followed by 400 ml 4% paraformaldehyde dissolved in 0.1 mol/l of 
phosphate buffer, pH 7.2. Subsequently, the brains were removed from the skull and 
postfixed overnight in 4% paraformaldehyde at 4°C. Before sectioning, the brains were 
cryoprotected with 30% sucrose in 0.1 mol/l of phosphate buffer. Forty micrometer 
thick brain sections were cut on a freezing microtome, and collected in six parallel 
series in 0.1 mol/l PBS containing 0.1% sodium azide. One series from each rat was 
used for every staining. The free-floating sections were washed three times in PBS and 
preincubated with 0.3% perhydrol (30% H2O2, Merck, Darmstadt, Germany) for 30 
min. After washing three times in PBS the sections were presoaked for 30 min in an 
incubation medium consisting of PBS with 0.1% bovine serum albumin and 0.5% Triton 
X-100. The sections were then incubated with goat anti-DCX, C-18 terminal, 1 : 3000 
(Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) overnight at room 
temperature, on a shaker, and consecutively incubated for 90 min at room temperature 
with donkey anti-rabbit, diluted 1 : 1500 in incubation medium, (Jackson Immuno 
Research Laboratories, West Grove, Pennsylvania, USA) and for 90 min at room 
temperature with ABC-elite, diluted 1 : 800 in PBS (Vector Laboratories, Burlingame, 
California, USA). Between incubations, sections were rinsed three times with PBS. The 
DCX–antibody peroxidase complex was made visible using 3,3’-diaminobenzidine tet-
rahydrochloride staining. Sections were incubated for 10 min in a chromogen solution 
consisting of 0.02% 3,3’-diaminobenzidine tetrahydrochloride and 0.03% nickel–
ammonium sulfate in 0.05 mol/l Tris-buffer (pH 7.6), and subsequently for 10 min in 
chromogen solution containing 0.006% hydrogen peroxide. This resulted in blue–
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black staining. Then the sections were rinsed three times in PBS and mounted on 
gelatin chrome alum-coated glass slides, dried overnight in a stove at 37°C, dehydrated 
in an increased series of ethanol, cleared in xylene, embedded with Entellan (Merck), 
and coverslipped. On account of technical difficulties during sectioning of the brains, 
several brains could not be used for immunohistochemistry or assessment of 
hippocampal volume.
Quantification 
Numbers of DCX-immunopositive cells were quantified using the software program 
Stereo Investigator (MicroBrightfield Inc, Williston, Vermont, USA). Cells were counted 
in the hippocampus in sections at Bregma -3.30 mm, -3.80 mm and -4.16 mm, at 20x 
magnification (Paxinos 2004). The results for each subject were expressed as the total 
amount of cells counted in these three sections. Hippocampal volume was deduced 
using photos of the hippocampus at Bregma -3.80mm taken at 2.5x magnification 
(Paxinos 2004). Using ImageJ, a public domain image processing program (http://rsb.
info.nih.gov/ij/) we subsequently drew a contour around the hippocampus of which 
the surface area was calculated.
Statistical analysis
Data are presented as mean±standard error of the mean (S.E.M.). All statistical 
analyses were performed using SPSS version 16.0 (SPSS Inc., Chicago, Illinois, USA). 
Data were analyzed using a two-way analysis of variance (ANOVA) or a repeated-mea-
sures ANOVA (fear extinction recall) with genotype and diet as between-subject 
factors. When appropriate, subsequent Student’s t-tests were performed. Probability 
P values of less than 0.05 were considered significant.
Results
Mixed PUFA diet exhibits anxiolytic properties in the elevated plus 
maze in 5-HTT-/- rats
Two-way ANOVA revealed a significant genotype effect (F(3,16) = 9.7, p < 0.01) and a 
significant genotype x diet interaction (F(3,16) = 9.8, p < 0.01) for time spent in the 
open arms, but no main diet effect (F(3,16) = 0.93, not significant (NS)) was obtained 
(Figure 1a). 5-HTT-/- rats on a control diet spent significantly less time in the open arms 
than their 5-HTT+/+ counterparts (t(1,8) = 4.2, p < 0.005). The mixed PUFA diet increased 
open arm time in the 5-HTT-/- group (t(1,8) = 3.2, p < 0.05), whereas 5-HTT+/+ rats were 
unaffected (p > 0.05). We observed no significant effect of genotype (F(3,16) = 0.13, NS), 
diet (F(3,16) = 0.0086, NS) or an interaction between the two (F(3,16) = 0.16, NS) on the 
total distance moved during the elevated plus maze test (Figure 1b). We saw a 
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significant genotype–diet interaction in the amount of closed arm entries during the 
elevated plus maze test (F(3,16) = 9.56, p < 0.01), but no separate effects of genotype 
(F(3,16) = 0.75, NS) or diet (F(3,16) < 0.001, NS). 5-HTT-/- rats on the control diet entered 
the closed arm more often than 5-HTT+/+ rats on the same diet (t(1,8) = 2.7, p < 0.05). 
Frequency of closed arm entry was also significantly higher in 5-HTT+/+ rats on the mixed 
PUFA diet compared with their control diet peers (t(1,8) = 2.85, p < 0.05) (Figure 1c).
Figure 1  Effects of mixed PUFA diet in 5-HTT-/- and 5-HTT+/+ rats on elevated plus 
maze performance. Data represent mean ± S.E.M. of time spent (seconds) in the open 
arms (A), total distance moved on the elevated plus maze (B), and the number of 
closed arm entries (C). * p < 0.05 5-HTT-/- versus 5-HTT+/+ rats on control diet; # p < 0.05 
5-HTT-/- rats on control diet versus mixed PUFA diet.
A B
C
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Mixed PUFA diet enhances social behavior in 5-HTT-/- rats
There was a significant genotype x diet interaction (F(3,12) = 14.3, p < 0.005) for total 
time spent in contact with the test partner (Figure 2A). In addition, there was a diet 
effect (F(3,12) = 5.3, p < 0.05), but no main genotype effect was obtained (F(3,12) = 0.01, 
NS). The 5-HTT+/+ rats on control diet spent significantly more time on contact than 
5-HTT-/- rats on control diet (t(1,6) = 4.8, p < 0.005). Further, the mixed PUFA diet 
significantly increased contact time in 5-HTT-/- rats (t(1,6) = 3.8, p < 0.01). There was no 
significant difference in contact time between the control and mixed PUFA diet groups 
Figure 2  Effects of mixed PUFA diet in 5-HTT-/- and 5-HTT+/+ rats on behavior in the 
social interaction test. Data represent mean ± S.E.M. of time spent (seconds) on social 
contact (A), no social contact (B), and self-grooming (C). * p < 0.05 5-HTT-/- versus 5-HTT+/+ 
rats on control diet; # p < 0.05 5-HTT-/- rats on control diet versus mixed PUFA diet.
A B
C
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for the 5-HTT+/+ rats (p > 0.05). None of these effects were found in the no-contact 
parameter (genotype (F(3,12) = 4.6, NS); diet (F(3,12) = 0.24, NS); genotype x diet 
interaction: (F(3,12) = 2.7, NS; Figure 2B)). When comparing the time spent on 
self-grooming we found a significant genotype x diet interaction (F(3,12) = 11.0, p < 0.01), 
a diet effect (F(3,12) = 7.0, p < 0.05), and a genotype effect (F(3,12) = 14.9, p < 0.005) 
(Figure 2C). More time was spent on self-grooming by 5-HTT-/- compared to 5-HTT+/+- 
rats when fed on control diet (t(1,6) = 6.6, p < 0.005). Comparing mixed PUFA diet fed 
5-HTT-/- subjects to control diet counterparts revealed that the latter group spent 
significantly more time on self- grooming (t(1,6) = 4.2, p < 0.005). This diet effect was not 
seen in 5-HTT+/+ animals (p > 0.05).
Mixed PUFA diet facilitates fear extinction recall in 5-HTT-/- rats
Due to technical issues with recording equipment, three animals were excluded from 
this analysis (one 5-HTT-/- rat on mixed PUFA diet, two 5-HTT-/- rats on control diet). 
Baseline freezing in response to the conditioning environment, prior to the conditioning 
session, was higher in 5-HTT+/+ rats compared to 5-HTT-/- rats (F(3,15) = 7.6, p < 0.05). No 
further effects or interactions (p > 0.05) were found in baseline freezing upon exposure 
to either conditioning or extinction environment. For time spent on freezing, expressed 
as % of freezing during test 1, we obtained a significant genotype x diet interaction 
(F(3,12) = 9.4, p < 0.05), and a genotype effect (F(3,12) = 5.1, p < 0.05), but no main diet 
effect (F(3,12) = 0.25, NS) (Figure 3). The data imply that the mixed PUFA diet facilitated 
fear extinction recall in the otherwise extinction recall impaired 5-HTT-/- rats, given 
that the significant diet effect in 5-HTT+/+ rats (t(1,6)  =  3.5, p < 0.05) was absent during 
test 3 (t(1,6) = 2.3, NS), while the significant genotype effect in animals on control diet 
during test 2 (t(1,6) = 2.7, p < 0.05) was maintained through test 3: t(1,6) = 2.9, p < 0.05). 
Furthermore, the significant diet effect in 5-HTT-/- rats was only observed during test 3 
(test 2: t(1,6) = 0.93, NS; test 3: t(1,6) = 2.4, p < 0.05). 
Mixed PUFA diet reduces hippocampal neurogenesis in 5-HTT-/- rats
In this analysis, three brains were excluded due to technical difficulties (one 5-HTT-/- rat 
on control diet (technical error during staining), one 5-HTT+/+ rat on control diet 
(spoiled) and one 5-HTT+/+ rat on mixed PUFA diet (hippocampal sections not intact)), 
and one rat was designated a statistical outlier (5-HTT-/- rat on mixed PUFA diet, > 3 
standard deviation from the mean). Examples of our immunohistochemical staining 
are displayed in Figure 4. We obtained a significant interaction between genotype and 
diet (F(3,31) = 4.5, p < 0.05) (Figure 5), as well as a significant effect of diet (F(3,31)=6.4, 
p<0.05). A significant genotype effect was not found (F(3,31) = 3.9, NS). 5-HTT-/- animals 
exhibited significantly more DCX immunostaining than 5-HTT+/+ rats when both were 
fed on the control diet (t(1,15) = 2.4, p < 0.05). The comparison of diet effects in 5-HTT-/- 
animals yielded a significant reduction in DCX-immunopositive hippocampal neurons 
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in the animals fed on n-3 PUFA (t(1,17) = 3.4, p < 0.005). In 5-HTT+/+ animals the diet had 
no significant effect (t(1,15) = 0.32, NS).
Mixed PUFA diet increases hippocampal volume of 5-HTT+/+ rats to  
a level indistinguishable from 5-HTT-/- rats
Because of technical reasons we were unable to determine hippocampal volume in 
four of the brains (hippocampal sections not intact: one 5-HTT-/- rat on control diet, 
and two 5-HTT+/+ rats on mixed PUFA diet; spoiled: one 5-HTT+/+ rat on control diet), 
one brain was a statistical outlier (5-HTT-/- rat on control diet, > 3 standard deviation 
from the mean). Hippocampal volume showed a genotype x diet interaction (F(3,30) = 
9.4, p < 0.005) (Figure 6), but no significant effects were found for diet (F(3,30) = 0.71, 
NS) or genotype (F(3,30) = 2.8, NS). Hippocampal volume was larger in 5-HTT-/- rats 
Figure 3  Effects of mixed PUFA diet in 5-HTT-/- and 5-HTT+/+ rats on the extinction 
recall of conditioned fear. Data represent mean ± S.E.M. of time spent on conditioned 
freezing behavior on test day 2 (48 hours following conditioning) and day 3 (72 hours 
following conditioning), expressed as % of freezing time on day 1 (24 hours following 
conditioning). * p < 0.05 5-HTT-/- versus 5-HTT+/+ rats on control diet; # p < 0.05 5-HTT-/- 
rats on control diet versus mixed PUFA diet; a p < 0.05 5-HTT+/+ rats on control diet 
versus mixed PUFA diet.
114 | Chapter 6
compared to 5-HTT+/+ rats (t(1,14) = 4.8, p < 0.0005), and a significant enlargement of 
the hippocampus in 5-HTT+/+ rats as a result of administering the mixed PUFA diet 
(t(1,14) = 3.0, p < 0.01) was found. Animals from both genotypes on the mixed PUFA diet 
did not differ in hippocampal volume (t(1,16) = 0.84, NS).
Figure 4  Doublecortin immunohistochemical staining. Displayed at 5x magnification: 
stained 40 µm hippocampal sections of a 5-HTT+/+ animal on control diet (A), a 5-HTT+/+ 
animal on mixed PUFA diet (B), a 5-HTT-/- animal on control diet (C), and a 5-HTT-/- 
animal on mixed PUFA diet (D). Displayed at 40x magnification: 5-HTT-/- animal on 
control diet (E).
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Figure 5  Effects of mixed PUFA diet in 5-HTT-/- and 5-HTT+/+ rats on hippocampal 
neurogenesis. Data expressed number of as nascent neuronal cell bodies identified 
by DCX staining. Data represent mean ± S.E.M. number of DCX immunoreactive 
neurons. * p < 0.05 5-HTT-/- versus 5-HTT+/+ rats on control diet; # p < 0.05 5-HTT-/- rats 
on control diet versus mixed PUFA diet.
Figure 6  Effects of mixed PUFA diet in 5-HTT-/- and 5-HTT+/+ rats on hippocampal 
volume. Data represent mean ± S.E.M. surface area (mm2). * p < 0.05 5-HTT-/- versus 5-HTT+/+ 
rats on control diet; a p < 0.05 5-HTT+/+ rats on control diet versus mixed PUFA diet.
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Discussion
We have investigated the effects of a mixed PUFA diet in 5-HTT-/- rats displaying 
anxiety- and depression-like symptoms (Olivier et al. 2008). We show for the first time 
that a mixed dietary intervention completely abolished anxiety-like symptoms in these 
animals. The diet-induced changes in behavior were accompanied by a normalization 
of hippocampal neurogenesis in 5-HTT-/- rats, and an increase in hippocampal volume 
in wild-type rats. 
Behavior
As previously demonstrated, 5-HTT-/- animals spent significantly less time on the open 
arms of the elevated plus maze, and spent less time on social interaction. These 
behavioral manifestations correspond to increased anxiety (Pellow and File 1986, 
Rodgers and Dalvi 1997, Cryan et al. 2002, File et al. 2004, Kalueff and Tuohimaa 2005, 
Milad et al. 2006, Moy et al. 2009). We also observed that fear extinction was impaired 
in 5-HTT-/- rats on control diet, potentially reflecting posttraumatic stress disorder-like 
emotionality (Wellman et al. 2007). Because the animals had five CS exposures during 
each of the conditioning/extinction/recall tests, the within session extinction was 
limited. Yet, we detected extinction between tests, suggesting that extinction 
consolidation and/or subsequent extinction recall were affected by genotype and 
mixed PUFA diet. Extinction recall was also found to be impaired in 5-HTT-/- mice 
(Wellman et al. 2007). Baseline freezing prior to the conditioning session was increased 
in 5-HTT+/+ rats. We believe the confounding effect of the difference in baseline fear is 
minimal, since the direction of the baseline fear effect is opposite to the genotype / 
diet effects seen during extinction (recall). Possibly it even causes an underestimation 
of our findings.
Collectively, while 5-HTT-/- rats do not respond to SSRIs (Homberg et al. 2007a), the 
mixed PUFA diet alleviated these symptoms to such a degree that 5-HTT-/- and 5-HTT+/+ 
rat behavior was indistinguishable. The underlying mechanisms are unclear, but could 
relate to parallel changes in hippocampal neurogenesis (see below), given that the 
hippocampus plays a critical role in fear extinction (Peters et al. 2010, Sierra-Mercado 
et al. 2010). These data suggest that mixed PUFA diets can serve as an adjunctive to 
treat anxiety-like symptoms in SSRI hyporesponsive subjects, in particular those 
characterised by inherited reduced 5-HTT function. Notably, our behavioral findings 
are not confounded by locomotor effects, given that distance moved on the elevated 
plus maze was not different between groups. In addition, the genotype and diet 
induced changes in open arm time were not paralleled by changes in closed arm 
entries, which is considered as another measurement of locomotor activity. 
Furthermore, although we conducted multiple tests in the same animals, prior testing 
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had no discernible effects on the outcomes since phenotypes of 5-HTT-/- rats on the 
control diet were very similar to those previously demonstrated in single-test studies 
(Kalueff et al. 2010).
 
Neurogenesis
In line with the behavioral data, the mixed PUFA diet significantly decreased 
hippocampal neurogenesis in 5-HTT-/- rats, bringing the amount of DCX immunoreactive 
neurons down to the level found in 5-HTT+/+ rats. While results are very similar, DCX 
holds some key advantages over the ‘gold standard’ bromodeoxyuridine (BrdU), since 
it does not require a secondary staining to identify neurons. DCX has been extensively 
validated as a neurogenic marker (Brown et al. 2003, Rao and Shetty 2004). Yet, in 
5-HTT-/- mice Schmitt et al. reported an increased proliferatory capacity of in vitro 
neuronal precursors using BrdU and the neuronal marker NeuN (Schmitt et al. 2007). 
This was, however, observed in old and not young adult mice, and was also not 
observed in vivo. Thus, although a great similarity exists between the outcomes of the 
two methods, there may be differences in the timeframe of expression of these 
markers (Brown et al. 2003). Further, it has been shown that certain behavioral tests, 
especially those that increase stress responses in 5 HTT-/- rats, can influence 
neurogenesis (Pham et al. 2005). However, our behavioral tests did not result in any 
discernible neurogenic effect. We speculate that the long-lasting effects of 3 months of 
mixed diet feeding overruled any potential effects of stress on neurogenesis. 
It has previously been reported that n-3 PUFA exposure affects neurogenesis (Kawakita 
et al. 2006, Beltz et al. 2007, Cao et al. 2009, He et al. 2009). We show for the first time 
that the effects of a mixed PUFA diet are 5-HTT genotype-dependent. Unexpectedly, 
neurogenesis was decreased in 5-HTT-/- rats fed on the mixed n-3 PUFA diet. As 
touched upon earlier, it is notable that neurogenesis measures differ across n-3 PUFA 
studies, and DCX assessments have not been obtained before. Further, several 
controversies exist in the field of hippocampal neurogenesis. For instance, both 
decreases and increases in neurogenesis have been observed in response to stress 
exposure (Rodgers and Dalvi 1997, Milad et al. 2006, Parihar et al. 2009). Likewise, 
SSRI exposure has been associated with increases in hippocampal neurogenesis 
(Santarelli et al. 2003, Wang et al. 2008), but in some studies SSRIs were without effect 
(Cowen et al. 2008, Navailles et al. 2008). A recent study showed even that chronic 
fluoxetine administration to adult mice induced a dematuration of mature granule 
cells in the dentate gyrus (Kobayashi et al. 2010). Interestingly, 5-HTT-/- rats show 
reduced amounts of brain-derived neurotrophic factor (BDNF) in the hippocampus 
and prefrontal cortex (Molteni et al. 2010a). This implies that survival of hippocampal 
neurons may be reduced, since BDNF and neuronal survival are believed to be closely 
associated (Choi et al. 2009). It is possible the reduction in BDNF thereby reduces the 
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effectiveness of the neurogenesis. The increased neural proliferation in 5-HTT-/- rats in 
the present study may reflect a compensatory mechanism. Since n-3 PUFA supplemen-
tation increases the level of hippocampal BDNF (Jiang et al. 2009, Venna et al. 2009, 
Cysneiros et al. 2010), neuronal survival may have improved, reducing the need for 
additional neurogenesis. Clearly, investigation of the ability of new neurons to survive 
and integrate into existing neural networks is needed to test this hypothesis. 
The mixed PUFA diet increased hippocampal volume in 5-HTT+/+ animals, an effect that 
has previously been reported in mice and humans as a result of n-3 PUFA mono-sup-
plementation (Conklin et al. 2007, Venna et al. 2009). We also observed increased 
hippocampal volume in 5-HTT-/- rats, which was not affected by the mixed PUFA diet. 
This indicates that the reduction in neurogenesis seen in 5-HTT-/- rats as a result of the 
dietary intervention was not accompanied by a decrease in hippocampal volume, 
suggesting that the reduction in new cell formation was compensated by increased 
neuropil production, neuron size and/or improved survival of existing neurons. It is 
worth noting that hippocampal volume was not corrected for whole brain volume or 
body weight, which may have affected the outcome. 
Limitations
A limitation of this study is that we do not have data on depression-related behavior in 
the 5-HTT-/- rat as a function of the mixed n-3 PUFA diet. Because several rats were 
excluded for lodging themselves with the front and hind paws between opposite walls 
of the glass cylinder (18 cm diameter) during the forced swim test, we did not achieve 
the statistical power necessary to make conclusive statements about depression-re-
lated behavior. Because of the importance to test the effect of the n-3 PUFA diet in the 
context of depression, we aim to elaborate the present findings to depression-like 
symptoms in future studies. We did not measure food intake during this study. 
Although our previous work has shown that there is a difference in food intake between 
female 5 HTT-/- and 5-HTT +/+ animals when expressed as calories/kg (Homberg et al. 
2010b), absolute food intake, measured in grams per rat per day did not differ between 
genotypes (data not shown). Therefore, we deem it very unlikely that measured effects 
in behavior and immunohistochemistry can be attributed to differences in diet intake. 
Furthermore, the number of animals used for the behavioral studies was low. 
Nonetheless, we obtained significant effects, and in view of animal ethics and the 
strive to limit the amount of animals we decided not to add more animals. Finally, we 
used a mixed diet that promised to exert antidepressant effects in rodents (Broersen 
2008). Here we show that this diet indeed reduces stress responses, but it remains to 
be determined whether this effect is attributed to a particular component of the diet, 
or the mixed nature of the diet. Administration of the separate components may be 
helpful to address this issue, which is also among our future aims.
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Conclusion
In conclusion, we show that a mixed n-3 PUFA diet has a profound anxiolytic effect in 
5-HTT-/- rats, and normalizes their increased neurogenesis. Although further research 
is required to understand the underlying mechanisms, our results strongly suggest 
this dietary intervention can serve as a putative therapeutic adjunctive for treating 
anxiety disorders. In particular, considering the resemblances between 5-HTT-/- 
rodents and the s-allelic variant of the 5-HTTLPR (Hariri and Holmes 2006, Kalueff et al. 
2010), and meta-analyses showing that s-allele carriers respond poorly to SSRIs (Lesch 
and Gutknecht 2005, Serretti et al. 2007), our findings may have heuristic value for 
treating 5-HTTLPR s-allele carriers suffering from mood or anxiety disorders that 
respond poorly to SSRIs.
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Summary of findings
The aim of this thesis was to investigate how serotonin transporter (5-HTT) gene 
variation and environment interact in determining the behavioral adaptation to stress. 
We targeted several negative environments that differed in intensity and designated 
optimal stress coping style, but also a positive environment (i.e., enriched diet). 
Moreover, we tested how this interaction between 5-HTT expression and environment 
evolves with ageing, targeting a critical period in brain development, i.e., adolescence. 
Cortical-subcortical developmental imbalance that occurs during adolescence is 
thought to increase the incidence of psychiatric disorders during this developmental 
period. A similar imbalance is seen in serotonin transporter linked polymorphic region 
(5-HTTLPR) short (s)-allele carriers, and may contribute to their increased risk of 
developing psychiatric disorders. In chapter 2, we set out to investigate how 5-HTT 
expression affects cortical-subcortical imbalance across adolescence, using fear 
extinction as a behavioral marker for cortical control. We assessed fear extinction and 
fear extinction recall behavior during pre-adolescence, adolescence and adulthood 
in serotonin transporter knockout (5-HTT-/-) and wild type animals, and tested 
whether potential behavioral differences observed in these developmental periods 
are accompanied by differential development of inhibitory cell populations in the 
infralimbic (IL) cortex and basolateral amygdala (BLA) by measuring regional glutamic 
acid decarboxylase (GAD) 65/67 immunoreactivity. In accordance with previous 
findings, fear extinction and extinction recall were impaired in adult 5-HTT-/- animals 
compared to wild type rats. We found that the same genotype effect can be observed 
in pre-adolescent rats, but remarkably, the effect is not present during adolescence; 
fear extinction and recall appear to be transiently normalized during this developmental 
period in 5-HTT-/- animals. While this was not accompanied by differences in GAD65/67 
immunoreactivity over development in IL and BLA, inhibitory cell populations were 
found to be decreased in the IL of 5-HTT-/- rats of all ages.
Since serotonin (5-HT) is known to play an important role in mediating the behavioral 
effects of uncontrollable stress (USt), we investigated in chapter 3 whether variation 
in 5-HTT expression modulates USt-induced adaptations in emotional behavior by 
assessing the effects of a severe USt experience on subsequent extinction of 
conditioned fear 5-HTT-/- and wild type rats. Animals were exposed to 100 inescapable 
tail shocks under restraint, or a control manipulation consisting of a period of restraint 
similar to the duration of the shock procedure, followed by a fear conditioning, fear 
extinction and extinction recall session 48, 72 and 96 hours after the inescapable 
shock or control manipulation. While fear extinction and recall were not affected by the 
USt in wild type animals, USt normalized fear extinction recall in 5-HTT-/- rats.
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Differential expression of 5-HTT is likely to affect how the dorsal raphe nucleus (DRN), 
a brain region that mediates (primarily maladaptive) behavioral consequences of USt, 
responds to USt and controllable stress (CSt). Therefore, in chapter 4, we explored 
how abolishment of the 5-HTT affects controllability-dependent stressor-induced 
activation of the DRN and prefrontal cortex (PFC) by exposing 5-HTT-/- and wild type 
animals to either a CSt signaled active avoidance (AA) paradigm, yoked signaled USt, 
or presentation of the signals used in the active avoidance context without the 
stressor. Subsequently we measured immediate early gene c-Fos immunoreactivity in 
the IL and prelimbic (PrL) region of the PFC and co-expression of 5-HT and c-Fos in the 
DRN to assess how CSt and USt affected neuronal activation in these regions. We 
found that active avoidance learning was improved as a result of 5-HTT abolishment. 
In both the IL and PrL cortices, c-Fos immunoreactivity was increased in both 5-HTT-/- 
and wild type rats that had undergone CSt, in the absence of genotype effects. 
However, no main effects of genotype were observed in terms of prefrontal or DRN 
(serotonergic) activation. Moreover, serotonergic activation in the DRN was controlla-
bility-dependent in wild type, but not 5-HTT-/- animals. Contrary to findings by others, 
DRN activation was increased in wild type rats that had been exposed to the 
controllable variant of the stressor paradigm, compared to those that experienced 
uncontrollable or no stress, and compared to all 5-HTT-/- groups. In 5-HTT-/- rats, DRN 
activation was not at all affected by stress exposure of either type. 
As 5-HTT-/- animals have demonstrated adaptive coping behavior in CSt assays, but 
maladaptive coping in settings where no control over the stressor is offered, we 
investigated whether 5-HTT affects the flexibility of stress coping response acquisition 
across different stressor types in chapter 5. To this end, we assessed behavior in 
5-HTT-/- and wild type rats during subsequent administration of fear- or sham- 
conditioning and a signaled shock active avoidance learning paradigm, in which the 
conditioned stimulus (CS) from the fear- or sham-conditioning was used to signal 
incoming shocks. Subsequently, we measured the behavioral response to that CS in a 
novel, neutral context. We found that prior fear conditioning had a small effect on 
signaled shock escape learning during AA in both genotypes, albeit only during the 
first few trials of the first escape learning session. In accordance with our findings 
described in chapter 4, we found that 5-HTT-/- rats acquired the escape response faster 
than wild types, regardless of prior fear conditioning. During the subsequent 
re-exposure to the CS in a novel context, we found that irrespective of sham- or 
fear-conditioning, CS-induced freezing was reduced in 5-HTT-/- animals compared to 
wild type animals. While fear conditioning did not affect freezing here, we found that 
the distance moved during the post AA CS exposure in 5-HTT-/- rats that had 
experienced fear conditioning, was reduced, while it did not affect distance moved in 
wild types. 
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Finally, in chapter 6, we examined the effect of a diet rich in n-3 polyunsaturated fatty 
acids (PUFA) on emotional behavior in 5-HTT-/- and wild type animals by comparing 
behavior of these animals fed either a diet rich in n-3 PUFA, B-vitamins and 
phospholipids, or an isocaloric control diet. We found that the n3-PUFA diet normalized 
anxiety, social behavior and fear extinction in 5-HTT-/- animals, while it had no effect 
on these behaviors in wild types. The behavioral normalization resulting from the n-3 
PUFA diet in 5-HTT-/- rats was accompanied by a normalization of hippocampal 
neurogenesis, which was found to be higher in 5-HTT-/- rats that were fed the control 
diet, compared to their wild type counterparts.
Fear regulation across development and influence of genetically 
induced reduction of 5-HTT 
Fear extinction efficacy has been reported to be variable across development. 
A substantial body of evidence suggests that fear extinction is transiently impaired 
during adolescence (McCallum et al. 2010, Pattwell et al. 2012, Baker et al. 2014, Baker 
et al. 2016). A general hypothesis describing the cause of this transiently impaired fear 
extinction is that the pacing of neural development of subcortical regions that facilitate 
fear conditioning and the expression of fear, and cortical regions that inhibit fear 
expression, are not synchronous (Casey et al. 2008); amygdala development completes 
before the onset of adolescence, whereas the PFC undergoes a protracted development 
that continues well into adulthood (Brenhouse and Andersen 2011). Specifically, during 
adolescence, the PFC undergoes substantial “pruning”, or synaptic loss, leading to 
significant volumetric thinning of and gray matter reduction in the cortex (Giedd et al. 
2015). This temporary imbalance is suggested to contribute to the increased incidence 
of psychiatric disorders seen during this developmental period (Casey et al. 2008). 
Rodent studies have demonstrated that the reduced efficacy of extinction during 
adolescence is accompanied by a reduced increase of phosphorylated mitogen- 
activated protein kinase (pMAPK) (Baker and Richardson 2015), as well as the absence 
of increased immediate early gene c-Fos expression in the IL following extinction 
(Pattwell et al. 2012). The finding of reduced extinction-induced pMAPK in the IL suggests 
adolescent extinction deficits result from reduced activity-dependent synaptic 
plasticity in the IL, for which pMAPK can be considered a marker (Huang et al. 2000). 
In the amygdala, plasticity that is induced by expression of (non-reinforced) conditioned 
fear is altered during adolescence as well. While pMAPK expression is upregulated in 
the adult BLA and IL after extinction and diminished in the central amygdala (CeA), 
during adolescence it is increased in CeA and reduced in BLA and IL, compared to 
animals that have not undergone fear extinction (Baker and Richardson 2015). 
Here, we investigated whether fear extinction develops differently in 5-HTT-/- rats, and 
whether this is accompanied by abnormal development of inhibitory networks in the 
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PFC and amygdala. Remarkably, we found that the impairment of fear extinction seen 
in pre-adolescent (p24) and adult (p70) 5-HTT-/- rats was transiently alleviated during 
adolescence (p35). We propose that this is attributable to an altered developmental 
trajectory of frontocortical and subcortical regions due to differential availability of 
5-HT during development in these animals. Previous research has indicated that the 
PrL frontocortical region controls expression of fear via activation of the CeA, but may 
be inhibited through a local inhibitory network via inhibitory GAD65-positive cells in 
the IL (Saffari et al. 2016), whereas inhibitory cells in the BLA, maintaining the learned 
fear association, control its excitability and may thereby attenuate fear behavior 
(Ehrlich et al. 2009). Therefore, we assessed whether 5-HTT expression dependent 
development of fear extinction behavior was related to altered development of 
inhibitory cell populations in the IL and BLA. We found that the inhibitory cell population 
in the IL was significantly smaller in 5-HTT-/- rats across all age groups. This suggests 
that activity of the PrL may be constitutively increased in 5-HTT-/- animals, which could 
not only contribute to the prolonged expression of conditioned fear seen in this 
genotype, but also to the other anxiety-related behavioral markers that appear to be 
enhanced in these animals (Olivier et al. 2008). However, it is unlikely that these 
alterations in local inhibitory networks contribute to the transient alleviation of the 
fear extinction impairment during adolescence, considering that this deficit in 
inhibitory capacity is persistent across all age groups. We observed no differences 
over development or due to genotype in the inhibitory cell populations in the BLA. 
Recent studies appointed the reduced ability to recruit NMDA receptors located in the 
IL during extinction as a root cause for impaired fear extinction during adolescence; 
while extinction in preadolescent and adult mice causes an increase in the AMPA/
NMDA receptor ratio in the IL, no such increase occurs in adolescent animals (Pattwell 
et al. 2012). Glutamatergic signaling in frontocortical areas has been suggested to 
contribute to mature higher cognitive function, and undergoes substantial development 
during adolescence (Flores-Barrera et al. 2014). In addition, new evidence suggests 
that extinction-induced plasticity operates by different mechanisms during 
adolescence, compared to extinction before and after adolescence. Specific disruption 
of the synthesis of ephrin type B receptor 2 in the IL, a receptor involved in synaptic 
remodeling, effectively inhibits extinction in adolescent, but not preadolescent or 
adult rats (Cruz et al. 2015). How these factors are modulated by available 5-HT, 
remains however largely unknown. A very recent study quantifying the expression of 
different NMDA receptor subunits revealed reduced transcription of NR1/NR2C in the 
prefrontal cortex of 5-HTT-/- rats (Karel et al. 2016). These subunits form the target 
receptors for pharmacological extinction stimulant d-cycloserin (Ogden et al. 2014), 
which has been shown to alleviate extinction deficits in adolescent rats (McCallum 
et al. 2010), but not adult 5-HTT-/- rats (Nonkes et al., unpublished observations). 
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Altogether, it seems that NMDA-mediated IL plasticity during extinction and a defunct 
local prefrontal inhibitory circuit may contribute to impaired fear regulation in 5-HTT-/- 
rats, but it remains unclear how these abnormalities develop across adolescence.
Notably, we did not replicate the finding of several others that fear extinction recall is 
transiently impaired during adolescence. Several possible reasons exist for this 
apparent discrepancy with existing literature. First, the extinction learning protocol 
used in chapter 2 may have obscured the effects of age on extinction recall because of 
its relatively long duration. Previous work has shown that utilizing an extended fear 
extinction protocol improved extinction in p35 rats, normalizing it to the levels seen in 
preadolescent and adult animals (McCallum et al. 2010), although the effects of 
extended extinction on preadolescent and adult rats were not reported. Second, the 
method of assessing fear extinction recall was different from previous paradigms, 
which used a single continuous tone to determine CS-induced freezing after extinction, 
where we utilized a protocol in which multiple CS presentations were interspersed with 
short stimulus-free periods, which was previously established to detect differences in 
fear extinction efficacy between 5-HTT-/- and wild type rats. Third, differences in the 
used rat strain may have contributed to the incongruence of findings. Here, Wistar rats 
were used, while other studies used Sprague Dawley rats. Rat strain has previously 
been shown to be an influential factor in determining the outcome of fear behavior-re-
lated experimental outcomes. For instance, lesioning of the IL, a region crucial in the 
extinction of conditioned fear in Sprague Dawley rats (Quirk et al. 2000), had no effect 
on fear extinction in Long Evans rats (Chang and Maren 2010). Beside altered effects 
of experimental manipulations, baseline fear acquisition and extinction may differ 
between strains, potentially introducing distinct floor and ceiling effects that may 
obscure or exaggerate the influence of other experimental factors (Sartory and 
Eysenck 1976). In addition, parameters of seemingly minor importance that are often 
adjusted during the optimization of behavioral paradigms, such as lighting conditions 
and habituation durations, can affect outcomes differentially depending on the animal 
strain that is used (Rex et al. 2004), making it difficult to predict how a change in rat 
strain will affect results. 
These results could be relevant for interpreting findings from studies investigating the 
effect of the 5-HTTLPR s-allele during adolescence. However, contrary to our findings, 
the 5-HTTLPR also appears to be positively correlated with the incidence and severity 
of affective disorders during adolescence (Xia and Yao 2015). In addition, adolescent 
s-allele carriers were found four times more likely to develop PTSD following a traumatic 
experience (Tian et al. 2015). A similar discrepancy with the observations in human 
s-allele carriers can be found in a developmental study of anxiety in 5-HTT-/- mice; 
increased anxiety was not seen in 5-HTT-/- mice until after adolescence (Sakakibara et 
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al. 2014), whereas the s-allele was positively associated with anxiety in human 
adolescents (Hemmings et al. 2016, Otten et al. 2016). A possible explanation for these 
incongruences is that the developmental effects of 5-HTT are possibly not synchronous 
between humans and rodents. Furthermore, the effect of age x 5-HTTLPR interaction 
on fear acquisition and extinction has not directly been studied in human subjects, 
further complicating the comparison between findings. In addition, a potential 
publication bias (i.e., not publishing of null-findings), could have contributed to 
exaggeration of the effect of the s-allele during adolescence (Munafo et al. 2008, 
Mohammad et al. 2016).
Severe inescapable stress produces unexpected amelioration of 
impaired recall of fear extinction
Severe USt is known to produce a behavioral phenotype that is characterized by 
maladaptivity as manifested by escape learning deficits and enhanced generalized 
anxiety (e.g. Maier et al. 1993). USt also affects the acquisition and extinction of 
conditioned fear, potentiating the former (Maier 1990, Baratta et al. 2007), and 
impairing the latter (Hartley et al. 2014, Hoffman et al. 2014). The effects of acute USt 
are supposedly mediated by the activation of DNR 5-HT positive neurons and 5-HT 
release from/in the DRN (Maswood et al. 1998, Grahn et al. 1999, Takase et al. 2004), 
while 5-HT levels in the amygdala and dorsolateral periaqueductal grey (dlPAG) 
increase as well (Amat et al. 1998a, Amat et al. 1998b). Similarly increased activation 
of 5-HTergic neurons in the DRN and elevated levels of 5-HT in the amygdala and dlPAG 
are induced by the exposure to a previously fear-conditioned stimulus (Zanoveli et al. 
2009, Spannuth et al. 2011). The persistence of USt-induced effects is however 
attributed to a desensitization of 5-HT1a autoreceptors situated in the DRN that 
persists as long as the behavioral adaptations resulting from USt do (Rozeske et al. 
2011). Taking into account that 5-HT1a receptors are already desensitized in naïve 
5-HTT-/- rats (Homberg et al. 2008), and that these animals are characterized by tonic 
high levels of extracellular 5-HT at baseline (Homberg et al. 2007c), it is to be expected 
that USt affects 5-HTT-/- and wild type rats differentially, and arguments for either 
exaggerated or diminished effects of USt in these animals could be put forward. 
Targeting the interaction between USt and 5-HTT genotype, we found that deficits in 
fear extinction recall in 5-HTT-/- animals were normalized in the USt group, improving 
recall to the level seen in naïve wild type animals, while USt did not affect behavior in 
wild types. This absence of an effect on fear extinction recall in wild types could be 
explained using findings from others, which suggest the most prominent effects of USt 
on conditioned fear lie in the acquisition thereof instead of its extinction (Rau et al. 
2005, Baratta et al. 2007, Herrmann et al. 2012). Effects in extinction learning and 
recall have been reported as well, but mainly following chronic stress paradigms 
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(Miracle et al. 2006, Hoffman et al. 2014). However, we also did not observe any effects 
of USt on the acquisition of fear. It is possible that such effects (in wild types, but also 
in 5-HTT-/- rats) have been obscured by our conditioning paradigm, which was 
sufficiently severe to induce the maximum level of freezing upon first presentation of 
the CS in all experimental groups. 
Due to the phenomenon that the expected USt-like serotonergic adaptations (such as 
5-HT1a desensitization) are already present in naïve 5-HTT-/- animals, it is possible that 
the serotonergic mechanisms described to mediate behavioral despair, operate 
differently or are irrelevant to the USt-induced modulation of fear behavior in these 
animals. For example, it is unknown whether the increase in extracellular 5-HT during 
and following USt exposure, or further adaptations to 5-HT1a receptor expression and 
function, occur in 5-HTT-/- animals. Studies into the effects of chronic selective 
serotonin reuptake inhibitor (SSRI) treatment, elevating circulating 5-HT levels, can 
provide valuable insight in the mechanistic effects of constitutively increased 5-HT 
levels (Popa et al. 2010), although importantly, they do not model the neurodevelop-
mental effects of genetic abolishment of 5-HTT. Moreover, chronic SSRI treatment 
seems to exert behavioral effects opposite to those of genetic 5-HTT abolishment and 
reduce fear acquisition (Burghardt et al. 2004). Elevation of circulating 5-HT levels (by 
chronic SSRI administration) suppresses the acquisition of fear by means of 
downregulation of NMDA receptor subunit NR2B in the amygdala (Burghardt et al. 
2013), a parameter which was found to be unaffected by 5-HTT abolishment (Karel et 
al. 2016).  Notably, chronic SSRI treatment does not reverse stress-induced deficits in 
fear extinction, whereas it does alleviate the anxiogenic effects of this stressor (Lin et 
al. 2016). As already mentioned, neurodevelopmental effects may account for this 
apparent discrepancy. In particular, altered development of the serotonergic 
projections from DRN to PFC (Witteveen et al. 2013), which are functionally relevant in 
mediating the behavioral effects of stress (Waselus et al. 2011), could play a role.
As we only looked at fear acquisition and extinction learning and recall, we cannot 
determine whether USt exposure actually induced a broader set of (adaptive) 
behavioral effects. Previous work has shown that USt exposure was ineffective in 
inducing escape learning deficits in 5-HTT-/- animals (van der Doelen et al. 2013), 
corroborating our finding that USt affects wild type and 5-HTT-/- rats differently. It 
remains to be investigated to what degree the serotonergic mechanisms to which 
USt-induced behavioral adaptations are ascribed are applicable in 5-HTT-/- animals, 
and how these may be affected by pre-existent serotonergic and non-serotonergic 
adaptations, such as desensitization of 5-HT1a receptors at baseline (Homberg 
et al. 2008).
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The controllability-dependent effects of 5-HTT abolishment  
on stress-induced DRN activation
As discussed previously in chapters 1 and 3, 5-HT signaling emerging from the DRN 
mediates the effects of uncontrollable stress on subsequent behavior. In chapter 4, we 
examined activation of 5-HTergic neuron population in the DRN after a controllable 
stressor, a yoked uncontrollable stressor, or a control manipulation. A signaled active 
avoidance paradigm was used as the controllable stressor, while the uncontrollable 
stress cohort received the same amount of shocks and signals in the same order 
without any element of control. The control group was only exposed to the signals.
Acquisition of signaled active avoidance is said to be dependent on overcoming the 
freezing response due to the CS-US contingency that is formed during the initial, failed 
AA trails (Moscarello and LeDoux 2013). As passive exposure to unreinforced CS 
presentations (as happens during typical fear extinction paradigms) has been shown 
to be less effective in reducing CS-induced freezing in 5-HTT-/- rats, these animals were 
expected to display stronger CS-induced freezing and thereby impaired AA learning. 
However, surprisingly, 5-HTT-/- rats acquired the active avoidance task faster than their 
wild type counter parts. 
5-HTergic activation in the DRN was increased in wild type animals that had undergone 
controllable stress compared to those that had undergone uncontrollable stress or no 
stress. This is incongruent with other reports, which state that DRN activation of 
5-HTergic neurons, as assessed through measuring immunoreactive co-labeling for 
immediate early gene c-Fos and 5-HT, is increased after uncontrollable stress, while 
animals that have undergone controllable stress maintain the low level of 5-HT activity 
seen in unstressed animals (Grahn et al. 1999, Amat et al. 2005). This discrepancy can 
most likely be attributed to differences in experimental proceedings (refer to Elements 
of controllability further in this chapter). Contrary to our findings in wild type animals, 
stressors of either type had no effect on 5-HTergic activation in the DRN of 5-HTT-/- 
rats, indicating stress-dependent 5-HT signaling is altered in 5-HTT-/- animals. Control 
over a stressor has been reported to suppress 5-HT signaling from the DRN by means 
of activation of the PFC (Amat et al. 2005). Indeed, we found IL and PrL activation to be 
increased in animals that had experienced the controllable stressor. However, this IL 
and PrL activation was not influenced by genotype, offering no explanation for the 
improved AA performance or altered controllability dependent serotonergic DRN 
signaling in 5-HTT-/- rats. Moreover, we found that time to avoidance/escape was 
positively correlated with 5-HT/c-Fos double labeling in wild type, but not 5-HTT-/- rats, 
implying that poor performance and thereby a greater quantity of experienced stress, 
was related to increased 5-HTergic DRN activation in wild type animals, but not in 
5-HTT-/- rats. Apparently, the 5-HTergic stress circuitry operates differently in 5-HTT-/- 
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rats. Enhanced 5-HT signaling mediated by 5-HT1a receptor desensitization in the DRN 
after uncontrollable stress has found to be a requirement for the behavioral adaptations 
resulting from uncontrollable stress experience (Rozeske et al. 2011). However, 5-HT1a 
receptors are desensitized at baseline in 5-HTT-/- rats (Homberg et al. 2008), and 
extracellular levels of 5-HT are tonically elevated (Homberg et al. 2007c). Given this, 
it should be expected that controllability-dependent behavioral consequences 
resulting from these stressor experiences may be most prominent in wild type animals 
that underwent the controllable stressor manipulation, not the uncontrollable stress, 
and may be absent entirely in 5-HTT-/- rats.
The influence of 5-HTT abolishment on passive-to-active stress cue 
retraining 
Acquiring signaled active avoidance training is dependent on suppressing the PrL-CeA 
mediated fear response that is forged during initial unsuccessful trials, wherein the 
stressor is perceived as inescapable and thus serves as unconditioned stimulus (US) 
that is paired to the AA signal that precedes it (serving as conditioned stimulus (CS)) 
(Lazaro-Munoz et al. 2010, Moscarello and LeDoux 2013). Thereby, animals that have 
acquired a fearful response to the AA signal prior to AA learning should exert delayed 
acquisition of the AA response compared to animals which are familiarized with the CS 
in a neutral setting (provided that the degree of familiarization was not sufficient to 
induce latent inhibition (Schauz and Koch 1998)). While fear extinction and AA 
acquisition are closely related in their mechanistic underpinnings (both relying on the 
IL to inhibit the PrL- and CeA-mediated fear response), 5-HTT-/- rats exert a seemingly 
contradictory behavioral phenotype featuring impaired fear extinction in conjunction 
with improved signaled AA acquisition. Apparently, 5-HTT-/- rats can display greater 
adaptability in their stress coping behavior when they are given means to actively 
respond to a stimulus signaling danger, while inflexibility (i.e., the delayed updating of 
the CS contingency in response to non-reinforced presentations) is seen when these 
possibilities are limited (such as observed during (passive) fear extinction) (Nonkes et 
al. 2012a). 
We hypothesized that 5-HTT-/- rats would be able to overcome the passive coping 
response to a previously learned CS-US association by offering control over it. To test 
this hypothesis, fear-conditioned and sham-conditioned 5-HTT-/- and wild type rats 
were trained in a signaled AA test using the fear CS to signal oncoming shocks. 
Unexpectedly, the effect of fear conditioning on AA acquisition tempo was only 
modest, with a significant effect being discernible only within the very first AA trials. In 
accordance with our earlier finding (chapter 4), 5-HTT-/- animals acquired the AA 
response faster than wild type rats, regardless of prior conditioning. When we assessed 
the behavioral response to the CS in a neutral, novel context after fear/sham 
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conditioning and AA learning, wild type animals exerted a higher degree of freezing 
than 5-HTT-/- rats, both before and during presentations of the CS. The stronger passive 
coping response to both novelty and the CS in wild types indicates that AA training 
may have been more stressful for these animals. Increased freezing in response to the 
novel context seen in wild types suggests increased anxiety that may potentially result 
from the generalization of contextual cues acquired during AA learning. This finding is 
however not in line with other reports on novelty-induced freezing in 5-HTT-/- rats as 
recorded prior to fear extinction; reporting on higher (Shan et al. 2014), similar (Nonkes 
et al. 2012a), and lower (Schipper et al. 2011a) levels of freezing compared to wild 
types, under similar experimental conditions. Most likely, experiences prior to the 
novelty exposure, such as AA learning in the case of the present study, contribute to 
variations in novelty-induced anxiety in a 5-HTT genotype dependent manner.
Although fear conditioning prior to AA learning had no discernible effect on freezing 
during post AA exposure to the CS, locomotor activity - expressed as the distance 
moved during CS presentation - was reduced by fear conditioning in 5-HTT-/- rats, while 
the (overall low) level of mobility in wild types was not affected by fear conditioning. 
As baseline locomotor activity is not affected by 5-HTT genotype (Homberg et al. 
2010a), these differences can likely be attributed to the stressor experience. The 
increased mobility as observed in the 5-HTT-/- animals may be interpreted as them 
adopting a more active coping style, which is reduced by prior fear conditioning 
leading to favoring more passive behavioral coping in these animals. However, the 
animals’ motivation for the increased mobility here cannot be discerned from these 
data alone. Enhanced locomotion in the presence of novelty or stressors is frequently 
observed in rodent strains known for, or individual rodents selected for, their active 
coping style (Tsuda et al. 1988, Veenema et al. 2003, Boersma et al. 2009, Boersma et 
al. 2011), even though it is not regarded as a defining quality of an active coping style 
as such (de Boer et al. 2016). In summary, we conclude fear conditioning causes only 
minor interference with CS-signaled active avoidance learning, and that the improved 
acquisition of AA in 5-HTT-/- rats leads to a decreased residual fear response to 
subsequent encounters with the CS in these animals.
A diet rich in omega-3 polyunsaturated fatty acids normalizes  
the behavioral profile of 5-HTT-/- rats
n-3 PUFAs have been deemed essential nutritional elements, implicated in the healthy 
development and function of the brain (Rathod et al. 2016). Accumulating evidence 
suggests that dietary supplementation with n-3 PUFAs docosahexanoic acid (DHA) 
and eicosapentanoic acid (EPA) may improve therapeutic outcomes of patients 
suffering from MDD (Sinn et al. 2010). n-3 PUFA supplementation enhances 
hippocampal neurogenesis, a form of cellular plasticity that is thought to be decreased 
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in MDD patients (Kawakita et al. 2006). However, findings from clinical trials in which 
their efficacy as therapy or therapeutic adjuvant in the treatment of psychiatric 
disorders is tested, have been uneven, with many studies reporting absence of (thera-
peutically relevant) beneficial effects (Bloch and Hannestad 2012, Appleton et al. 
2015). This may reflect existing heterogeneity within patients suffering from this 
disorder, as depression can be caused by a wide array of triggers and vulnerability 
factors, of both genetic and environmental nature. Possibly, a specific subset of these 
patients can benefit from the therapeutic actions of additional dietary intake of 
n3-PUFAs, while others do not.
As 5-HTT-/- rats exert a number of behavioral features that resemble those seen in 
depression, such as reduced social interaction, anhedonia, and despair-like behavior 
in the forced swim test (discussed later in the section Disentangling stress coping in 
5-HTT-/- rats) (Kalueff et al. 2010), we hypothesized that n-3 PUFA supplementation 
could ameliorate these symptoms. Given that improvement of hippocampal 
neurogenesis is the main proposed mechanism for antidepressant action of n-3 PUFA 
supplementation (as well as many other antidepressant treatments) (Santarelli et al. 
2003), we assessed whether any behavioral changes were accompanied by alterations 
in this type of plasticity. We found that while a diet rich in n-3 PUFAs had no effect on 
behavioral parameters in wild type rats, it normalized levels of anxiety, social 
interaction and fear extinction in 5-HTT-/- rats. Surprisingly, baseline neurogenesis was 
increased in 5-HTT-/- rats, and was normalized to the lower level seen in wild types fed 
on either type of diet. We hypothesized that previously observed reductions in 
hippocampal BDNF reduce neuronal survival in the hippocampus of 5-HTT-/- rats 
(Molteni et al. 2010b, Gray et al. 2013), which thereby requires additional compensatory 
neurogenesis. n-3 PUFA supplementation may have promoted neuronal survival, 
thereby eliminating the need for this compensation. However, as hippocampal 
apoptosis was not assessed, we cannot state this with certainty.  
Hippocampal neurogenesis affects fear extinction in multiple ways. Ablation of 
hippocampal neurogenesis impairs extinction of contextual fear (Pan et al. 2012). 
Conversely, boosting neurogenesis enhances pattern separation, and may thereby aid 
in reducing the generalization of conditioned fear response (Sahay et al. 2011), which 
is thought to contribute to the pervasiveness of trauma-related conditioned fear 
present in post-traumatic stress disorder (Lopresto et al. 2016). However, the present 
findings suggest an opposite relationship in 5-HTT-/- animals, with excessive 
neurogenesis prolonging the conditioned fear response. Notably, abolishment of 
5-HTT and chronic SSRI administration both elevate extracellular 5-HT levels as well as 
hippocampal neurogenesis. However, as mentioned before, in spite of this mechanistic 
similarity, their behavioral outcomes in terms of fear processing and anxiety are 
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opposite. In order to definitively determine whether neurogenesis is instrumental in 
causing the emotional behavioral patterns seen in 5-HTT-/- rats, and whether behavioral 
changes due to n-3 PUFA supplementation are mediated by decreased neurogenesis 
or changes in neuronal survival, future studies implementing an apoptotic assay and 
selective reduction of neurogenesis using focal irradiation may prove informative 
(Tada et al. 2000). 
Disentangling stress coping in 5-HTT-/- rats 
Genetically reduced expression and function of 5-HTT has previously been reported to 
increase an individual’s sensitivity to stress (Caspi et al. 2010, Karg et al. 2011), and 
different tendencies in behavioral coping strategies have been suggested as a 
mediating factor therein (Wellman et al. 2007, Schillani et al. 2012, Cline et al. 2015). 
While data obtained from 5-HTT-/- rats corroborate the link between 5-HTT expression 
and altered stress coping and sensitivity, only a limited subset of stressful behavioral 
assays support the notion that 5-HTT abolishment increases stress sensitivity or 
diminishes the ability to adapt the coping response to suit the given stressor. That is, 
5-HTT-/- rat behavior in signaled AA (chapter 4) and learned helplessness assays (van 
der Doelen et al. 2013) fits the interpretation of adaptive behavior, while their behavior 
during fear extinction (Nonkes et al. 2012a) and the Porsolt forced swim test (FST) 
(Olivier et al. 2008) can be interpreted as maladaptive and matches human findings. In 
this sense, the behavioral stress coping profile in these animals appears paradoxical 
at times, and whether 5-HTT-/- animals can adapt to the challenge a stressor imposes 
on them, seems to be strongly dependent on the type of stressor and the exact 
context. Here, we will attempt to define what stressor properties determine the effect 
of 5-HTT abolishment on stressor coping and subsequent behavioral adaptation.
5-HTT-/- rats show a persistent passive coping response to a conditioned fear response, 
even upon repeated non-reinforced exposure to the CS. Yet, during signaled AA 
learning, initial failure to escape the signaled stressor, which has been reported to 
induce freezing and inhibit AA acquisition (Moscarello and LeDoux 2013), does not 
induce a (lasting) passive coping response in these animals, as AA responding was 
not delayed, but in fact accelerated, in 5-HTT-/- rats (chapter 4, chapter 5). Similarly, 
establishment of a passive coping response to a CS by fear conditioning does not 
impair CS signaled AA learning in these animals (chapter 5). A parallel of sorts to these 
findings can be observed when comparing the behavior of 5-HTT-/- rats in assays of 
learned helplessness assays behavioral despair. The induction of escape deficits 
through inescapable shock exposure and the FST share several conceptual and 
mechanistic similarities; both initial stressor experiences elicit passive coping 
behavior in the subsequent assay (Porsolt et al. 1977, Maier 1990), which is reduced by 
antidepressant (but not anxiolytic) treatment, leading to the interpretation that 
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USt-induced passive coping can be described as ‘depressive-like’ (Porsolt et al. 1977, 
Sherman et al. 1982). However, a crucial difference between the two assays is that the 
conditions under which post-stress behavior is tested either allow for the animal to 
escape the stressor (i.e., in the shock escape test), or not (in the FST). 5-HTT-/- rats 
show increased passive coping in the FST (Olivier et al. 2008), while they are resistant 
to USt-induced deficits in shock escape learning (van der Doelen et al. 2013). This 
could imply that these animals have an improved capacity to determine whether their 
behavioral efforts can actually influence the stressor, i.e., whether the stressor is 
escapable or not. It can be argued that 5-HTT-/- animals appropriately adapt their 
coping response to the situation, conserving energy by showing passivity when 
behavior does not influence the outcome (in the FST), while making an effort to escape 
the stressor when it is escapable (in a shock escape assay). By extension, the more 
active coping response seen in the FST after antidepressant treatment may actually be 
interpreted as a shift towards a maladaptive coping response, as the additional efforts 
expended in attempting to escape the water basin will not improve the outcome for 
the animal. A recent evaluation of the FST corroborates this, and suggests that FST 
outcomes should instead be interpreted as an assessment of whether an animal can 
recall the (un)controllability of the repeated stressor (de Kloet and Molendijk 2016). A 
parallel can be drawn between these findings and the seemingly discrepant outcomes 
from fear extinction and signaled AA assays in 5-HTT-/- rats. While prolonged freezing 
in response to a fear CS is interpreted as a maladaptive coping response, whether the 
animal freezes or not has no real influence on the animal’s wellbeing. Potentially, the 
5-HTT-/- rat correctly determines that the environment in which post-conditioning 
freezing is assessed offers no opportunities to interact with the stressor, thereby 
causing it to adopt a conservational coping response (i.e., freezing). On the other 
hand, during a signaled AA assay, it correctly identifies the stressor as controllable, 
and appropriately adopts an active coping response. 
During typical rodent fear extinction assays, conditioned stimuli are presented in a 
novel, neutral environment, where possibilities to exert active coping behavior other 
than exploration are few. In a study examining the influence of a form of behavioral 
therapy on fear extinction in 5-HTT-/- rats, it was found that when fear-CS presentations 
were combined with the presentation of distracting appetitively conditioned stimuli 
(which were previously paired with the arrival of a food pellet in an available dispenser), 
5-HTT-/- rats did not freeze more than wild type animals during extinction training or 
extinction recall (Nonkes et al. 2012a). This effect was present regardless of whether 
the appetitive stimulus contingency was reinforced during the extinction. Here, 
animals had to balance a conservative freezing response with their motivation to 
collect the food pellet, and similar to a signaled AA paradigm, a freezing response 
would interfere with another competing survival oriented response (i.e., pellet 
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collection), yet this response does not directly influence the stressor (i.e. the aversive 
CS presentation). While exploration of novel contexts elicits similar activity from 
5-HTT-/- and wild type rats (Homberg et al. 2010a), it is possible that fear interferes 
specifically with novelty exploration. The reduction in freezing in 5-HTT-/- rats due to 
the aforementioned ‘behavioral therapy’ was maintained when CS-induced freezing 
was assessed 5 days after the last extinction session, without the presence of the 
appetitive stimulus. This implies that this ‘behavioral therapy’ had a lasting impact on 
the CS-associated fear response in 5-HTT-/- rats. The availability of an operant response 
mechanisms to deactivate the stressor may have had a similar distracting function in 
signaled AA. However, it is presently unclear how (consolidation of) extinction memory 
is persistently improved in this manner. It is possible that failed extinction recall, as 
occurs in 5-HTT-/- rats in the control condition, maintains or increases the fear response 
to the CS due to the aversiveness of the CS presentations only in the absence of 
distractor stimuli. However, additional data are needed to verify this.
In conclusion, experimental observations here and elsewhere support the notion that 
5-HTT-/- animals exert a coping profile that is not necessarily slanted towards 
maladaptive, passive coping, but instead may be better adjusted to the situational 
demands, and therefore in fact more adaptive than that seen in wild types. The lack of 
congruence between behavioral outcomes in different paradigms that are supposedly 
directed by similar mechanisms might suggest availability of control and the means to 
exercise it in these paradigms may be better detected by 5-HTT-/- animals. This may 
misdirect our interpretation of their behavior in certain situations (e.g., in fear 
extinction), leading us to conclude that 5-HTT abolishment results in favoring passive 
stress coping strategies. Coping behavior in these animals may be heavily dependent 
on the opportunities that the environment offers, but additional studies are needed to 
determine which environmental conditions direct active and passive coping.
Extrapolating these findings to the human situation is not straightforward, as both the 
coping strategies and encountered stressors differ vastly between rodents and 
humans. As briefly discussed in chapter 1, the human 5-HTTLPR s-allele has also been 
seen to modulate stress coping, although defining coping here as adaptive, 
maladaptive, (pro)active, or passive is rather problematic. Coping in humans primarily 
consists of self-reported attitudes towards adversity and mental coping mechanism 
and is measured retrospectively through questionnaires and interviews. In contrast, 
stress coping in animal models is assessed through the behavior that is displayed in 
response to experimental stressors; (lack of) behavioral responses and latencies are 
then interpreted and categorized, and attitudes towards adversity are deduced. While 
coping is understood to be important in mitigating the effects of adversity, finding 
parallels between coping studies in humans and animals is complex. Nevertheless, as 
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discussed in chapter 1, 5-HTTLPR seems to influence the reported coping strategies in 
humans in several ways. The degree to which problems are externalized was found to 
be greater in children carrying two s-alleles, which also utilized distraction coping 
styles more often (Cline et al. 2015). Emotional eating, a coping mechanism that is 
sometimes seen in MDD, is more frequent in s-allele carriers compared to l-allele 
carriers (van Strien et al. 2010). Moreover, rumination, or engaging in a negative spiral 
of self-deprecating thought, is a coping strategy that occurs more frequently in s-allele 
carriers (Canli et al. 2006, Clasen et al. 2011) (but see (Beevers et al. 2009)). Rumination 
is primarily seen as a maladaptive coping strategy: it elevates the level of cortisol for a 
prolonged period of time (Zoccola and Dickerson 2012), suggesting it greatly increases 
allostatic load, and it is said to amplify negativity (Nolen-Hoeksema 2000). Another 
coping behavior that can almost certainly be designated as maladaptive is drinking-
to-cope, or (excessive) alcohol intake to help cope with adversity. Interestingly, s-allele 
carriers report a reduced motivation for drinking alcohol as stress coping strategy 
(Armeli et al. 2008). Altogether, it is clear that genetically determined variation in 
5-HTT expression and function affects stress coping strategy in humans as well as 
rodents. However, it is presently not known to what degree these differences in coping 
preference mediate alterations in susceptibility to stress-related disorders.
 
Elements of controllability
The concept of stressor controllability has been mainly explored by means of various 
stress manipulations in rodents. These offer several advantages over studies in human 
subjects; greater control over experimental conditions (including rearing circumstances 
and genetic and epigenetic factors) and the availability of invasive experimental 
techniques that can provide a higher level of detail than what can be obtained in 
humans. However, translation of rodent data to the human situation can be difficult, 
and depends on how closely one can model the environmental and genetic factors 
that contribute to the pathogenesis of human stress-related disorders, as well as the 
relevant behavioral readouts (Homberg 2013). 
Stressor controllability, and particularly its interaction with the serotonergic system, 
has been studied primarily using the triadic wheel turning paradigm in rats (described 
in chapter 1, box 1). This design elegantly equalizes the quantity of the given stressors 
between the CSt and USt animals by ‘yoking’ their behavioral experience; applying all 
shocks the CSt animal failed to escape from to the USt animal as well. Controllability is 
defined here as being able to influence stressor exposure; the CSt animal can directly 
terminate shocks by manipulating the wheel, while the USt animal receives shocks 
regardless of its efforts. In a different type of controllability assay, animals are 
restrained by the tail while receiving tail shocks and  controllability is determined by 
the availability of a wooden dowel to chew on, which USt animals do not have 
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(Helmreich et al. 2012). Here, controllability is defined as the presence of a behavioral 
outlet for coping, even though the stressor itself cannot be influenced or escaped 
from. Yet, the realization of this type of controllability induces a similar distinction in 
phenotypical outcomes between CSt and USt experienced animals to that observed in 
triadic wheel turning experiments (Maier and Watkins 2010), with CSt animals 
displaying lower levels of anxiety in open field and social exploration paradigms than 
their USt counterparts (Helmreich et al. 2012). This raises the question of how control-
lability should be defined; either as control over the stressor or control over coping 
behavior.
In determining whether a stressor is controllable, a distinction could first of all be 
made on the basis of whether the subject perceives the stressor as susceptible to 
behavioral manipulation. To meet this criterion of controllability, behavior that leads to 
circumvention or aborting of the stressor should be goal-oriented, and motivated by 
this outcome. Goal-oriented behavior has been found to be a prerequisite for 
instrumental controllability (Amat et al. 2014), and is mediated through a prelimbic–
dorsomedial striatal circuit (Balleine and O’Doherty 2010) both in rodents and humans 
(Balleine and O’Doherty 2010). In contrast, habitual behavior prevents goal-directed 
behavior. Habitual behavior is mediated by a circuit of the dorsolateral striatum and 
sensorimotor cortex (Shiflett and Balleine 2011), and appears to prevail over 
goal-directed behavior under stressful circumstances; an effect mediated by 
β-adrenergic activity (Schwabe et al. 2011). Activation of the dorsomedial striatum 
during CSt is necessary for its protective effects, and blocking its activity gives CSt 
properties and consequences similar to those of USt (Amat et al. 2014). The shift 
between habitual and goal-oriented behavior is mediated by the orbitofrontal cortex 
(Gremel and Costa 2013). In 5-HTT-/- rats, improved cognitive flexibility in a reversal 
learning test was found to be accompanied by enhanced activation of this cortical 
region (Nonkes et al. 2010). Potentially, this is directed by the same mechanisms that 
facilitate the detection of instrumental controllability in these animals.
Otherwise, the ability of the subject to engage in coping behavior that does not affect 
stressor exposure could contribute to the experience of controllability. This 
phenomenon has also been referred to as ‘stress blunting’ displacement behavior 
(Berridge et al. 1999), and is exemplified by the aforementioned wood dowel stress 
paradigm. Multiple studies have confirmed that the availability of indigestible chewing 
materials alters the neuroendocrine stress response; corticosterone release in 
response to novelty exposure was found to be decreased in the presence of 
non-digestible chewing materials, but not by highly palatable food (Hennessy and Foy 
1987). In addition, the corticotropin releasing factor (CRF) response to restraint was 
diminished in animals that had a wooden dowel available (Hori et al. 2004), although 
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this was not the case for experiencing tail shocks (Helmreich et al. 2012). Furthermore, 
the restraint stress-induced inhibition of hippocampal neurogenesis was prevented by 
allowing mice to chew indigestible material during the restraint period (Kubo et al. 
2009). In contrast, while only limited evidence is available, it is suggested that the 
neuroendocrine stress response in instrumental controllability assays (such as triadic 
wheel turning) is not different between CSt and USt experienced animals; CRF levels in 
the paraventricular nucleus after CSt and USt wheel turning experience are not different 
(Helmreich et al. 1999) nor are plasma levels of ACTH and CORT (Maier et al. 1986). 
However, when foot shocks were given in an escapable or inescapable fashion, plasma 
CORT levels were increased in rats that had experienced inescapable shock relative to 
those that experienced escapable ones (Swenson and Vogel 1983). In terms of 
stress-induced 5-HT release, differences between the CSt- and USt-elicited serotonergic 
response are known to occur in triadic wheel turning assays (Amat et al. 1998b), but 
availability of chewing material does not affect a novelty-induced serotonergic 
response in rats (Berridge et al. 1999). In summary, the mode of controllability has 
clear effects on HPA-axis mediators and stress-induced 5-HT release, but also appears 
to heavily depend on the dimension and severity of the stressor used. Many of the 
‘stress blunting’ studies use restraint as a stressor, which may be less aversive than 
the tail and foot shocks often utilized in instrumental stressor controllability assays.
As 5-HTT-/- rats feature a wide array of adaptations in both functioning of the HPA-axis 
and serotonergic system (Homberg et al. 2007c, Homberg et al. 2008, van der Doelen 
et al. 2014b, van der Doelen et al. 2015), it seems likely that resilience in these animals 
is strongly determined by the aforementioned stressor parameters. The dimension of 
the stressor (be it physical or psychological), its severity, and degree and type of con-
trollability are likely to influence how variations in 5-HTT expression contribute to 
vulnerability or resilience to it. The findings described in this thesis clearly indicate 
that describing 5-HTT expression as a factor that simply enhances or limits stress 
vulnerability is an oversimplification. Specifically, 5-HTT-/- animals may find controlla-
bility in stressors that wild type animals find unsurmountable, while (perhaps 
accurately) assessing the situation is out of their hands in other settings. The general 
consensus on how outcomes from behavioral assays are interpreted may lead to 
inaccurate conclusions in this regard; in assays in which 5-HTT-/- animals cannot 
control exposure to the stressor, they exert behavior that we interpret as maladaptive, 
e.g., freezing during fear extinction and floating during a FST. It is possible that this 
alternative perspective on controllability may benefit 5-HTT-/- animals in some 
situations, and harm them in others. 
These findings may give nuance to stress vulnerability in 5-HTTLPR s-allele carriers as 
they suggest that controllability may modulate the effects of stress differently in these 
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individuals. However, at this time, neuropsychiatric research describing controllabili-
ty-dependent effects of stress exposure on the risk of developing mood disorders in 
human populations is scarce. Controllability can be defined very clearly in instrumental 
stress escape and avoidance paradigms, in rodents (as discussed above) as well as in 
humans, in laboratory settings (Hartley et al. 2014, Wood et al. 2015); a stressor and 
some operant means of turning it off that either works or not are all that is needed. 
However, defining controllability in the real-life stressors that contribute to the 
development of stress-related disorders, like chronic stressors such as work stress, 
but especially in highly traumatic stressors of an acute nature such as sexual abuse 
and violence, can be problematic. Many traumatic stressors contain a social element, 
such as the interaction with an aggressor. While active and passive coping behaviors 
are frequently studied using paradigms of social interactions, for instance by assessing 
attack latency in a resident-intruder paradigm (e.g. (de Boer et al. 2016)), it is not 
known how these relate to controllability. Ostensibly, adopting an active coping style 
could be viewed as an attempt to gain control over a stressor, and upon successfully 
doing so the stressor may exert CSt properties. However, this is highly speculative and 
currently unsubstantiated by experimental findings. 
Considering the high likelihood of the involvement of social components in traumatic 
stress, defining the boundaries of controllability in a social context is highly relevant, 
but a very delicate issue. As controllable stress is understood to be less harmful than 
uncontrollable stress (Maier and Watkins 2010), categorizing traumatic events that 
lead to the development of stress-related disorders as “controllable” may even be 
harmful to victims. After all, implying that a victim has “control” over a traumatic 
incident is tantamount to putting responsibility for such an incident and its sequelae 
in the hands of the victim. Considering that self-blaming and decreased sense of 
self-worth are important features of both PTSD and MDD (American Psychiatric 2013), 
it is even possible that a greater degree of perceived controllability in such a traumatic 
event is detrimental to a victim, instead of empowering.
In animal studies, the concept of controllability is generally studied with the aim of 
assessing how the risk of a stressor contributing to psychiatric illness is modulated by 
its controllability, and by which mechanisms. In human literature, however, controlla-
bility is conceptualized as a cognitive psychological coping mechanism. It has been 
suggested that engendering a sense of controllability over factors that generate stress 
in life can empower and activate those suffering from MDD (Duckworth et al. 2005, 
Seligman et al. 2006). The findings in this thesis suggest that “giving control” over 
stressors provide the greatest benefit to animals with reduced expression of 5-HTT. In 
parallel with this, 5-HTTLPR s-allele carriers may benefit more from cognitive therapy 
that emphasizes the (perception of) control over situations and stressors. 
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Depressieve en angststoornissen zijn ingrijpende aandoeningen die vaak voorkomen 
en een hoge ziektelast veroorzaken. Hoe deze aandoeningen ontstaan is niet precies 
bekend, maar duidelijk is wel dat stress hierin een grote rol speelt. We begrijpen ook 
nog niet goed waarom sommige mensen ten gevolge van stress wel een psychiatrische 
aandoening krijgen, en anderen niet. Genetische factoren kunnen daarin een rol 
spelen. Het is bekend dat een genetische factor die beïnvloedt in welke mate de 
serotonine transporter (5-HTT) aangemaakt wordt, de zogenaamde “5-HTT linked 
polymorphic region” (5-HTTLPR), mede bepaalt hoe gevoelig een individu is voor 
stress. Bij dragers van korte variant hiervan, het short (s) allel, wordt minder 5-HTT 
aangemaakt in het brein. Klinische studies hebben aangetoond dat depressieve en 
angststoornissen vaker voorkomen bij dragers van dit s-allel, en dat dit effect versterkt 
wordt door traumatische gebeurtenissen. Een theorie over de relatie tussen 5-HTTLPR 
en stressgevoeligheid is dat het verband hiertussen zijn oorzaak vindt in hoe s-allel 
dragers met stress omgaan: dit wordt “stress coping” gedrag genoemd. Succesvol met 
een stressor omgaan is in sterke mate afhankelijk van of het individu zijn stijl van 
coping kan aanpassen aan de specifieke stressor. Sommige stressoren worden het 
beste benaderd met een actieve coping strategie, waarbij het individu inspanningen 
verricht om de stressor bij de bron aan te pakken (te confronteren), of eraan te 
ontkomen. Andere stressoren vereisen een passieve coping strategie, waarbij het 
individu de stressor “ondergaat” en daarbij probeert leed en letsel tot een minimum te 
beperken, en energie te conserveren. 
In het onderzoek dat wordt beschreven in dit proefschrift wordt getracht de relatie 
tussen de expressie van 5-HTT en stress coping gedrag te beschrijven. Hiervoor wordt 
gebruik gemaakt van ratten die via genetische modificatie verminderd (5-HTT+/-) of 
geen 5-HTT (5-HTT-/-) aanmaken. Het uitvoeren van dit onderzoek in ratten in plaats 
van in menselijke proefpersonen heeft twee belangrijke voordelen. De experimentele 
stressoren die toegepast kunnen worden in proefdieronderzoek zijn heviger, en 
daarmee traumatischer, dan wat toelaatbaar is in gezonde humane proefpersonen, en 
beter te standaardiseren, kwalificeren en kwantificeren dan (retrospectief) mogelijk in 
menselijke patiënten die lijden aan stress-gerelateerde psychiatrische aandoeningen. 
Bovendien kunnen door middel van invasieve experimentele technieken belangrijke 
inzichten vergaard worden over welk effect deze stressoren hebben op het brein. Deze 
5-HTT-/- ratten hebben veel gedragsmatige overeenkomsten met menselijke s-allel 
dragers: ze zijn angstiger en vertonen slechte uitdoving van een geconditioneerde 
Pavloviaanse angstrespons. Bij Pavloviaanse angstconditionering wordt een neutrale 
stimulus, zoals bijvoorbeeld een toon, gekoppeld aan een aversieve stimulus, 
zoals bijvoorbeeld een milde elektrische schok, door deze na elkaar te presenteren. 
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De daarop volgende associatie tussen beide stimuli kan worden bepaald door de 
angstrespons (“freezing”) op de neutrale stimulus (de toon) te meten, en worden 
uitgedoofd door deze herhaaldelijk te presenteren in de afwezigheid van de aversieve 
stimulus (de schok). Het afleren van zo’n negatieve associatie is belangrijk in de 
succesvolle behandeling van het post-traumatisch stress syndroom, een aandoening 
die vaker voorkomt en moeilijker te behandelen is bij s-allel dragers. Tegelijkertijd 
laten 5-HTT-/- ratten een hogere mate van cognitieve flexibiliteit zien dan wildtype 
ratten, de evenknie van de 5-HTT-/- rat met normale 5-HTT expressie; soortgelijke 
cognitieve voordelen worden gezien bij menselijke dragers van het s-allel. Door deze 
dieren bloot te stellen aan verschillende (opeenvolgende) stressoren, en te meten 
welke invloed deze stressoren hebben op gedrag en het brein, is getracht in kaart te 
brengen hoe 5-HTT expressie stress coping en stress coping flexibiliteit beïnvloedt.
In hoofdstuk 2 wordt bezien hoe de uitdoving van geconditioneerde angst wordt 
beïnvloed door interacties tussen de ontwikkelingsfase waarin een individu zich 
bevindt en 5-HTT expressie. Eerder onderzoek in mensen heeft aangetoond dat 
angstuitdoving moeizamer verloopt tijdens adolescentie, wat zou kunnen bijdragen 
aan de toegenomen incidentie van psychiatrische stoornissen tijdens die ontwikkel-
ingsfase. 5-HTT zou hier een sleutelrol in kunnen spelen, aangezien bekend is dat 
diens expressie de neurale ontwikkeling beïnvloedt: 5-HTT reguleert de hoeveelheid 
beschikbare serotonine in het brein, en serotonine is een belangrijke groeifactor 
tijdens de neurale ontwikkeling. De prefrontale cortex (PFC) en amygdala spelen een 
sleutelrol in de conditionering en uitdoving van angst. Mogelijk ontwikkelen deze 
hersendelen zich anders bij verlaagde expressie van 5-HTT. Andere studies hebben 
een andere verhouding van inhibitoire (onderdrukkende) en excitatoire (activerende) 
cellen aangetoond in corticale hersengebieden in 5-HTT-/- dieren. Een dergelijke 
afwijking in de PFC en amygdala zou ten grondslag kunnen liggen aan de verslechterde 
uitdoving van angst in deze dieren. In deze studie zijn 5-HTT-/-, 5-HTT+/- en wildtype 
dieren van pre-adolescente, adolescente en volwassen leeftijd blootgesteld aan een 
angstconditionering protocol. Er werd bekeken wat het effect van 5-HTT genotype en 
leeftijd was op de snelheid waarmee de angstreactie kon worden uitgedoofd. 
Vervolgens werd de populatie inhibitoire neuronen in de basolaterale amygdala en het 
infralimbische gebied van de PFC bepaald door via immunohistochemie het eiwit 
glutaminezuur decarboxylase 65/67 (GAD65/67) aan te kleuren en te kwantificeren. De 
retentie van angstuitdoving, gemeten op de tweede dag van het uitdovingsprotocol, 
was zoals eerder al aangetoond was slechter in volwassen 5-HTT-/- ratten dan in 
5-HTT+/- ratten en in wildtypes. Opmerkelijk genoeg vonden we dit ook in pre-adoles-
cente 5-HTT-/- dieren, maar niet tijdens adolescentie: het lijkt erop dat uitdoving juist 
tijdelijk genormaliseerd is tijdens deze ontwikkelingsfase. GAD65/67 expressie was 
verlaagd in 5-HTT-/- ratten van alle leeftijden.
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Niet-beïnvloedbare stress heeft een sterker negatief effect op het individu dan stress 
die beïnvloedbaar is. Experimenten in de jaren ‘60 hebben al aangetoond dat dieren 
die een ernstige traumatische ervaring hebben gehad met een niet-beïnvloedbare 
stressor, daarna niet of verminderd kunnen ontkomen aan een eenvoudig vermijdbare 
stressor. Dit fenomeen heet “learned helplessness” (aangeleerde hulpeloosheid) en 
wordt gemedieerd door sterke serotonine afgifte in de dorsale raphe nucleus (DRN), 
het hersendeel waar de serotonerge innervatie van andere hersendelen zijn oorsprong 
vindt. Naast een verminderd vermogen tot het aanleren van stressontwijking heeft 
ernstige niet-beïnvloedbare stress ook gevolgen voor geconditioneerde angst: 
conditionering van angst wordt erdoor versterkt en de uitdoving ervan verzwakt. In de 
studie beschreven in hoofdstuk 3 werd bepaald hoe verminderde expressie van 5-HTT 
de effecten van niet-beïnvloedbare stress op angstconditionering en uitdoving beïnvloedt, 
door 5-HTT-/- en wildtype dieren bloot te stellen aan een zware, niet beïnvloedbare 
stressor en vervolgens een geconditioneerde angstrespons te creëren en uit te 
doven. De stressor bleek geen effect op de wildtype dieren te hebben, maar was in 
staat de retentie van de uitdoving van geconditioneerde angst in de 5-HTT-/- ratten te 
normaliseren naar het niveau van de wildtypes. Deze opmerkelijke bevinding suggereert 
dat zware stress ook een therapeutisch effect teweeg kan brengen in sommige 
gevallen, maar nader onderzoek is nodig om het exacte werkingsmechanisme van dit 
effect vast te stellen.
De effecten van beïnvloedbare en niet-beïnvloedbare stress zijn tegengesteld aan 
elkaar: een stressor waarover het individu geen controle kan uitoefenen heeft 
maladaptieve effecten, maar ervaring met een beïnvloedbare stressor kan juist 
beschermen tegen de effecten van toekomstige stressoren en helpen bij de omgang 
ermee. Controleerbare stress activeert de PFC, en zorgt dat deze weer geactiveerd 
wordt bij een volgende stresservaring. Deze activatie van de PFC onderdrukt serotonine 
afgifte in de DRN, wat de maladaptieve effecten van stress zou voorkomen. In hoofdstuk 
4 is beschreven hoe 5-HTT expressie de activatie van de PFC en DRN na beïnvloedbare 
en niet-beïnvloedbare stress moduleert. 5-HTT-/- en wildtype ratten werden tien dagen 
achtereen geleerd schokken te ontwijken door de neus in een sensor te plaatsen 
wanneer er een signaal van toon en licht waarneembaar was. Een niet-beïnvloedbare 
variant van deze stressor werd gerealiseerd door een andere groep 5-HTT-/- en wildtype 
ratten aan dezelfde signalen en schokken bloot te stellen als de eerder genoemde 
groep, maar zonder de mogelijkheid deze te ontwijken. Een niet-gestreste controle 
groep kreeg enkel de signalen gepresenteerd. Vervolgens werden via immunohisto-
chemie serotonine en c-Fos, een eiwit dat kort na activatie van een neuron tot expressie 
komt, zichtbaar gemaakt en gekwantificeerd in de DRN, en enkel c-Fos in de PFC. 
De 5-HTT-/- ratten bleken het ontwijken van de stressor sneller aan te leren dan 
wildtypes. Activatie van serotonerge neuronen in de wildtypes bleek alleen op te 
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treden als de stressor beïnvloedbaar was geweest, terwijl serotonerge activatie in 
de DRN in 5-HTT-/- dieren onder alle drie de omstandigheden (beïnvloedbare, niet- 
beïnvloedbare en geen stress) op hetzelfde, lage niveau bleef. In beide genotypes 
was activiteit in de PFC op gelijke manier verhoogd na beïnvloedbare stress, maar niet 
na niet-beïnvloedbare stress. Er kan geconcludeerd worden dat de DRN in wildtype 
ratten gevoeliger is voor de beïnvloedbaarheid van de stressor dan die van 5-HTT-/- 
dieren. Welke rol de PFC speelt in de verbeterde actieve stress coping van 5-HTT-/- 
ratten wordt uit deze resultaten niet duidelijk.
Stress coping flexibiliteit, het vermogen om de stress coping stijl aan te passen aan de 
situatie, lijkt een belangrijke voorspeller voor iemands mate van stress-gevoeligheid. 
In hoofdstuk 5 wordt besproken hoe 5-HTT genotype de gedragsmatige respons 
op verschillende opeenvolgende stressoren beïnvloedt. Hiertoe werd bij 5-HTT-/- 
en wildtype ratten eerst een Pavloviaanse associatie tussen een toon en een 
onvermijdbare elektrische schok gecreëerd door deze achtereenvolgens te 
presenteren; de controlegroepen kregen hier enkel de tonen gepresenteerd. Een dag 
later werd diezelfde toon gebruikt om schokken aan te kondigen in een “active 
avoidance” gedragsparadigma in een nieuwe, onbekende omgeving, waarbij de ratten 
de schokken kunnen vermijden door tweemaal de kooi over te steken. Vervolgens 
werd in een derde, voor de ratten onbekende omgeving de gedragsmatige reactie op 
de toon gemeten, in afwezigheid van de schokken. In de active avoidance taak 
ontsnapten de ratten uit de controlegroep niet sneller dan de geconditioneerde ratten. 
De passieve coping respons die aangeleerd werd gedurende de conditionering op de 
eerste dag had het aanleren van de ontwijkrespons op de tweede dag blijkbaar niet 
kunnen verhinderen, in zowel de 5-HTT-/- als de wildtype ratten. De 5-HTT-/- ratten 
leerden wederom sneller te ontsnappen dan de wildtypes, conform de bevindingen in 
hoofdstuk 4. Het blootstellen aan de geluidssignalen in een nieuwe context in de 
afwezigheid van schokken resulteerde in een grotere passieve coping respons in de 
wildtype ratten dan in de 5-HTT-/- ratten, blijkens hun langer aanhoudende angstreactie. 
Ook legden wildtype ratten een kleinere afstand af gedurende deze test, wat aan zou 
kunnen duiden dat de aanwezigheid van de toon het exploreren van de kooi 
ontmoedigde. Bij 5-HTT-/- ratten bleek de afgelegde afstand (en daarmee de mate van 
exploratie) afhankelijk van of de ratten waren geconditioneerd op de eerste dag van 
het experiment: deze ratten legden een significant kleinere afstand af dan de 5-HTT-/- 
ratten uit de controlegroep. Dit kan duiden op een grotere gevoeligheid voor de angst-
conditionering in deze dieren met lagere 5-HTT expressie, maar zou ook verklaard 
kunnen worden doordat de mobiliteit van wildtype ratten in de controlegroep al op 
een laag niveau zat, waardoor een verdere verlaging ten gevolge van de conditionering 
niet kon worden gedetecteerd. Duidelijk is dat de verbeterde actieve coping van 
5-HTT-/- ratten leidde tot geringere passieve coping wanneer het stressor-voorspellende 
 Nederlandstalige samenvatting | 173
signaal in een andere omgeving gepresenteerd werd, wat erop lijkt te wijzen dat de 
active avoidance ervaring minder traumatisch was voor de 5-HTT-/- dieren.
De gedragsmatige kenmerken van 5-HTT-/- dieren vertonen sterke overeenkomsten met 
gedrag dat waargenomen wordt in depressieve menselijke patiënten. Het voorschrijven 
van voedingssupplementen met omega-3 meervoudig onverzadigde vetzuren wordt 
gezien als een veelbelovende (co)therapie voor de behandeling van depressie. 
In hoofdstuk 6 werd bepaald of het gedragspatroon van 5-HTT-/- ratten, wat gekenmerkt 
wordt door verhoogde angst, verlaagde sociale capaciteit, en persistentie van gecon-
ditioneerde angst, beïnvloed kon worden door een dieet rijk aan omega-3 vetten. 
Hiertoe werden volwassen 5-HTT-/- en wildtype ratten drie maanden lang op een dieet 
rijk aan visolie gezet, of een isocalorisch controledieet, waarbij de visolie vervangen 
was door soja-, kokos- en maisolie. Vervolgens werden angst, sociaal gedrag en 
uitdoving van de geconditioneerde angstrespons bepaald in alle ratten. Ten opzichte 
van wildtype ratten uit de controlegroep vertoonden 5-HTT-/- ratten die het controle -
dieet hadden gekregen meer angst, minder sociaal gedrag en slechtere uitdoving van 
geconditioneerde angst, in overeenstemming met eerder gerapporteerde bevindingen 
over deze dieren. In 5-HTT-/- ratten die het omega-3 dieet hadden gekregen bleken al 
deze gedragsparameters genormaliseerd naar het niveau van wildtypes, terwijl het 
omega-3 dieet geen effect bleek te hebben op het gedrag van de wildtype ratten. 
 Immunohistochemische aankleuring en kwantificatie van cellen positief voor het eiwit 
dubbelcortine liet zien dat het niveau van neurogenese, de aanmaak van nieuwe 
neuronen in de hippocampus, was verhoogd in 5-HTT-/- dieren die het controle dieet 
hadden gekregen, maar dat dit werd genormaliseerd door het omega-3 dieet. Dit is 
opmerkelijk, omdat depressieve patiënten vaak juist een verlaging van neurogenese 
laten zien, en succesvolle antidepressieve behandelingen vaak samengaan met een 
verhoging ervan. Verondersteld wordt dat de verhoogde neurogenese in 5-HTT-/- ratten 
onderdeel is van een pathologisch compensatiemechanisme.
Concluderend kan gesteld worden dat de gedragsmatige stress coping respons in 
5-HTT-/- ratten sterk afhankelijk is van bepaalde eigenschappen van de stressor. 
Stressoren die weinig mogelijkheden tot interactie (of actieve coping) bieden, zoals 
Pavloviaanse angstconditionering, induceren maladaptief gedrag in 5-HTT-/- dieren. 
Dit wordt gekenmerkt door een aanhoudende passieve angst/coping respons, lang 
nadat het gevaar is geweken. 5-HTT-/- dieren excelleren echter in het omgaan met 
stressoren waarmee ze wel kunnen interacteren, d.w.z. waarbij ze een actieve coping 
respons kunnen aanleren, getuige hun prestaties in de active avoidance paradigma’s 
beschreven in hoofdstukken 4 en 5. De bevindingen beschreven in hoofdstuk 5 
suggereren bovendien dat een actieve stress coping ervaring daardoor minder 
traumatisch is voor 5-HTT-/- dan voor wildtype dieren. Er zijn echter ook tegenstrijdige 
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bevindingen: de niet-beïnvloedbare stressor beschreven in hoofdstuk 3 produceerde 
een adaptieve respons in 5-HTT-/- ratten. De angstuitdoving trad in deze dieren sneller 
op dan in hun soortgenoten die niet aan de stressor waren blootgesteld. Vooralsnog 
is niet bekend welke hersenmechanismen ten grondslag liggen aan het afwijkende 
stress coping gedrag in 5-HTT-/- ratten. De geringere gevoeligheid van de DRN voor de 
controleerbaarheid van stress (beschreven in hoofdstuk 4) suggereert dat de 
serotonerge reactie die volgt op zware niet-beïnvloedbare stress wellicht een kleinere 
rol speelt in deze dieren, en dat de stressor in hoofdstuk 3 wellicht via andere 
mechanismen een uitwerking op latere angstuitdoving heeft. Nadere studies zijn 
echter nodig om dit te bevestigen. Met name het meten van de directe serotonerge 
respons op stress in deze dieren kan hierin informatief zijn. De bevindingen hebben 
mogelijk relevantie voor onderzoek naar stressgevoeligheid in menselijke s-allel 
dragers en de rol die de beïnvloedbaarheid van de stressoren hierin speelt. Er moet 
echter wel benadrukt worden dat er aanzienlijke verschillen bestaan in stress coping 
strategieën tussen mensen en dieren, en dat het trekken van parallellen hiertussen 
niet eenduidig is. Klinische onderzoeken die de relatie tussen stress en psychiatrische 
aandoeningen trachten te beschrijven zouden baat hebben bij een nauwkeuriger 
definitie van de eigenschappen van de stressor en de coping respons erop, terwijl 
preklinisch dieronderzoek naar stress behoefte heeft aan stress paradigma’s die 
traumatische stressoren in mensen nauwkeuriger benaderen.
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Dankwoord
Beste lezer,
Het uitvoeren van een promotieonderzoek kan gezien worden als een potente stressor, 
en zonder adequate coping strategieën zou men er wel eens aan ten onder kunnen 
gaan. Coping doe je niet alleen: zonder de steun van vrienden, familie en collega’s was 
het nog slecht met me afgelopen. Hier wil ik de ruimte nemen om mijn dank te betuigen 
aan iedereen die die me bijgestaan heeft in deze monsterklus: degenen die me 
voorzien hebben van inhoudelijke input en discussie, praktische ondersteuning, 
onderricht in technieken en uiteraard de vele, vele schouders waar ik op heb mogen 
uithuilen als het me allemaal teveel werd: dit hoofdstuk is voor jullie.
We beginnen met mijn promotieteam: Judith Homberg, Marloes Henckens en Tamas 
Kozicz. Judith, ik heb veel bewondering voor je vakinhoudelijk inzicht, maar het zijn je 
doorzettingsvermogen en optimisme die doorslaggevend zijn geweest voor het slagen 
van dit project en de totstandkoming van dit product. Ik weet dat ik niet altijd de 
makkelijkste promovendus geweest ben, en ik heb veel waardering voor het geduld en 
de zachtzinnigheid waarmee je een koppige en recalcitrante PhD hebt bejegend. 
Bedankt voor het vertrouwen dat je in me hebt gesteld door me dit project te laten 
doen, en alle ruimte die je me ervoor hebt gegeven! Marloes, jij kwam er wat later bij 
maar je stempel op dit project was onmisbaar en onmiskenbaar. Jouw creatieve 
inbreng heeft het onderzoek naar een hoger plan getild, en je enthousiasme voor het 
onderwerp is aanstekelijk. Ik ben trots jouw eerst-begeleide PhD student te mogen 
zijn, en ik weet zeker dat je het nog ver gaat schoppen (zeker met die Nature paper die 
we nog gaan schrijven.. nog één kleuring om het af te leren!). Bedankt dat ik jullie 
overdag, ’s nachts, tijdens jullie weekenden en vakanties, congressen en huwelijksreis 
heb mogelijk lastigvallen met vragen! We hebben nog flink wat in de pijplijn zitten dus 
ik hoop ook de komende tijd op prettige en productieve samenwerking. Tamas, heel 
hartelijk dank dat je mijn promotor hebt willen zijn. Ik heb veel gehad aan de discussies 
die we hebben gehad over onverwachte resultaten, de sturing van het project en zaken 
die niets met wetenschap te maken hebben. Ik wens je heel veel succes en goeds als 
professor bij de afdeling Anatomie!
A special word of thanks goes out to the members of the manuscript committee, Tansu 
Celikel, Indira Tendolkar and Daniel van der Hove. Thank you for the taking time to 
review this manuscript and for agreeing participate in the thesis defense committee.
De onderzoeksgroep is flink uitgebreid sinds ik op mijn eerste werkdag met mijn 
lotgenoten het rommelhok in het dierenlab mocht ombouwen tot werkkamer, met lood- 
zware bureaus en laboratoriumwerkbanken van de “spullenhulp” van het ziekenhuis. 
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Daar, en in de daaropvolgende kantoren op diverse plaatsen in de prekliniek van het 
Radboudumc, heb ik lief en leed gedeeld met de harde kern van de groep Homberg. 
Allereerst Anthonieke, onze onwrikbare analist; je draaide je hand niet om voor mijn 
onredelijke verzoeken voor enorme groepen dieren en mega-genotyperingen op het 
laatste moment, je hebt me ontelbare keren uit de brand geholpen. Ik hoop dat je de 
viool nog eens oppakt, dat is te mooi om te laten liggen! Medepromovendi Yvetje 
Kroes, Peter Karel, Noortje, Deborah, Rick, Stephanie en Yacine: bedankt voor alle 
gezelligheid en samenwerking. Een biermenu van de Aesculaaf is teveel voor één 
persoon, bedankt dat jullie ze met me wilden delen! Van cocktails in een verwarmd 
zwembad in San Diego tot plankwedstrijden op de vieze vloer van het Cognitive 
Neuroscience PhD hok tot verkleedpartijtjes in Oss: ik koester de herinneringen. Jullie 
zijn inmiddels allemaal min of meer bij de laatste loodjes aangekomen, dus nog even 
de kiezen op elkaar: achter de wolken schijnt de zon, er is licht aan het einde van de 
tunnel, en meer van zulks. Elisavet and Giuseppe: thanks for the good times. All the 
best for the last bits of your PhD project and what comes after. Don’t get scammed by 
uncle Lucas!
Lourens, hartelijk dank dat ik van je ervaring (en je houtje-touwtje troep) gebruik heb 
mogen maken. Mijn project bouwde grotendeels voort op het jouwe, maar of ik de 
kwalificatie Lourens 2.0 waar heb kunnen maken..  Aan de kwaliteit van onze interactie 
heeft het in ieder geval niet gelegen, laten we snel nog eens een bitter, bitter biertje 
drinken! Michel, likewise, hartelijk dank voor je steun en adviezen over hoe de 
wetenschap en de wereld werken. Jammer dat we die microdialyse uiteindelijk niet 
hebben kunnen doen, maar zeg nooit nooit! Aan jou en Moppie alle goeds gewenst in 
Malden, de mooiste en bruisendste stad op aard. Jozevus van Hulten, ik ben u zeer 
erkentelijk voor de hulp in barre tijden, en het gezelschap in goede tijden. Als ik weer 
eens bang was voor een iets groter uitgevallen ratje was jij nooit te beroerd om hem 
voor mij een prikje (of erger) te geven. 
Ook bij andere CNS onderzoekers sta ik in het krijt. Bijvoorbeeld bij de onderzoeks-
groep van Benno Roozendaal: Benno, hartelijk dank dat we uit je ervaring en kennis 
mochten putten, binnen en buiten de pizza-meetings; ik heb veel van je geleerd. Je 
proefschrift ligt nog immer op mijn nachtkastje en als ik de slaap niet kan vatten vind 
ik er altijd troost en inspiratie in. Very special thanks to Piray Atsak: aside from teaching 
me useful techniques (surgery, telemetry, mojito) and helping me understand my data, 
you’ve been a great friend. I’m sorry I haven’t been in touch lately, let’s catch up soon! 
Erica, thanks for the great talks, rarely have I met a more passionate scientist than 
yourself. Evelien, succes met je 13-urige operaties met drie verplichte assistenten en 
twee proefdierdeskundigen die in je nek hijgen, hou het hoofd koel. Areg.. stay strong!
Andere collega’s aan wie ik veel te danken heb: Dirk Schubert, hartelijk dank voor je 
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input bij mijn kleuringen en het gebruik van de Neurolucida (en aan Moritz voor de 
uitleg!). Sharon Kolk, jij hebt het rijk der fluorescentie voor me geopend: het was niet 
alleen een visueel spektakel maar ook op wetenschappelijk vlak heel nuttig. Irene 
Otte-Holler, jij hebt me geleerd hoe ik die prachtige kleuringen vakkundig en efficiënt 
kan fotograferen. Erno Hermans en Floris Klumpers, heel hartelijk dank voor jullie 
ondersteuning in het analyseren van humane puls-oximetrie data, ik vond het erg leuk 
om een stukje van de humane kant in mijn onderzoek te krijgen (wordt vervolgd!). 
Tansu Celikel, thanks for getting me into MATLAB! Even though the program I made 
then wasn’t used in the end, the experience remains useful to me up until the present 
day. Karin Roelofs, bedankt voor je input in het linken van onze bevindingen in ratten 
aan die van mensen: ook daar hoop ik in de toekomst nog meer invulling aan te geven. 
Charlotte Oomen, ik wens jou en Poekie alle goeds! Also thanks to: Shaggy Abghari, 
Marco Benevento, Baha Kasap, Linda de Voogd, Isabella Wagner, Ruud Berkers, 
Guillen Fernandez, Hans van Bokhoven, Annemarie Hoppenreijs, David de Louw, Marieke, 
Ellen en Renée, Martha and Abdel, Armaz, Aron en Nikkie, Frouwke, Roald Maes, 
Marco Riva and Francesca Calabrese, en Karin, Maikel, Wilma, Janneke en vele anderen 
van het CDL.
Veel van het immunohistochemisch werk heb ik mogen doen in het lab van de afdeling 
Anatomie, waar ik sinds mijn bachelor-stage kind aan huis ben. Daarbij heb ik kunnen 
rekenen op de steun van Jos Dederen en Bram Geenen. Jos, jouw decennialange 
ervaring op het gebied van immunohistochemie en weefselverwerking heeft me vaak 
uit de brand geholpen. Bram, jouw kunde op het gebied van fluorescentie heeft talloze 
nieuwe mogelijkheden voor ons onderzoek geopend. Amanda, jij hebt tijdens mijn 
bachelor stage mijn interesse om wetenschapper te worden aangewakkerd. Of dat 
iets is om dankbaar voor te zijn zullen we in het midden laten, maar laat ik het in ieder 
geval benoemen. Waar ik je zeker dankbaar voor ben is onze samenwerkingen en 
onze informele gesprekken, ik vond het altijd erg leuk om je te storen. Voor nu zeg ik 
de academie gedag, maar mocht het bloed kruipen waar het niet kan gaan, dan klop 
ik misschien wel weer eens bij je aan. Het ga je goed! Max, Diane, Carola, Ilse, 
Maartje, Tim, Teun en Valerio: bedankt dat ik jullie van je werk mocht houden tussen 
het kleuren door.
Over de tijdsspanne van mijn promotie heb ik het genoegen gehad een aantal 
studenten te mogen begeleiden. Het zijn er teveel om ze allemaal op te noemen, maar 
een aantal wil ik hier nog even apart bedanken. Dora Lopresto, the fact that you appear 
on nearly all my publications is clear evidence of your excellent contributions to the 
research. After recovering from a near-death vegan experience, you stayed on for a 
full year, helping out with nearly everything that’s written down in this book, and some 
things yet to be published. You’re the best! Roy, wat hebben we een prachtige 
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experimenten uitgevoerd in de medische archiefkast van gebouw D. Suggestief als 
bovenstaande zin klinkt, zonder jou had hoofdstuk 4 niet bestaan. Jeffrey Martin, 
thank you for helping me commit an administrative felony. I just wanted to get that it in 
writing here. Bart Borghans, Willem Cox, David de Leest, Jana van Luttikhuizen, Valerie 
Koeken, Maud Plouvier, Jesse Stoop, Joep Joosten, Leoni Creemers, Margot Gerritse, 
all the Italians (Ciccio Bombo loves you) en anderen, allen hartelijk dank!
Nietzsche, Jeffrey, Christian and a slew of temporary drummers (sorry it didn’t work 
out) of the band erstwhile known as Luxury Perfusion and a bunch of not so wholesome 
names later on, thank you for putting up with my tantrums and diva behavior. 
Oprichters en redactie van het wetenschappelijk blog Donders Wonders (Lieneke, 
Alina, Romy, Jeroen, Richard, Jeanette, Susanne, Julian, Annelies en anderen), hartelijk 
bedankt voor de prettige samenwerking. We hebben iets moois van de grond getild! 
Mark en Ingrid, Wibout en Veronique (en junior reuper Olivia!): bedankt dat jullie zo 
regelmatig tijd hebben uitgetrokken om naar mijn gewauwel over rattenonderzoek te 
luisteren. Dikwijls kwam het voor dat ik, terwijl ik laat in de avond of in het weekend 
met mijn diertjes in de weer was, bij mezelf dacht: was ik ook maar oliemagnaat of 
bus- en trambaron geworden. Echter, het werk is gedaan en de payoff is eindelijk hier. 
Niet in de vorm van een hoog salaris of maatschappelijke status, maar het recht om 
jullie er tot in lengte van dagen aan te herinneren dat jullie tot de laagst opgeleide 
mensen in mijn kennissenkring behoren. Ha! Schertsen terzijde, bedankt voor jullie 
steun, inzichten, prachtige discussies en kameraadschap; ik hoop deze zaken nog 
lang met jullie te mogen delen. Reupers 4 life!
Mijn BMW kameraden, het Radboudumc lunch-team en het genootschap Mannenavond 
(drie instituten met overlappende lidmaatschappen): Thomas en Sanne, Kim en Emile, 
Mark, Roddy, Marlijn en Martijn, Duby en Viola, Lard en Josje, Christiaan en Lieke, 
Maarke en Schattiemans, Arie en Floor de Beukelaar, bedankt voor de mooie tijden. 
Thomas en Christiaan, zeer gerespecteerde en geliefde paranimfen, hartelijk dank dat 
jullie deze verantwoordelijkheid op je hebben willen nemen. Ik zal mijn uiterste best 
doen om jullie niet voor schut te zetten op de grote dag. Verder dank aan: Marieke van 
de Belt, Dominik Kiser, Jessica en Eva, Onnies, Sjors en Thiele (en de rest van Dispiet) 
en deernes Lotte, Hedwig, Laura en Martine.
Aan de gehele familie Schipper, met voorop mijn vader, mijn zusters Anna en Kitty, en 
natuurlijk Vincent en baby Floris: ik heb geboft met jullie. Ik ben dan geen tandarts 
geworden, maar Schipper is nu wel een gevestigde naam in de neurowetenschap.. min 
of meer. Bedankt voor alles!
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Lieve Ellen, er is niets wat ik hier op kan schrijven wat recht zou doen aan hoeveel je 
voor me betekent. Je bent de liefste, ik hou van je!
Donders Graduate School for Cognitive Neuroscience
For a successful research Institute, it is vital to train the next generation of young 
scientists. To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour 
established the Donders Graduate School for Cognitive Neuroscience (DGCN), which was 
officially recognised as a national graduate school in 2009. The Graduate School covers 
training at both Master’s and PhD level and provides an excellent educational context 
fully aligned with the research programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of 
the best and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, 
e.g. Stanford University, University of Oxford, University of Cambridge, UCL London, 
MPI Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, 
North Western University, Northeastern University in Boston, ETH Zürich, University of 
Vienna etc.. Positions outside academia spread among the following sectors: specialists 
in a medical environment, mainly in genetics, geriatrics, psychiatry and neurology. 
Specialists in a psychological environment, e.g. as specialist in neuro psychology, 
psychological diagnostics or therapy. Positions in higher education as coordinators 
or lecturers. A smaller percentage enters business as research consultants, analysts 
or head of research and development. Fewer graduates  stay in a research environment 
as lab coordinators, technical support or policy advisors. Upcoming possibilities 
are positions in the IT sector and management position in pharmaceutical industry. 
In general, the PhDs graduates almost invariably continue with high-quality positions 
that play an important role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit: 
http://www.ru.nl/donders/graduate-school/phd/
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